Chromatin Topology and Transcription in Myogenesis by Fisher-Aylor, Katherine Irene
  
 
Chromatin Topology and Transcription in 
Myogenesis 
 
Thesis by 
Katherine I Fisher-Aylor 
 
In Partial Fulfillment of the Requirements for the 
degree of 
Doctor of Philosophy 
CALIFORNIA INSTITUTE OF TECHNOLOGY 
Pasadena, California 
2017 
(Defended August 19, 2016) 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2017 
Katherine Irene Fisher-Aylor 
ORCID: 0000-0003-3371-2947 
All rights reserved 
 
iii 
Acknowledgments Page 
 
  
iv 
Abstract 
 
 
High-throughput sequencing and the resulting development of biochemical “-Seq” 
experiments such as ChIP-Seq, DNase-Seq, and Methyl-Seq over the past decade has 
given rise to a wealth of predicted enhancers and other cis-regulatory regions (CRMs).  
These new assays provide a new opportunity to compare the number, location, and 
possible nature of CRMs that are predicted by various new biochemical techniques to 
instances of known CRMs, which until recently have primarily been located—for reasons 
of technological limitations—at a few tens of highly expressed, mostly developmentally-
specific genes and the several kilobases (kb) upstream of their promoters.  For example, 
an early surprise in the first ChIP-Seq experiments was that the number of predicted 
tissue-specific transcription factor-occupied sites outnumbered the number of tissue-
specific genes by at least a factor of 10, and that many of these occupied sites were 
nowhere near developmentally relevant genes.  In this thesis, I use the ChIA-PET 
technique, which preserves factor-containing physical interactions between loci in the 
genome that are far from each other (10kb-2Mb), where the factors used in this thesis 
are RNA Polymerase II (pol2) to capture active genes, and separately the developmental 
transcription factor Myogenin to additionally capture CRMs not at promoters.  Overall, I 
report that (1) the closer together two occupied regions are, the more likely they are to 
be connected, and (2) that a gene’s activity level is highly correlated with its likelihood of 
being physically engaged with a distant occupied locus.  These lead to the discoveries 
that occupied regions tend to engage with the active genes nearest to them regardless 
of the developmental profile of the genes, that many genes engage with multiple 
individual loci, and that many occupied regions interact with multiple genes, including 
genes that are not at all related in terms of their expression patterns.  Individual 
elements that have multiple connections likely represent sequential rather than 
simultaneous interactions, and developmental genes may require more engaged 
enhancers than genes that are expressed in all cell types.  Most excitingly, it is possible 
that many genes with unchanging expression patterns, including so-called 
“housekeeping genes,” use CRMs; very few such genes have ever been assayed with 
respect to gene regulation, and they are the vast majority of genes in the genome.  
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Chapter I: Introduction 
I.1: Overview  
 This project aims to map the physical landscape of DNA interactions that are 
associated with key regulatory molecules, and to relate the resulting map to changes in 
gene regulated across muscle differentiation.  A specific goal was to use a genomic 
assay to define the genomic repertoire of distally located candidate cis-acting regulatory 
elements in myoblasts and myocytes and to learn how they associate with each other 
physically.  To do this, I refined and made much more sensitive and robust an assay that 
was then in its early stages of development, called ChIA-PET (chromatin interaction 
analysis by paired-end tag sequencing).  This method is designed to detect complexes 
that join relatively long-distance interactions (10kb-2Mb) and also contain a regulatory 
protein of interest.  Here, the proteins I investigate are RNA polymerase II (pol2), which 
transcribes protein coding and lnc RNAs; and myogenin, a major tissue specific 
transcription factor necessary for muscle differentiation.  
 A longstanding model for transcriptional regulation in large eukaryotic genomes 
centers on specific physical looping events that are thought to join active transcriptional 
enhancer elements with their proximal promoters.  As summarized below, this textbook 
model (Fig. I-1) had been built up beginning in the 1980s mainly by dissecting a 
relatively small set of “model” genes in increasing detail. The focal genes for this work, 
such as the globins, immunoglobulins, interferon, or in my myogenesis system, muscle 
creatine kinase (MCK), actin and MyoD, had not been selected randomly from the 
genome.   Rather, they had become central because they were either especially 
accessible technically or were thought to be exceptionally interesting due to the function 
of their protein product – most often both.   
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 As I began my thesis work, new methods had just been developed to map the 
entire genome for biochemical signatures associated with gene regulatory elements in 
the DNA, and to detect physical contacts between sites on the chromosome. The 
regulatory elements, called cis-acting regulatory modules (CRM), contain clusters of 
binding sites for sequence specific DNA binding proteins, and those proteins can in turn 
engage a variety of cofactors and chromatin modifying enzymes.  CRMs are understood 
to alter transcription at their target promoters through mechanistically diverse actions of 
their bound protein complexes.  As reviewed below, these interactions were thought to 
be mainly focused on the nearest promoter in DNA space, although it was well 
appreciated that some long distances in DNA-space could be bridged  (1MB for a limb 
shh enhancer) and there is evidence for a few cases of cross-chromosomal regulation 
(transvection) which might or might not be a special instances of conventional CRM 
function.  The functional impact of a CRM is defined operationally for each given cell 
type and state, where its net effect will be to activate (enhance) or repress (silence) 
productive transcription from a target gene. A third function is insulation.  An active 
insulator can prevent an enhancer positioned on one side from affecting a promoter 
located on the other side of the insulator.    
 What I found was exciting because it made me question some established ideas 
about transcriptional enhancement and also our way of thinking about the distinctions 
made previously between so-called housekeeping genes and other genes that are 
aggressively regulated during differentiation.  
I.2: The origin of the CRM as a distinct concept 
 Cis-Regulatory Modules (CRMs) are elements in the DNA which affect 
transcription of a targeted promoter, but which are not themselves promoters.  They are 
currently divided into three major types: enhancers, insulators, and silencers, and are 
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made up of DNA binding sites for a variety of sequence-specific DNA binding proteins.  
These proteins in turn engage a variety of transcriptional co-factors and chromatin 
modifying enzymes which enable or inhibit transcription.  The promoter is the DNA 
sequence which enables correct transcription of a gene, and the functional impact of a 
CRM is defined operationally for each given cell type and state (and, perhaps in the 
future, for each different promoter), where its net effect will be to increase transcription 
(enhance), decrease transcription (silence), or protect transcription from the effects of 
enhancers and silencers (insulate).   
It is useful to introduce these four entities as distinct concepts because the 
experimental history distinguishing them underlies much of our current thinking whether 
we realize it or not: those who worked during this era or have studied the original 
literature likely realize where the empirical definitions end and the models and their 
correlates begin.  However, in some contemporary papers, it seems that the definitions 
have drifted in ways that can be confusing or even circular.  It is also useful to recognize 
the molecular basis for our current knowledge before delving into a discussion of how, 
excitingly, the clear-cut distinctions between the four entities become blurred as we learn 
more about the complexities of gene regulation. An important example is that it is 
conceptually difficult at times to draw lines between where a promoter ends and a CRM 
begins. In the muscle system studied here, some known CRMs have elements of more 
than one molecular mechanism that operate in different cells or cell states (e.g., 
Berghella, De Angelis et al. 2008).  I find it most exciting that large-scale genome 
mapping data like mine can be analyzed to build testable models for CRM sub-classes 
or to, in some cases, refute existing models.  It is possible that not all CRMs of a type 
behave in the same way as each other, and CRMs of one type may have more in 
common with CRMs of another type, or with promoters, than previously imagined.  
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I.2.1: Experiments and prior knowledge of the early CRM era 
 In the early 1980s, at the birth of CRMs as a concept, there were enough 
biochemical techniques to do excellent single-locus gene studies, but there were no 
genomics and any sequencing at all was slow and expensive.  Some widespread 
experimental techniques for studying molecular genetics were, for DNA sequencing, gel-
style Sanger sequencing (e.g., Schaffner, Kunz et al. 1978); for quantification of 
transcription at the mRNA level, Rot curves and Northern blot quantification (e.g., Wold, 
Wigler et al. 1979) and later transfection assays such as CAT; and for gene knock-in and 
knock-out experiments, transfections of recombinant plasmids into cultured cells (Wigler, 
Sweet et al. 1979; Wold, Wigler et al. 1979).  It was the DNA sequencing and mRNA 
quantifications that made things most difficult for scientists of the time.  This was well 
before the sequencing of the human, or any, genome, and DNA sequencing was 
extremely slow.  Similarly, the cDNA quantifications necessitated studying genes with a 
very high level of transcriptional output at the level of mRNA.  Taken together, this meant 
that although many at the time knew this would give them a biased view of regulation 
across genome, molecular genetics studies had to focus on (1) genes that stood out by 
classical genetics because their mutation and phenotype allowed their cloning and focal 
interest; (2) genes with extremely high mRNA levels, making them technically more 
accessible; (3) genes strongly expressed in organisms or cell types easy to culture; (4) 
the region of each gene that is the proximal promoter and areas very close to it (usually 
within 2-5kb), since the search for enhancers typically ended after finding one; and (5) 
using large cloned regions of DNA, which made it difficult to find small functional 
elements and to differentiate between the effects of neighboring elements. 
 Enabling the discovery and working definition of the “enhancer,” the promoter 
was already a reasonably defined functional DNA element type. In the early 1980s, 
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promoters had been studied for over a decade in the context of several important genes 
of simpler organisms.  Bacterial promoters such as in the lac operon in E. coli (e.g., 
Kennell and Riezman 1977), and viral promoters such as lambda phage cI (e.g.,  
Hochschild, Irwin et al. 1983) and T7 phage A3 (e.g., Siebenlist, Simpson et al. 1980) 
were among the first genes studied.  Then genes such as cytochrome C from single-
celled eukaryotic yeast (e.g., Faye, Leung et al. 1981) and genes of animal cell viruses 
such as tk from herpesvirus (e.g., McKnight, Kingsbury et al. 1984) and T-antigen from 
simian virus 40 (e.g., Gluzman, Sambrook et al. 1980) paved the way for the study of 
endogenous genes of animals such as H2A in sea urchin (e.g., Grosschedl and Birnstiel 
1980a,b) and globin genes in rodents (e.g., Wold, Wigler et al. 1979).  The question in 
these early animal studies was to see how the expression of animal genes in large 
genomes differed or was similar to smaller genomes like yeast and to constrained 
genomes in bacteria and viruses.  In asking this question, the first enhancer sequences 
were found. 
I.2.2: Promoters 
 Because CRMs are defined in relation to their own promoter(s), affecting 
promoters without themselves being promoters, it is necessary first to understand what a 
promoter is and then to define its specific meaning for the purposes of this work.  There 
are a number of different overlapping and context-specific uses of the term “promoter” 
when it comes to discussing promoter DNA sequence content: minimal promoter, core 
promoter, basal promoter, proximal promoter, and more.  However, the biochemical 
definition of a promoter – DNA sequence proximally upstream of a gene that is 
necessary for the proper mRNA expression of that gene – has remained constant even 
as we have learned about the diversity of promoter sequences.  Another aspect of the 
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promoter that has remained unchanged throughout history is that promoters are thought 
to be uni-directional.   
 An efficient, conserved bacterial promoter had been found (Siebenlist, Simpson 
et al. 1980), but it was clear that there would be no such consensus sequence for an 
eukaryotic promoter.  The TATA box was discovered (Goldberg, 1979, Stanford PhD 
thesis) which turned out to be necessary for transcriptional initiation of approximately 
30% of genes, including the most developmentally regulated genes and most highly 
expressed (reviewed in Breathnach and Chambon 1981), while the more numerous 
TATA-less genes were thought mainly to control low-level housekeeping genes 
(reviewed by Dynan 1986).  In similar genes, it was found that TATA was not sufficient to 
support transcription on its own (necessary for fixing the proper transcriptional start site 
and direction, but not sufficient to power transcription), while sequences ~75-150bp 
upstream were necessary for initiation itself and proper stabilization of the mRNA 
product (Benoist and Chambon 1981; Dierks, van Ooyen et al. 1981).  Various 
bidirectional (Grosschedl and Birnstiel 1980) sequences such as the CCAAT box and 
the GC box were found upstream of the TATA box which partially but not completely 
explained some of these requirements (Grosschedl and Birnstiel 1980a,b; Dierks, van 
Ooyen et al. 1983).   
 The lack of a fully functional consensus promoter sequence, or sequences, in 
large metazoan genomes is due in part to finding many different variations of promoter 
sequences and corresponding transcriptional machinery that are used to achieve 
“necessary and sufficient” status for proper transcription initiation.  Also, we appreciate 
now that elongation, termination and control of turnover all affect mRNA output from both 
native genes and reporter genes.  This becomes relevant in future chapters when I test 
for correlations of candidate CRM and promoter connectivity with measured RNA output.   
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 Things that remain unknown or ambiguous about the full range of promoters in 
the genome and about how they work mean that in the following chapters I have to 
select and use the most appropriate definition and then clarify the ramifications of that 
choice.  For the results and conclusions of this thesis, this biochemical definition of the 
promoter is approximated by the use of the gencode M1 annotated TSSs, which uses 
protein, mRNA, and ncRNA sequences to make a set of biologically derived, 
informatically predicted TSSs.  
I.2.3: Enhancers 
 By studying the operation of viral promoters in eukaryotic cells, the first enhancer 
element was isolated from DNA of simian virus 40 (Banerji, Rusconi et al. 1981; Benoist 
and Chambon 1981; Gruss, Dhar et al. 1981).  It was named as an enhancer and 
recognized as its own conceptual class of regulatory element (Banerji, Rusconi et al. 
1981) based on its action in a gain-of-function plasmid transfection experiment: to 
increase transcriptional output of a nearby reporter gene.  “Enhancer” was then and is 
still an assay-specific term.  Upon studying known enhancers, many properties were 
found in most or all of them, but it is important to remember the distinction between the 
definitional description of “enhancer” (an assay-specific biochemical definition) and the 
characteristics observed to associate with them in subsequent one-off enhancer studies.  
It is not always clear, when the term “enhancer” is used, which enhancer characteristics 
are definitional and which are observational.  It was found that enhancers bind 
transcription factors, often more than one type, and that they affect promoters by 
interacting with them physically.  However, the observed characteristics of enhancers do 
not operate commutatively: not all reproducibly factor-occupied DNA sites and not all 
sites that interact physically with genes will act as enhancers on their own.  This is true 
both in the modern-day versions of the first enhancer assays, which are gain-of-function 
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experiments, and in the smaller but growing set of loss-of-function mutational assays. I 
will therefore refer to factor binding sites and physically associated regions where 
appropriate as “candidate CRMs” to be agnostic. 
 The first set of enhancer characteristics were described in 1983: (1) they act in 
cis- to increase transcription of a promoter, (2) they can be 3’ or 5’ relative to the 
promoter, (3) their sequences can be flipped; they are non-directional, (4) they are able 
to act on different promoters (Mercola, Wang et al. 1983).  These four descriptive “rules” 
encompassed the actions of the handful of known enhancers that had been studied in 
the preceding few years, but did not change the underlying assay-specific definition of 
“enhancer.”  To wit, the first cellular enhancers were then found, proving that there were 
at least a few enhancers in eukaryotic genomes, and that enhancers were not a virus-
specific phenomenon (Mercola, Wang et al. 1983; Neuberger 1983; Weber, de Villiers et 
al. 1984).  Based on these studies, the descriptive “rules” in common between 
experimentally validated enhancers changed: (1) they act in cis- to increase transcription 
of a promoter, (2) they can be 3’ or 5’ relative to the promoter, overlapping with 
promoters (Weber, de Villiers et al. 1984), or in an intron (Gillies, Morrison et al. 1983), 
(3) non-directional, (4) preferentially stimulate the closest of two promoters, (5) they can 
be cell type preferential (Gillies, Morrison et al. 1983) and inducible (Serfling, Lubbe et 
al. 1985; reviewed by Serfling, Jasin et al. 1985).  Since only aspects (1) and (3) are 
definitional—enhancers are non-promoter cis- elements that have a measurably positive 
effect on promoters in assay—all of the other “rules” were and are observational and are 
likely to change or to apply to subsets of the overall “enhancer” group as we discover 
and learn more about thousands of enhancers. 
 Some of the major questions at the time of enhancer discovery were whether 
enhancers can or do act in cis- only, or also in trans- (i.e. how important was the DNA 
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backbone in how enhancers acted?) and also whether enhancers acted by looping or by 
somehow scanning along the DNA.  Evidence for the existence of some scanning-like 
behavior (then posited to be pol2 crawling along the DNA backbone) included “barrier” 
experiments that impeded enhancement by positioning a chemical barrier in the DNA 
between enhancer and promoter (Brent and Ptashne 1984; Plon and Wang 1986) and a 
persistent bias in enhancers to their action on closer promoters (Muller, Gerster et al. 
1988).  Scanning via gyrase activity of pol2 had been ruled out (Plon and Wang 1986), 
but the barrier experiments and the closest-promoter bias were still reasonably strong 
evidence in favor of some sort of scanning-like behavior, if not by pol2 then by 
something else.  There was also circumstantial evidence that looping was possible in the 
distances between known enhancers and promoters, though.  Looped-out DNA had 
been visualized near active genes in prokaryotes (Griffith, Hochschild et al. 1986; 
Kramer, Niemoller et al. 1987) and then in eukaryotes (Theveny, Bailly et al. 1987).  
 Both of these debates – on the necessity to be linked in cis- on the chromosome, 
or for polymerase to scan through DNA, separating an enhancer spatially from its target 
promoter – ended in 1989 when it was shown that enhancers could act in trans- via a 
protein bridge to the promoter (Muller, Sogo et al. 1989).  It was accepted that while 
some enhancers may possibly act by different methods, the “enhancer effect” did not 
require cis- (past the fact that its sequence is DNA), only trans-, because enhancers and 
promoters could loop to interact with each other physically.  The looping model of 
enhancement predominated (Muller and Schaffner 1990). Essentially, enhancers can, at 
least in some instances, act in cis- or in trans-, in cis- because they are DNA sequences 
and thus subject to certain constraints of the DNA backbone and location in the nucleus 
and in trans- because enhancers act on promoters in 3D, the DNA sequences of both 
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the enhancer and the promoter providing a scaffold for the formation of a protein bridge 
between them. 
 Assuming the looping model of enhancement, what variety of cis- elements will 
be connected to active genes?  Will the interactions be simple or complex?  Will 
differentially expressed, highly expressed, or well-studied genes be connected any 
differently than other genes in the genome?   
I.2.4: Transcription Factor Interactions at CRMs and Promoters 
 Shortly after the discovery of enhancers, it was noticed that a certain motif in the 
DNA was present in many enhancers as well as in many promoters (McKnight 1984).  In 
studying this motif, it was proposed that some factor might occupy it in order to cause a 
bridge between the enhancer and promoter.  It was then found that a protein, called Sp1, 
did indeed recognize the identified DNA motif (Gidoni, Dynan et al. 1984).  Proteins of 
this type were called transcription factors, and transcription factors were shortly found in 
every system studying transcriptional regulation.  One interesting seeming paradox that 
was discovered early (Muller, Gerster et al. 1988) and seldom remarked upon, although 
it has been demonstrated in a variety of systems, is that general transcription factors can 
seemingly regulate tissue-specific genes while tissue-specific transcription factors can 
seemingly regulate constitutively active genes.  For example, the muscle-specific factor 
myoD occupies sites in and near muscle-specific and constitutively active genes alike 
(Cao, Yao et al. 2010; Kwan G and Wold B, unpublished), and so do more ubiquitous 
transcription factors such as USF1, Jun/Fos, and E-proteins (Fisher-Aylor K, Marinov G, 
Kwan G, Desalvo G, Kirilusha A, and Wold B, unpublished; Kirilusha A 2014 thesis).  In 
worm muscle, the myoD homolog HLH1 caused changes in both muscle-specific and 
constitutively active genes when knocked out (Kuntz, Williams et al. 2012). 
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Other factors to consider when thinking about chromatin and gene expression 
 It is not just enhancers that interact with genes – far from it.  While enhancers 
have attracted the most attention, partly because of the relative ease of the most-used 
assays, two other classes of elements, sometimes co-occurring with enhancer elements 
in compound CRM sequences, are also important in gene regulation and in the 
interpretation of data in this thesis. 
I.2.5: Insulators 
 Since the late 1970s, it had been noticed that the chromatin state – active or 
inactive/silenced – as assayed by nucleosome accessibility and core histone tail 
acetylation, was closely and perhaps causatively related to gene expression.  In studying 
this, the concept of the insulator was born.  The first insulator work was done in 
Drosophila, on scs and scs’, two elements marking the end of an active chromatin region 
around hsp70 (Udvardy, Maine et al. 1985).  These elements and a similar element, 
gypsy, were tested in gain-of-function transfection assay.  It was found that these 
elements had two characteristics in common: they protected elements from their 
neighboring chromatin environment, and they also protected a promoter from 
enhancement by an enhancer (Kellum and Schedl 1991). 
 The ability of certain elements to block enhancement of a promoter had been 
noticed before: first, in the original enhancer paper by inclusion of a long stretch of un-
sequenced DNA (Banerji, Rusconi et al. 1981) and then by two experiments that sought 
to differentiate between the looping and scanning models of enhancement by adding a 
biochemical road block in between the enhancer and the promoter (Brent and Ptashne 
1984; Courey, Plon et al. 1986).  However, this was the first time such an element had 
been found in an organism itself, with at least one apparent function: serving as a border 
between chromatin states.  The first insulators in vertebrate were also isolated and 
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described (Chung, Whiteley et al. 1993) from previously described sharp transitions in 
chromatin state near the chicken β-globin locus (Hebbes, Clayton et al. 1994). 
 It was found that insulators acted as barriers to polycomb-group repression 
(Mallin, Myung et al. 1998).  They were also found to act as barriers to DNA replication 
(Wiesendanger, Lucchini et al. 1994), including imprinting-specific replication (Greally, 
Starr et al. 1998) and that some MARs acted as insulators (Namciu, Blochlinger et al. 
1998) and co-localized with the gypsy insulator in the nucleus (Nabirochkin, Ossokina et 
al. 1998).  It did not take much imagination to wonder if this bordering or blocking 
mechanism acted similarly in all cases, particularly with respect to the blockage of 
enhancers, and particularly since insulation can be directional (Chung, Bell et al. 1997) 
and can seemingly prevent enhancers from acting in trans- (Krebs and Dunaway 1998). 
A major hypothesis of the time was that factors binding to insulators may disrupt the 
assembly or stabilization of a trans- E:P complex, particularly through the Chip or Ldb1 
family of factors (Morcillo, Rosen et al. 1997). 
 Upon studying insulators, proteins that bound them were found.  The first were 
suppressor of hairy wing (Nabirochkin, Ossokina et al. 1998; Gerasimova, Gdula et al. 
1995), bithorax, and trithorax (Gerasimova and Corces 1998) in Drosophila.  Similar 
proteins were found in other systems.  The role(s) of insulators are therefore similar to 
other CRMs in the way they bind proteins.  The ways that insulators have been 
demonstrated to affect transcriptional activation are various and conceptually relate 
transcriptional regulation to chromatin states and chromatin conformation. 
I.2.6. Chromatin, LADs/LASs, MARs/SARs 
 It was later found that SATB1, a homeobox protein which associates with the 
nuclear matrix, also recognizes a non-specific “secondary” DNA binding motif made up 
of ~25bp A/T-rich non-palindromic sequence, and that SATB1 is the likely mediator of 
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DNA-nuclear matrix interactions (Nakagomi, Kohwi et al. 1994; Galande, Purbey et al. 
2007).  Later molecular methods showed that the nuclear lamina also appears to play a 
structural role in some chromatin interactions.  Genes are often connected to the lamina, 
although it appears true that in different cell types or organisms, these lamina-associated 
genes are expressed (Pickersgill, Kalverda et al. 2006), repressed (Guelen, Pagie et al. 
2008), or temporally associated with the lamina in a way that establishes lineage 
commitment programs (Peric-Hupkes, Meuleman et al. 2010).  Possibly related to these 
phenomena is the fact that occasionally gene activity is reported as being related to 
proximity to telomeres or centromeres in various cells (Brown, Guest et al. 1997; 
Francastel, Walters et al. 1999; Andrey, Montavon et al. 2013; Robin, Ludlow et al. 
2015).  In addition to genic interactions that inspired many of these experiments, CTCF 
was found to be involved in many chromatin interactions (Ling, Li et al. 2006; Splinter, 
Heath et al. 2006). CTCF is now primarily understood to be an insulator whose pattern of 
occupancy varies relatively little across cell and tissue types, although it also has 
additional active and repressive functions at some loci (Kim, Abdullaev et al. 2007), 
showing that some chromatin interactions other than MARs, namely insulators, might be 
structural.  In fact, it has been shown that many CTCF sites are associated physically 
with other CTCF sites, suggesting that at least some looping (likely the most invariant 
loops in the genome) may be mediated by CTCF (Ong and Corces 2014). 
I.2.7: Silencers and Compound CRMs 
Silencers are cis-regulatory modules that, when brought into proximity of an 
active promoter, cause decreased expression in a knock-in assay.  Silencers bind 
protein factors called repressors that cause the negative regulation.  Some silencers 
appear to work by binding a factor that disrupts proper binding of an activating 
transcription factor, whether binding directly to sites that prevent access of necessary 
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transcription factors (Johnson, Mortazavi et al. 2007) or by physically interacting with 
scaffold proteins that in turn recruit transcriptional disruptors or otherwise block 
association of enhancers and promoters (Lupo, Cesaro et al. 2013).  In addition to 
silencers, insulators, promoters, and enhancers, there also exist mixed-category CRMs, 
sometimes called “compound CRMs,” which have binding sites for a wide variety of 
protein factors and which may sometimes bind activating factors, acting as enhancers, 
and sometimes bind repressors, acting as silencers (Davidson 2006).   
I.3: Skeletal Myogenesis and the C2C12 model system 
 Skeletal myogenesis is a highly conserved and ancient developmental process 
that is characterized in all systems studied by having at least one bHLH Muscle 
Regulatory Factor (MRF) and usually also involves MADs cofactors such as Myocyte 
enhancer factors (MEF-2s) and Serum response factors (SRFs).  For example, in 
Drosophila and in C. elegans, nautilus and bHLH1 are the respective myoD orthologs, 
and dMef2 is a major MADs family gene in fly. 
 For over 30 years, mammalian skeletal muscle differentiation has been studied in 
the mouse using a model cell line called system called C2C12 (Yaffe and Saxel 1977; 
Blau, Chiu et al. 1983; Blau, Pavlath et al. 1985).  That work provides a vast background 
of molecular biological data to draw on to interpret genome-scale data in this thesis.   
Most skeletal muscle – the trunk and limb skeletal muscles – all originate from the 
somites of the developing embryo.  The first committed myoblast precursor cells appear 
in the dermomyotome, and then begin to differentiate and migrate (see (Buckingham 
and Rigby 2014)).  At this time, the somite has flattened and is wrapped around the 
neural tube in a “C” shape with the notochord (a signaling center) positioned close to its 
ventral side.  The inner portion of the dermomyotome is fated to become the vertebral 
column, ribs, and tendons of the midsection.  The portion of the outer dermomyotome 
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expresses Pax3, and nearer the center, Pax7 is also detected.  Cells in this domain, 
expressing one or both of these PAX-family factors, comprise a renewing source of 
myoblasts fated to become skeletal muscles of the trunk.  Meanwhile, Pax3-positive 
cells from the hypaxial (proximal to notochord) dermomyotome migrate to the limb bud, 
where they later express the three MRF determination factors – MyoD, Myf5, and MRF4 
and eventually myogenin – to become skeletal muscles of the limbs. 
 Much is known about the factors involved in limb skeletal myogenesis.  The Pax3 
precursor cells begin to migrate, and while doing so, they express c-met and Lbx1, 
which activates CXCR4 (Buckingham and Rigby 2014).  During migration, the cells are 
prevented from differentiating by factors that repress both the MRF’s and their cofactors: 
Snail represses an important subset of myoD-binding sites, Sim2 represses myoD, Msx1 
represses myoD and Myf5, and the Dach factors repress Six and Eya transcription 
factors.  However, upon reaching the limb bud, the migratory limb skeletal muscle 
precursors express MRF’s and begin to differentiate.  This is due in part to Shh 
signaling, which activates Myf5 by way of Gli, but also to Wnt signaling, which activates 
Pitx2 by way of Tcf4.  Pitx2 activates Six and Eya, which in turn activate myoD and 
Myf5.  Meox2 is another transcription factor turned on at this time, and it contributes to 
activating expression of Myf5 as well.  
 Once myoD and/or Myf5 are activated, they are able to positively regulate 
themselves, each other, and some of their precursors such as Pax3 and the Six 
transcription factors.  The same goes for Mrf4 (also known as Myf6 and herculin), the 
third myogenic determination factor.  All three determination factors then switch on 
myogenin – the only MRF that is solely a differentiation factor – and all four MRFs are 
then able to activate the myogenic differentiation program.  This is actually the 
conserved part of skeletal myogenesis: myogenesis in the trunk and face use different 
16 
 
cofactors, but once one or all MRF’s are turned on, skeletal myogenesis is fated to 
occur. 
 The C2C12 muscle cell line is a long-studied (Yaffe and Saxel 1977; Casas-
Delucchi, Brero et al. 2011) stable myogenic cell line that is propagated in culture in a 
committed myoblast-like state.  Upon withdrawal from the cell cycle, it undergoes cyto-
differentiation to a myocyte-like state and partial fusion into myotube structures (Fig. I-2).   
 In our C2C12 RNA-Seq data, NRSF, a repressor expressed at 1 copy per cell 
(Johnson, Mortazavi et al. 2007), has a value of 5FPKM.  Using this as an initial practical 
threshold to define biologically pertinent expression, these cells do not express either 
Pax3 or Pax7.  However, some of the Six and Eya factors are significantly expressed 
(Six1: 46FPKM blast, 36FPKM cyte; Six4: 5FPKM blast, 4FPKM cyte; Eya3: 5FPKM 
blast, 7FPKM cyte; Eya4: 18FPKM blast, 16FPKM cyte).  Further, Myf5 is expressed at 
relatively low levels (10FPKM blast, 11FPKM cyte) and Mrf4 is essentially off (0FPKM 
blast, 3FPKM cyte).  By contrast, the system strongly expresses myoD in both myoblasts 
and myocytes (166FPKM blast, 200FPKM cyte).  C2C12s differentiate and ultimately, 
most will fuse into multi-nucleated “myotubes.”  In this thesis, the main focus in on gene 
regulation, so I choose to call all differentiating cells “myocytes,” and I base this 
designation on their gene expression status, whether they are mononucleate or 
multinucleate.  C2C12 myocytes express the well-studied myogenic transcription factors, 
enzymes, and proteins including myogenin (17 FPKM blast, 1,026 FPKM cyte), 
myoglobin (2 FPKM blast, 642 FPKM cyte), muscle creatine kinase (1 FPKM blast, 759 
FPKM cyte), myosin heavy chain Mybph (1 FPKM blast, 841 FPKM cyte), actin Acta1 
(12 FPKM blast, 4,337 FPKM cyte), and myosin light chain Myl4 (3 FPKM blast, 2,787 
FPKM cyte).  Altogether, C2C12s have 7,325 genes expressed above 5 FPKM in one 
timepoint or the other, of which 714 genes are up-regulated more than 3x and 363 genes 
17 
 
downregulated more than 3x (Fig. I-3).  I use these unambiguous developmentally 
defined gene sets for clarity of biological analysis when examining the association of 
connectivity with putatively regulated sets of genes. 
I.4: A history of chromatin topology 
 It is now understood that chromatin structure is a vital component of 
transcriptional regulation, but at the time enhancers and promoters were being defined, 
work on chromatin topology and dynamics was conceptually a separate field.  Chromatin 
biology of the time necessarily focused on the major structural changes of chromatin and 
sought to understand which molecules were responsible.  This gene-non-centric 
approach to understanding the nucleus, however, revealed many events that occurred at 
the same time as gene expression.  Many of these events are now understood to be 
required for the proper regulation of genes. 
 From a variety of traditional microscopy and molecular labeling experiments, it 
has been known since the late 1970s that there are topologically independent loops or 
small domains of chromatin, perhaps governed by attachment to the nuclear matrix 
(Berezney and Coffey 1974; Benyajati and Worcel 1976; Cook and Brazell 1978; 
Lebkowski and Laemmli 1982; Gasser and Laemmli 1986; Gasser and Laemmli 1987).  
Chromosomes themselves also have relatively distinct domains in the nucleus (Cremer, 
Cremer et al. 1982), and later methods substantiated this, though noting that there are 
intermingling interchromosomal interactions between chromosomes.  
 When chromatin is viewed in bulk, rather than at specific loci, it is apparent that 
active regions co-localize with each other and repressed heterochromatin also co-
localize with each other.  This is such a general phenomenon that it is observable at the 
level of light microcsopy.  The interphase nucleus, when stained in certain ways, exhibits 
a dark and light banding pattern that suggested the nucleus is filled by a series of 
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alternating discs of more and less dense chromatin. D-bands, which overlap spatially 
with early DNA replicating Giemsa light bands (Kerem, Goitein et al. 1984), correspond 
to transcriptionally active (Goldman, Holmquist et al. 1984).  At the time, an accepted 
interpretation of the results was that genes actively co-localized with each other, but 
another possible interpretation is that highly condensed heterochromatin is segregated.  
These interpretations are not mutually exclusive, and some current notions, such as the 
hypothetical “transcription factory” that will be discussed later, question whether co-
localization of active genes is an active or a passive process. 
More recently, it was shown via DNA-FISH that active and silent genes are in 
different areas of the nucleus from each other (Kosak, Skok et al. 2002).  DamID, a 
technique that uses an engineered protein by joining DNA adenine methyltransferase 
(DAM) to the binding portion of a chromatin protein, and which methylates regions of the 
genome to which the chromatin protein is bound, has also showed that heterochromatin 
preferentially interacts with hererochromatin (van Steensel and Henikoff 2000); this was 
later substantiated by 6C (Tiwari, Cope et al. 2008), one of the 3C family of assays – the 
only assays since FISH that are able to quantify 3D chromatin interactions. One domain 
of active chromatin corresponding to a nuclear subcompartment was investigated using 
3C, and it was found that chromatin within the domain interacted locally with other 
members of chromatin in the domain, and with no chromatin without (Chubb, Boyle et al. 
2002). 
I.5: Enhancer and Promoter multiplicity 
 In studying developmentally regulated genes and in looking for enhancers that 
recapitulated the native expression patterns, it was soon found that some genes could 
be influenced by multiple enhancers.  Some of this was done in my system, mouse 
myogenesis.  In the case of MYOG, although in some assays it appeared that the 
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promoter by itself was able to recapitulate proper gene expression (Buonanno, 
Edmondson et al. 1993), it soon became apparent that there were at least two 
enhancers required, one for proper expression in the limb and one for proper expression 
in the somites (Cheng, Wallace et al. 1993).  In the case of MyoD, two enhancers are 
currently known.  The DRR enhancer, which is 5 kb away (Tapscott, Lassar et al. 1992), 
first appeared to drive proper expression of MyoD in adult muscle (Hughes, Taylor et al. 
1993), but it eventually became apparent that this enhancer is required for expression in 
adult muscle but not for developing muscle (Asakura, Lyons et al. 1995; Kablar, Krastel 
et al. 1997; Chen, Ramachandran et al. 2002). The second enhancer, termed the core 
enhancer, which is 20 kb away, while insufficient to create proper MyoD expression in 
adult muscle (Faerman, Goldhamer et al. 1995) is highly active during the course of 
muscle development and is required for expression of somites, limb buds, and branchial 
arches (Faerman, Goldhamer et al. 1995; Goldhamer, Brunk et al. 1995; Kablar, 
Asakura et al. 1998).  In a third gene, MCK, which is one of the most highly expressed 
genes in adult muscle, there are also two known enhancers, one which synergizes with 
the promoter, although the promoter can function independently at a lower level. 
However, the small intronic enhancer is necessary for proper expression of the gene in 
slow-twitch muscle (Tai, Fisher-Aylor et al. 2011).   
 Studies of other genes in other systems also turned up multiple enhancers for 
well-studied genes, although sometimes the developmental necessity of these 
enhancers was not as easily understood.  Some people even hypothesized that certain 
multiple enhancers were redundant (Fiering, Epner et al. 1995; Zakany, Fromental-
Ramain et al. 1997; Monroe, Sleckman et al. 1999).  More recent assays in the high 
throughput genomic era identified multiple transcription factor occupied sites, and many 
labs independently noted and gave names to hypothesized special enhancers.  In the 
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Levine lab, it was noted that “shadow enhancers” occurred near developmentally 
important enhancers (Zeitlinger, Zinzen et al. 2007; Hong, Hendrix et al. 2008).  
Meanwhile, the Young and Collins labs took note of regions containing perhaps multiple 
enhancers or perhaps massive single enhancers binding many different factors, and 
called them “super enhancers” (Hnisz, Abraham et al. 2013; Whyte, Orlando et al. 2013) 
or “stretch enhancers” (Collins lab).  When multiple putative enhancers occur near a 
gene, it remains an open question whether or not all of these elements are required 
throughout the development and lifespan of the animal, whether they may be redundant, 
or whether they are even enhancers at all.  
 In addition to studying enhancers in conjunction with single promoters, and as 
expected from the twin observations that active genes associate with other active genes 
and many genes co-occur with closely related genes on the genome, it has been 
observed that multiple promoters can interact with one enhancer.  In a type of interaction 
called “promoter competition,” the handoff of one enhancer from E-globin to B-globin 
was shown to underlie the developmental switch between these two globins in the 
developing chicken embryo (Foley and Engel 1992).  Likewise, the notion of “enhancer 
competition,” where one enhancer competes for two different genes, was raised in 
conjunction with the alternate expression of H19 and IGF2; however, although this 
enhancer does regulate both of these genes, competition was proven not to be the 
cause of the handoff, but rather imprinting (Schmidt, Levorse et al. 1999).  Other studies 
of loci containing related genes soon also uncovered single enhancers that interacted 
with multiple genes, and the majority of these studies hypothesized that the shared 
enhancers were responsible for coordinately regulating the entire multi-gene locus (IL4 
(Loots, Locksley et al. 2000; Mohrs, Blankespoor et al. 2001), Myf5/6 (Carvajal, Cox et 
al. 2001), DLX (Sumiyama, Irvine et al. 2002), HOX (Spitz, Gonzalez et al. 2003)).  One 
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group, interpreting this conclusion even further, suggested that the co-association of an 
enhancer with two globin promoters represented an “active chromatin hub” (Tolhuis, 
Palstra et al. 2002).  Still others, looking at the same locus and perhaps drawing on the 
several anecdotes of single enhancers interacting with multiple promoters, combined all 
of these observations with the knowledge that certain factors, such as pol2, are localized 
in specific loci in the nucleus to create the hypothesis of the transcription factory.   
 In addition to the phenomena of enhancer and promoter competition, there are 
other factors that could affect how enhancers and promoters join together selectively, 
given a group of potential matches.   
I.6: Promoter and Enhancer agreement 
 In 1980 an efficient conserved promoter was discovered in bacteria (Siebenlist, 
Simpson et al. 1980).  However, it quickly became apparent that eukaryotic promoters 
had a much greater range of diversity.  The TATA box was the first eukaryotic promoter 
motif discovered.  TATA determines transcription initiation in many non-housekeeping 
genes (rev. (Breathnach and Chambon 1981) and TATA is conserved from archaea to 
human (Reeve 2003).  However, it is only found in 10 to 15% of mammalian core 
promoters (Kim, Barrera et al. 2005; Carninci, Sandelin et al. 2006; Cooper, Trinklein et 
al. 2006).  Non-TATA genes have for a while been thought to be constitutively 
expressed, low output genes with multiple 5’ start sites (Dynan 1986).   
 In the past three decades, multiple other eukaryotic promoter motifs have been 
found, such as CCAAT boxes, GC boxes (Grosschedl and Birnstiel 1980a,b; Dierks, van 
Ooyen et al. 1983; McKnight and Tjian 1986), BRE upstream (Lagrange, Kapanidis et al. 
1998), BRE downstream (Deng and Roberts 2005), initiator (Inr) (Smale and Baltimore 
1989), motif 10 element (MTE) (Burke and Kadonaga 1997; Kutach and Kadonaga 
2000), and the DPE motif (Burke and Kadonaga 1996; Burke and Kadonaga 1997).  The 
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latter three motifs co-occur in promoters with strict spacing requirements (Burke and 
Kadonaga 1997; Kutach and Kadonaga 2000), while the former motifs co-occur in a 
functionally different set of promoters.  The currently popular view is that TATA and its 
co-occurring motifs are used to cause focused initiation, which is used in about 35% of 
vertebrate genes including most of the known differentially regulated genes (rev. (Juven-
Gershon and Kadonaga 2010).  Also in focused promoters are DPE and its related 
motifs, Inr and MTE, which co-occur given strict spacing requirements (Kutach and 
Kadonaga 2000; Lim, Santoso et al. 2004).  Certain enhancers preferentially connect to 
TATA over DPE’s promoters and vice versa (Ohtsuki, Levine et al. 1998; Butler and 
Kadonaga 2001).  In fact, this preference is important in how caudal regulates HOX 
genes (Juven-Gershon, Hsu et al. 2008), and some transcription factors such as NC2 
(Willy, Kobayashi et al. 2000) and MOT1 block TATA function while activating DPE and 
vice versa (Hsu, Juven-Gershon et al. 2008; van Werven, van Bakel et al. 2008).  
Although these well-characterized instances of promoter and enhancer selectivity occur 
only in the approximately 30% of genes that are highly expressed or differentially 
regulated, it stands to reason that similar selectivity may occur in at least a portion of the 
remaining 70% of genes.  Less studied are dispersed promoters, which generally lack 
both TATA and DPE and their related motifs (Carninci, Sandelin et al. 2006; Sandelin, 
Carninci et al. 2007), although dispersed initiation is used in the majority of eukaryotic 
genes (Smale and Kadonaga 2003; Carninci, Sandelin et al. 2006; Juven-Gershon, Hsu 
et al. 2006; Juven-Gershon, Hsu et al. 2008).   
I.7: Enhancer assembly and dynamics 
 The initial view of enhancer assembly was that the transcription factor would bind 
to the recognition site and remain there in a static fashion (Becker, Renkawitz et al. 
1984).  However, transcription factor occupancy, at least in a few specific cases, has 
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been shown to be dynamic.  In a now classic set of experiments done in muscle, it was 
shown that MyoD requires four binding motifs in order to stably occupy muscle 
enhancers (4Rcat).  Related to this phenomenon is the hit-and-run model of enhancer 
function, in which the transcription factor does not stably occupy the enhancer but 
recruits a set of factors that does (Suen, Berrodin et al. 1998).  This model of 
enhancement was demonstrated for the GR transcription factor by photo bleaching GFP-
tagged transcription factors and showing that it exchanged rapidly with chromatin 
regulatory elements (McNally, Müller et al. 2000).  Like the 4Rcat experiment, this result 
suggests that some, perhaps many, initiation complexes are created through an 
equilibrium reaction of a transcription factor with its DNA motif or motifs rather than being 
stably occupied. 
 That is not to say, however, that stable initiation complexes do not exist.  Some 
people have noticed that enhancers can have tightly clustered transcription factor 
binding sites, whereas other enhancers, termed modular enhancers, have more loosely 
clustered factor binding sites (Arnosti and Kulkarni 2005).  The former case has been 
hypothesized to result in the formation of a stable enhanceosome structure between the 
enhancer and promoter (Thanos and Maniatis 1995).  The enhanceosome was first 
characterized by the Maniatis lab using a well-characterized viral inducible enhancer that 
relies entirely on general transcription factors at the interferon-R gene.  This 
enhanceosome is so stable that it was even able to be partially crystallized so that the 
structure of three transcription factors bound to half of the enhancer has been 
completely described (Panne, Maniatis et al. 2007).  Perhaps these two different models 
of initiation complex formation reflect the biological necessity for certain promoters to be 
regulated slowly and precisely, like interferon-R, while others must assemble quickly and 
are therefore more structurally loose, like GR and the model of 4Rcat.  If many genes 
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are regulated in the quicker and looser way, it would be reflective in the appearance of 
multiple different enhancers interacting with one promoter, since some instances of all 
the dynamic possibilities would be captured. 
I.8: Possible sequestration of important transcriptional machinery 
 The notion of the transcription factory is currently the most popular interpretation 
of the result from microscopy that certain factors, in this case pol2, occur in a limited 
number of foci per cell (Osborne, Chakalova et al. 2004).  However, other factors also 
appear to be sequestered in the nucleus.  Many transcription factors, such as GR (Htun, 
Barsony et al. 1996) and Myog (unpublished observations), are also visible in 
microscopy as bright foci in the nucleus.  In addition to these transcription factors, which 
are found both in enhancers and promoters, it has also been noted that basal 
transcription factors can be sequestered.  During muscle development, for example, the 
canonical TFIID complex is replaced by a complex made up of TRF3 in place of TBP 
and TAF3 in place of one of the canonical TAFs (Deato and Tjian 2007; Deato, Marr et 
al. 2008).  These non-canonical basal transcription factors have also been implicated in 
hematopoiesis (Hart, Raha et al. 2007).   
  
25 
 
Figures for Chapter I 
 
 
 
Figure I-1: Schematic depicting the looping model of enhancement.  An enhancer 
(black square) and the promoter of a gene (green squares) are each bound by sets of 
transcription factors which interact with each other physically (green and orange blobs).  
The complex created by this interaction recruits pol2 (red blob), which activates the 
gene.  
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Figure I-2 
 
 
Figure I-2: C2C12 skeletal muscle differentiation.  A. Top: Four major stages of in 
vivo skeletal muscle development and the transcription factors that are causatively 
expressed to do this.  Bottom: The two stages of C2C12 skeletal muscle development 
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and the levels of the same transcription factors.  C2C12’s approximate the myoblast to 
myotube phase of terminal skeletal myogenesis.   B. The stages of C2C12 skeletal 
muscle development illustrating different metrics of activity in each stage: RNA 
expression, pol2 occupancy, and myogenic transcription factor occupancy. Data and 
numbers courtesy of G Kwan, A Mortazavi, and A Kirilusha. 
 
 
 
Figure I-3: Expression of all genes in C2C12 myoblasts and myocytes.  With 
respect to RNA expression analysis presented in later thesis chapters, the values 
graphed are assigned to gene promoter candidate “Wellington” graph vertices, which are 
defined in Chapter II.  Off genes (black) are never expressed above 1FPKM.  The three 
“special” groups of genes – up (red),   
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Chapter II: Chromatin topology 
II.1: Introduction 
3C is a powerful assay, but it is difficult to perform and it only asks about one-to-
one interactions.  The mid-2000s saw a development of more and more high-throughput 
chromatin capture assays alongside the “next-generation” sequencer revolution, sparked 
by ChIP-Seq (Johnson, Mortazavi et al. 2007) and RNA-Seq (Mortazavi, Williams et al. 
2008).  4C in various forms found one-to-many interactions with about a 50kb resolution 
(Simonis, Klous et al. 2006; Zhao, Tavoosidana et al. 2006; Wurtele and Chartrand 
2006; Branco and Pombo 2006).  5C (Dostie, Richmond et al. 2006) and 6C (Tiwari, 
Cope et al. 2008), two different assays that are able to detect many-to-many 
interactions, found that many-to-many interactions are possible, instead of single CRM 
to single CRM. 
 Two genome-wide many-to-many chromatin capture assays hit the scene in 
2009: Hi-C, which detects physical interactions agnostically with a 1Mb detection 
threshold (Lieberman-Aiden, van Berkum et al. 2009), and ChIA-PET, which improves 
resolution (5kb) at the expense of agnosticism by detecting only the physical interactions 
that also contain a ChIP-pable factor (Fullwood, Liu et al. 2009).  These two assays do 
not agree as much as one would suspect.  The Liberman-Aiden group found gene-rich 
euchromatin regions interacting with each other separately from gene-poor 
heterochromatin domains, and they reported lots of structure was constant between cell 
lines.  The Fullwood group, which analyzed interactions containing an activating 
transcription factor, reported that interactions depend on factor occupancy and 
insinuated that interactions are transient with respect to development. 
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II.1.2: Major questions about general chromatin topology 
 When I began this project, there were thought to be three canonical types of 
chromatin loops: enhancer to gene, insulator to insulator, and gene start to genes end 
(de Wit and de Laat 2012).  However, there was also hints of other, structural 
interactions such as those involving the nuclear matrix (Galande, Purbey et al. 2007) 
and the nuclear lamina (Peric-Hupkes, Meuleman et al. 2010).  The field of chromatin 
structure has not historically interacted with gene regulation, though many elements of 
chromatin organization seem to be organized around active and inactive genes.  In fact, 
it is unknown to what elements, overall, active genes connect physically.  Are enhancers 
most common?  Insulators or silencers?  What about structural elements?  Are the 
connected elements local, or are 1Mb interactions like at Shh common?  And how often 
do multiple genes share an enhancer? 
 I created a set of pol2 ChIA-PET datasets in two cell states in order to detect 
physical interactions of distal elements with active genes.  In order to determine which 
detected connections exist independently of a pol2 ChIP-Seq, as well as to better detect 
classically defined myogenic enhancers, I also created a separate ChIA-PET dataset for 
the myogenic transcription factor myogenin (Fig. II-1).   
II.2: Results 
II.2.1: Simplifying ChIA-PET data to elucidate the most reproducible connections 
 ChIA-PET poses a particular problem above and beyond the ordinary noisiness of 
genome-wide data in that certain areas of the genome have connectivity patterns that are 
extremely complex (Fig. II-2).  
 Other ChIA-PET bodies of work have done little to elucidate what is occurring at 
these complex loci (Fullwood, Liu et al. 2009; Handoko, Xu et al. 2011; Li, Ruan et al. 
2012; Chepelev, Wei et al. 2012).  To simplify the ChIA-PET raw data, I took a graph 
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theoretical approach.  First, I specified a set of candidate vertices out of regions of the 
genome likely to be connected and removed all PETs that do not have both ends in a 
vertex (Fig. II-3). 
 I used an independent genome-wide assay, DNase-Seq, as the source of the 
candidate vertices, along with all annotated TSSs.  This narrows the pool of connected 
regions of the genome to genes and occupied putative CRMs, more easily interpretable by 
current knowledge in the era of ENCODE.  Second, for pol2 ChIA-PET, I reported as 
edges only the places where there were two individual occurrences of ChIA-PET raw 
paired tags between candidate vertices.  In order to focus on the most reproducible, 
highest-confidence set of interactions, I performed two separate biological and technical 
ChIA-PET experiments for each condition and I only reported the edges found in both 
experiments (Fig. II-1).  This purposefully sacrifices weak signal at the threshold of noise 
for high-confidence, reproducible signal so that I can be certain of the existence of the  
connections I report.  A third dataset, myogenin at the myocyte timepoint, has no replicate.  
It will be used to determine which aspects of the pol2 ChIA-PETs are factor-dependent.  
Both the raw and processed data are shown for the CIG containing MyoD, one of the 
master regulators of myogenesis (Fig. II-4), since MyoD is a locus representative of a 
medium-sized one gene CIG. 
 A ChIA-PET edge means that there is evidence of a single physical complex that 
contains two regions of DNA and the factor for which the ChIP was done.  Lack of a ChIA-
PET edge suggests that either there is no physical connectivity between the regions, or 
that connectivity occurs without the presence of the ChIPped factor.  A common 
misconception of ChIA-PET data is that it represents a complete physical connectivity 
map; it does not (Fig. II-5). 
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II.2.2: ChIA-PET general characteristics 
 ChIA-PET connectivity is particularly striking at the myogenic locus containing 
myogenin (Myog) and myosin binding heavy protein H (Mybph) (Fig. II-6).  
 At the myoblast timepoint, when both myogenic genes are unexpressed, no 
connections are recovered.  However, they connect to each other as well as many nearby 
myog+ and myog- DNase-hypersensitive vertices.  This locus with around 60 
interconnected vertices is in fact spectacularly large compared to most other loci in the 
genome.  Most CIGs are small, though large, multi-genic CIGs like myogenin number in 
the hundreds (Fig. II-9).   
 Most CIGs contain at least one gene, but surprisingly, there are CIGs that have no 
annotated genes.  This does not appear to be a characteristic of data stringency (data not 
shown), so the most likely explanations are that some vertices are unannotated genes 
(though I used gene models bordering on the extensive), or that pol2 sometimes comes 
into contact with regions of the genome that don’t have genes. 
 As for the edges themselves, most are local, and strength is inversely correlated 
with distance (Fig. II-7). However, there are some long edges over 50kb, even a rare few 
as long as the 1Mb Shh to enhancer interaction.  One related property of these local 
edges is that the ChIA-PET CIGs themselves are relatively localized (Fig II-9). The 
elements that the edges connect, gene-vertices and distal-vertices, tend to be wider than 
unconnected candidate vertices, and gene-vertices are also wider than distal-vertices 
(data not shown).  This is due to the merging algorithm in the creation of candidate 
vertices: some regions of the genome, particularly the bodies of active genes, have 
multiple DNase regions blanketing a small area.  I have standardized edge weights to 
account for the differing vertex widths (and therefore edge capture likelihood) by 
normalizing on the basis of the connected vertex widths. 
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 All of these properties are true for the myogenin ChIA-PET as well.  However, 
there is one notable difference between myogenin and pol2 ChIA-PET edge strengths.  
Pol2 edges are strongest when they involve genes (Fig. II-8, top), and myogenin edges 
are strongest when they involve non-genic elements (Fig. II-8, bottom). Though there is 
little relationship between ChIA-PET signal and the antecedent ChIP signal (data not 
shown), it is likely this means that ChIA-PET signal strength is partially influenced by factor 
occupancy: pol2 at genes and myog at enhancers. 
 Since ChIA-PET is an assay done in bulk on a large cell population, there is a 
major question to ask: when a vertex has connections to multiple other vertices, are the 
interactions simultaneous or sequential?  Is there any evidence for the promoter factory 
hypothesis (Osborne, Chakalova et al. 2004) and if so, is this the exception or the rule?  I 
chose to use the graph theoretical concept of the clique as a way of determining the 
likelihood of having simultaneous interactions. A clique is a set of vertices where every 
vertex is connected to every other vertex. (Fig. II-10A, middle; Fig. II-10B, purple).  If there 
are simultaneous interactions captured by ChIA-PET, they would show up as cliques, 
though not all cliques need be simultaneous interactions (Fig. II-11A).  However, because 
cliques and non-cliques alike are just as susceptible to the rigorous data treatment, it is not 
their absolute number but the ratio between their numbers that will tell us which type of 
interaction is most common.  This ratio is 8 to 92% regardless of the data set and data 
treatment (Fig. II-11B; some analyses not shown).  There are indeed cliques in the ChIA-
PET data, including a clique of the classic MRF myogenin connected to two other 
upregulated genes (Mybph and Ppfia4) and a few distal elements (Fig. II-10A, left).  
However, there are surprisingly few cliques genome-wide, only a few hundred overall (Fig. 
II-10A, right).  In fact, it appears to be a general principle of these data that there is a very 
narrow range of observed connectivity: most CIGs have about one extra edge per three 
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vertices above the absolute minimum level of connectivity (Fig. II-10B, red). Taken all 
together, the most likely explanation for these phenomena are that most multiple 
interactions in the nucleus are sequential rather than simultaneous, and that instances 
such as the promoter factory are the exception rather than the rule. 
II.3: Discussion/Conclusions 
 Most connections are local; Shh-length cases (1Mb) are seen but are rare.  This 
is consistent with the notions that chromatin movement is restricted to certain 
subdomains such as nuclear compartments (Chubb, Boyle et al. 2002; Noordermeer, 
Branco et al. 2008; Noordermeer, de Wit et al. 2011). 
Complexity – in the sense of there being multiple overlapping edges within a 
genomic region – varies widely among active genes.  Most interactions are simple paired 
edges, but there are nevertheless hundreds of multiply interacting CIGs containing more 
than one gene, more than one putative CIG, and sometimes tens of each.  Though most 
genes connect to one other element, if there is a detected connection > 10kb at all, there 
are hundreds of cases of genes interacting with multiple non-genic elements and of 
single non-genic elements interacting with multiple genes.  However, complexity in the 
sense of the ratio of edges to vertices is surprisingly simple and invariant, suggesting 
that little simultaneity within these multiply connected regions is possible. 
 Given the first principle that most edges are local, it seems that gene 
neighborhood could be very important when predicting – or in enabling – the physical 
interactions of most active genes.   
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Figures for Chapter II 
 
 
Figure II-1: Experimental design.  Two biological and technical replicates for RNA pol2 
were performed for each of the developmental states, myoblast and myocyte.  To ensure 
the edges I analyzed were real, I chose to take the high-confidence step of analyzing 
only the intersect edges between the two replicates.  A third dataset, myogenin in 
myocytes, was performed in one library and analyzed to determine which data properties 
are in common between the pol2 and transcription factor ChIA-PET experiments. 
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Figure II-2: ChIA-PET raw data.  ChIA-PET individual paired-end tags (light purple) are 
shown for pol2 myoblast (left) and myocyte (right) at the myoD locus.   
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Figure II-3: ChIA-PET data processing.  DNase-Seq data was collected for C2 
myoblast and myocyte timepoints (blue and red) and were used to call Wellington digital 
footprints.  These footprints were then expanded to 1kb and combined with annotated 
TSS’s in the genome (see methods) to create a set of candidate vertices (purple).  The 
ChIA-PET raw paired-end tags for each timepoint (black and gray) were then mapped 
onto the candidate vertices to create interconnected CIGs (gray figure at bottom).  Unless 
otherwise specified, the subgraphs reported are the intersect set of two individual ChIA-
PET biological replicates.   
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Figure II-4A: ChIA-PET data processing example: myoD. Myoblast factor occupancy 
(green: myoD; gray: DNase) is shown over raw ChIA-PET paired-end tags (light blue) at 
the myoD locus.  The numerous ChIA-PET tags are reduced into a 6-vertex CIG 
showing myoD connecting to 5 nearby occupied regions.  
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Figure II-4B: ChIA-PET data processing example: myoD. Myocyte factor occupancy 
(blue: myogenin; black: DNase) is shown over raw ChIA-PET paired-end tags (green) at 
the myoD locus.  The numerous ChIA-PET tags are reduced into a 9-vertex CIG (the 
leftmost 7 vertices are shown here) showing myoD connecting to 8 nearby occupied 
regions.  
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Figure II-5: How to interpret ChIA-PET data.  A ChIA-PET edge means that there is 
evidence of a single physical complex that contains two regions of DNA and the factor 
for which the ChIP was done (top right).  Lack of a ChIA-PET edge suggests that either 
there is no physical connectivity between the regions, or that connectivity occurs without 
the presence of the ChIPped factor (bottom right).  A common misconception of ChIA-
PET data is that it represents a complete physical connectivity map (middle column); it 
does not. 
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Figure II-6 
 
 
Figure II-6: Simplification of ChIA-PET data at the myogenin locus.  ChIA-PET 
subgraphs at the myogenin gene locus exemplify the way in which ChIA-PET data relate 
to other data types.  Top: DNase-Seq, ChIP-Seq for muscle regulatory transcription 
factors (MRF’s), and RNA-Seq data for myoblast and myocyte timepoints are shown.  
Bottom: Two sets of ChIA-PET analyses are shown.  For each, candidate vertices are 
shown above connected myoblast and myocyte pol2 ChIA-PET CIGs.  In the CIGs, the 
orange vertices represent TSS-containing gene vertices and the orange edges gene-to-
gene connections.  The blue vertices represent distal vertices and the blue edges 
represent distal-distal and gene-distal connections.  The width and darkness of an edge 
represents the edge strength, which is the number of raw ChIA-PET reads contributing 
to the edge.  There are no reported connections to myogenin in the myoblast footprint 
resolution dataset.  CIG art at the bottom courtesy of Santiago Lombeyda. 
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Figure II-7: ChIA-PET edge distance.  Distribution of pol2 (red, blue) and myogenin 
(green) ChIA-PET edge distances for weak edges <1.0 EPK (light) and strong edges 
(dark).  Over 300 hundred ChIA-PET pol2 connections are > 100kb, and of these about 
half are in the high edge-weight group.  Two thirds of edges are between 10-and 50kb in 
length, and 10kb is the threshold for inclusion of raw PETs in the analysis. There is only 
one myogenin dataset, while the intersects of two pol2 datasets each are shown.   
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Figure II-8: ChIA-PET edge strengths.  Pol2 edges (red, blue) are strongest and most 
numerous for gene-vertex-containing edges (darker two colors).  Myogenin edges 
(green) are the opposite: strongest and most numerous for edges that do not contain 
gene-vertices (light green).   
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Figure II-9: General CIG characteristics.  The vast majority of CIGs are paired edges, 
and CIG size decreases monotonically  with CIG number.  Nevertheless, there are 
hundreds of complex CIGs with tens of vertices. 
  
53 
 
 
 
 
Figure II-10: Cliques and complex interactions in ChIA-PET. (A) There is a very tight 
observed relationship between the number of edges and the number of vertices.  
Although cliques are theoretically possible, they are rarely found and instead, there is 
roughly one extra edge every three edges over the bare minimum connectivity. 
 
(B) Cliques, special CIGs in which every vertex is connected to every other vertex 
(middle column), and exemplified in the myogenin locus (left, red and orange edges) are 
present in ChIA-PET data but rare.  Overall, there are only a few hundred cliques in the 
genome (right).  Wellington pol2 myocyte intersect data are shown. 
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Figure II-11: Complex interactions are rare. (A) Possible arrangements of chromatin 
in individual nuclei within a cell sample (left), and what the resulting CIGs would look like 
(right).   
 
(B) The number of vertex triplets that are fully connected cliques (purple) is only 8%, and 
this is true even when looking at less stringent ChIA-PET data (bottom). Wellington pol2 
myocyte data are shown. 
  
55 
 
Sources for Chapter II 
Andrey, G., T. Montavon, B. Mascrez, F. Gonzalez, D. Noordermeer, M. Leleu, D. Trono, 
F. Spitz and D. Duboule (2013). "A switch between topological domains underlies 
HoxD genes collinearity in mouse limbs." Science 340(6137): 1234167. 
Bailey, A. M. and J. W. Posakony (1995). "Suppressor of hairless directly activates 
transcription of enhancer of split complex genes in response to Notch receptor 
activity." Genes Dev 9(21): 2609-2622. 
Bailey, S. D., X. Zhang, K. Desai, M. Aid, O. Corradin, R. Cowper-Sal Lari, B. Akhtar-
Zaidi, P. C. Scacheri, B. Haibe-Kains and M. Lupien (2015). "ZNF143 provides 
sequence specificity to secure chromatin interactions at gene promoters." Nat 
Commun 2: 6186. 
Bailey, T. L., N. Williams, C. Misleh and W. W. Li (2006). "MEME: discovering and 
analyzing DNA and protein sequence motifs." Nucleic Acids Res 34(Web Server 
issue): W369-373. 
Banerji, J., S. Rusconi and W. Schaffner (1981). "Expression of a beta-globin gene is 
enhanced by remote SV40 DNA sequences." Cell 27(2 Pt 1): 299-308. 
Benoist, C. and P. Chambon (1981). "In vivo sequence requirements of the SV40 early 
promotor region." Nature 290(5804): 304-310. 
Benyajati, C. and A. Worcel (1976). "Isolation, characterization, and structure of the 
folded interphase genome of Drosophila melanogaster." Cell 9(3): 393-407. 
Berezney, R. and D. S. Coffey (1974). "Identification of a nuclear protein matrix." 
Biochem Biophys Res Commun 60(4): 1410-1417. 
Berghella, L., L. De Angelis, T. De Buysscher, A. Mortazavi, S. Biressi, S. V. Forcales, 
D. Sirabella, G. Cossu and B. J. Wold (2008). "A highly conserved molecular 
switch binds MSY-3 to regulate myogenin repression in postnatal muscle." 
Genes & Development 22(15): 2125-2138. 
Blau, H. M., C. P. Chiu and C. Webster (1983). "Cytoplasmic activation of human 
nuclear genes in stable heterocaryons." Cell 32(4): 1171-1180. 
Blau, H. M., G. K. Pavlath, E. C. Hardeman, C. P. Chiu, L. Silberstein, S. G. Webster, S. 
C. Miller and C. Webster (1985). "Plasticity of the differentiated state." Science 
230(4727): 758-766. 
Branco, M. R. and A. Pombo (2006). "Intermingling of chromosome territories in 
interphase suggests role in translocations and transcription-dependent 
associations." PLoS Biol 4(5): e138. 
Breathnach, R. and P. Chambon (1981). "Organization and expression of eucaryotic split 
genes coding for proteins." Annu Rev Biochem 50: 349-383. 
Brent, R. and M. Ptashne (1984). "A bacterial repressor protein or a yeast transcriptional 
terminator can block upstream activation of a yeast gene." Nature 312(5995): 
612-615. 
Brown, K. E., S. S. Guest, S. T. Smale, K. Hahm, M. Merkenschlager and A. G. Fisher 
(1997). "Association of transcriptionally silent genes with Ikaros complexes at 
centromeric heterochromatin." Cell 91(6): 845-854. 
Buckingham, M. and P. W. Rigby (2014). "Gene regulatory networks and transcriptional 
mechanisms that control myogenesis." Dev Cell 28(3): 225-238. 
Casas-Delucchi, C. S., A. Brero, H. P. Rahn, I. Solovei, A. Wutz, T. Cremer, H. 
Leonhardt and M. C. Cardoso (2011). "Histone acetylation controls the inactive X 
chromosome replication dynamics." Nat Commun 2: 222. 
56 
 
Chambeyron, S. and W. A. Bickmore (2004). "Chromatin decondensation and nuclear 
reorganization of the HoxB locus upon induction of transcription." Genes Dev 
18(10): 1119-1130. 
Chepelev, I., G. Wei, D. Wangsa, Q. Tang and K. Zhao (2012). "Characterization of 
genome-wide enhancer-promoter interactions reveals co-expression of 
interacting genes and modes of higher order chromatin organization." Cell Res 
22(3): 490-503. 
Cheutin, T., M. F. O'Donohue, A. Beorchia, C. Klein, H. Kaplan and D. Ploton (2003). 
"Three-dimensional organization of pKi-67: a comparative fluorescence and 
electron tomography study using FluoroNanogold." J Histochem Cytochem 
51(11): 1411-1423. 
Chubb, J. R., S. Boyle, P. Perry and W. A. Bickmore (2002). "Chromatin motion is 
constrained by association with nuclear compartments in human cells." Current 
Biology 12(6): 439-445. 
Chung, J. H., A. C. Bell and G. Felsenfeld (1997). "Characterization of the chicken beta-
globin insulator." Proc Natl Acad Sci U S A 94(2): 575-580. 
Chung, J. H., M. Whiteley and G. Felsenfeld (1993). "A 5' element of the chicken beta-
globin domain serves as an insulator in human erythroid cells and protects 
against position effect in Drosophila." Cell 74(3): 505-514. 
Ciejek, E. M., M. J. Tsai and B. W. O'Malley (1983). "Actively transcribed genes are 
associated with the nuclear matrix." Nature 306(5943): 607-609. 
Cook, P. R. and I. A. Brazell (1978). "Spectrofluorometric measurement of the binding of 
ethidium to superhelical DNA from cell nuclei." Eur J Biochem 84(2): 465-477. 
Courey, A. J., S. E. Plon and J. C. Wang (1986). "The use of psoralen-modified DNA to 
probe the mechanism of enhancer action." Cell 45(4): 567-574. 
Cremer, T., C. Cremer, T. Schneider, H. Baumann, L. Hens and M. Kirsch-Volders 
(1982). "Analysis of chromosome positions in the interphase nucleus of Chinese 
hamster cells by laser-UV-microirradiation experiments." Hum Genet 62(3): 201-
209. 
de Wit, E. and W. de Laat (2012). "A decade of 3C technologies: insights into nuclear 
organization." Genes Dev 26(1): 11-24. 
Dierks, P., A. van Ooyen, M. D. Cochran, C. Dobkin, J. Reiser and C. Weissmann 
(1983). "Three regions upstream from the cap site are required for efficient and 
accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells." Cell 
32(3): 695-706. 
Dierks, P., A. van Ooyen, N. Mantei and C. Weissmann (1981). "DNA sequences 
preceding the rabbit beta-globin gene are required for formation in mouse L cells 
of beta-globin RNA with the correct 5' terminus." Proc Natl Acad Sci U S A 78(3): 
1411-1415. 
Dixon, J. R., S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J. S. Liu and B. Ren 
(2012). "Topological domains in mammalian genomes identified by analysis of 
chromatin interactions." Nature 485(7398): 376-380. 
Dostie, J., T. A. Richmond, R. A. Arnaout, R. R. Selzer, W. L. Lee, T. A. Honan, E. D. 
Rubio, A. Krumm, J. Lamb, C. Nusbaum, R. D. Green and J. Dekker (2006). 
"Chromosome Conformation Capture Carbon Copy (5C): a massively parallel 
solution for mapping interactions between genomic elements." Genome Res 
16(10): 1299-1309. 
Dynan, W. S. (1986). "Promoters for housekeeping genes." Trends in Genetics 2: 196-
197. 
57 
 
Farnham, P. J. and R. T. Schimke (1985). "Transcriptional regulation of mouse 
dihydrofolate-reductase in the cell-cycle." Journal of Biological Chemistry 
260(12): 7675-7680. 
Faye, G., D. W. Leung, K. Tatchell, B. D. Hall and M. Smith (1981). "Deletion mapping of 
sequences essential for in vivo transcription of the iso-1-cytochrome c gene." 
Proc Natl Acad Sci U S A 78(4): 2258-2262. 
Filippova, D., R. Patro, G. Duggal and C. Kingsford (2014). "Identification of alternative 
topological domains in chromatin." Algorithms Mol Biol 9: 14. 
Fisher-Aylor, K. I. (2011). Long distance looping maps: RNA Pol2 during differentiation. 
Nuclear Structure and Dynamics. L'Isle sur la Sorgue, France, EMBO. 
Francastel, C., M. C. Walters, M. Groudine and D. I. Martin (1999). "A functional 
enhancer suppresses silencing of a transgene and prevents its localization close 
to centrometric heterochromatin." Cell 99(3): 259-269. 
Fullwood, M. J., M. H. Liu, Y. F. Pan, J. Liu, H. Xu, Y. B. Mohamed, Y. L. Orlov, S. 
Velkov, A. Ho, P. H. Mei, E. G. Chew, P. Y. Huang, W. J. Welboren, Y. Han, H. 
S. Ooi, P. N. Ariyaratne, V. B. Vega, Y. Luo, P. Y. Tan, P. Y. Choy, K. D. Wansa, 
B. Zhao, K. S. Lim, S. C. Leow, J. S. Yow, R. Joseph, H. Li, K. V. Desai, J. S. 
Thomsen, Y. K. Lee, R. K. Karuturi, T. Herve, G. Bourque, H. G. Stunnenberg, X. 
Ruan, V. Cacheux-Rataboul, W. K. Sung, E. T. Liu, C. L. Wei, E. Cheung and Y. 
Ruan (2009). "An oestrogen-receptor-alpha-bound human chromatin 
interactome." Nature 462(7269): 58-64. 
Galande, S., P. K. Purbey, D. Notani and P. P. Kumar (2007). "The third dimension of 
gene regulation: organization of dynamic chromatin loopscape by SATB1." Curr 
Opin Genet Dev 17(5): 408-414. 
Gasser, S. M. and U. K. Laemmli (1986). "The organisation of chromatin loops: 
characterization of a scaffold attachment site." EMBO J 5(3): 511-518. 
Gasser, S. M. and U. K. Laemmli (1987). "Improved methods for the isolation of 
individual and clustered mitotic chromosomes." Exp Cell Res 173(1): 85-98. 
Gerasimova, T. I. and V. G. Corces (1998). "Polycomb and trithorax group proteins 
mediate the function of a chromatin insulator." Cell 92(4): 511-521. 
Gerasimova, T. I., D. A. Gdula, D. V. Gerasimov, O. Simonova and V. G. Corces (1995). 
"A Drosophila protein that imparts directionality on a chromatin insulator is an 
enhancer of position-effect variegation." Cell 82(4): 587-597. 
Gillies, S. D., S. L. Morrison, V. T. Oi and S. Tonegawa (1983). "A tissue-specific 
transcription enhancer element is located in the major intron of a rearranged 
immunoglobulin heavy chain gene." Cell 33(3): 717-728. 
Gluzman, Y., J. F. Sambrook and R. J. Frisque (1980). "Expression of early genes of 
origin-defective mutants of simian virus 40." Proc Natl Acad Sci U S A 77(7): 
3898-3902. 
Greally, J. M., D. J. Starr, S. Hwang, L. Song, M. Jaarola and S. Zemel (1998). "The 
mouse H19 locus mediates a transition between imprinted and non-imprinted 
DNA replication patterns." Hum Mol Genet 7(1): 91-95. 
Griffith, J., A. Hochschild and M. Ptashne (1986). "DNA loops induced by cooperative 
binding of lambda repressor." Nature 322(6081): 750-752. 
Grosschedl, R. and M. L. Birnstiel (1980). "Identification of regulatory sequences in the 
prelude sequences of an H2A histone gene by the study of specific deletion 
mutants in vivo." Proc Natl Acad Sci U S A 77(3): 1432-1436. 
Grosschedl, R. and M. L. Birnstiel (1980). "Spacer DNA sequences upstream of the T-A-
T-A-A-A-T-A sequence are essential for promotion of H2A histone gene 
transcription in vivo." Proc Natl Acad Sci U S A 77(12): 7102-7106. 
58 
 
Gruss, P., R. Dhar and G. Khoury (1981). "Simian virus 40 tandem repeated sequences 
as an element of the early promoter." Proc Natl Acad Sci U S A 78(2): 943-947. 
Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M. B. Faza, W. Talhout, B. H. Eussen, 
A. de Klein, L. Wessels, W. de Laat and B. van Steensel (2008). "Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions." Nature 453(7197): 948-951. 
Hakim, O., M. H. Sung, T. C. Voss, E. Splinter, S. John, P. J. Sabo, R. E. Thurman, J. A. 
Stamatoyannopoulos, W. de Laat and G. L. Hager (2011). "Diverse gene 
reprogramming events occur in the same spatial clusters of distal regulatory 
elements." Genome Res 21(5): 697-706. 
Handoko, L., H. Xu, G. Li, C. Y. Ngan, E. Chew, M. Schnapp, C. W. Lee, C. Ye, J. L. 
Ping, F. Mulawadi, E. Wong, J. Sheng, Y. Zhang, T. Poh, C. S. Chan, G. 
Kunarso, A. Shahab, G. Bourque, V. Cacheux-Rataboul, W. K. Sung, Y. Ruan 
and C. L. Wei (2011). "CTCF-mediated functional chromatin interactome in 
pluripotent cells." Nat Genet 43(7): 630-638. 
Harr, J. C., T. R. Luperchio, X. Wong, E. Cohen, S. J. Wheelan and K. L. Reddy (2015). 
"Directed targeting of chromatin to the nuclear lamina is mediated by chromatin 
state and A-type lamins." J Cell Biol 208(1): 33-52. 
Hebbes, T. R., A. L. Clayton, A. W. Thorne and C. Crane-Robinson (1994). "Core 
histone hyperacetylation co-maps with generalized DNase I sensitivity in the 
chicken beta-globin chromosomal domain." EMBO J 13(8): 1823-1830. 
Hochschild, A., N. Irwin and M. Ptashne (1983). "Repressor structure and the 
mechanism of positive control." Cell 32(2): 319-325. 
Iborra, F. J., A. Pombo, D. A. Jackson and P. R. Cook (1996). "Active RNA polymerases 
are localized within discrete transcription "factories' in human nuclei." J Cell Sci 
109(Pt 6): 1427-1436. 
Ip, Y. T., R. E. Park, D. Kosman, E. Bier and M. Levine (1992). "The dorsal gradient 
morphogen regulates stripes of rhomboid expression in the presumptive …." 
Genes Dev 6(9): 1728-1739. 
Jackson, D. A., A. B. Hassan, R. J. Errington and P. R. Cook (1993). "Visualization of 
focal sites of transcription within human nuclei." EMBO J 12(3): 1059-1065. 
Johnson, D. S., A. Mortazavi, R. M. Myers and B. Wold (2007). "Genome-wide mapping 
of in vivo protein-DNA interactions." Science 316(5830): 1497-1502. 
Kanji, G. K. (1999). 100 Statistical Tests, SAGE Publications Ltd., London, England. 
Kellum, R. and P. Schedl (1991). "A position-effect assay for boundaries of higher order 
chromosomal domains." Cell 64(5): 941-950. 
Kennell, D. and H. Riezman (1977). "Transcription and translation initiation frequencies 
of the Escherichia coli lac operon." Journal of Molecular Biology 114(1): 1-21. 
Kieffer-Kwon, K. R., Z. Tang, E. Mathe, J. Qian, M. H. Sung, G. Li, W. Resch, S. Baek, 
N. Pruett, L. Grontved, L. Vian, S. Nelson, H. Zare, O. Hakim, D. Reyon, A. 
Yamane, H. Nakahashi, A. L. Kovalchuk, J. Zou, J. K. Joung, V. Sartorelli, C. L. 
Wei, X. Ruan, G. L. Hager, Y. Ruan and R. Casellas (2013). "Interactome maps 
of mouse gene regulatory domains reveal basic principles of transcriptional 
regulation." Cell 155(7): 1507-1520. 
Kim, T. H., Z. K. Abdullaev, A. D. Smith, K. A. Ching, D. I. Loukinov, R. D. Green, M. Q. 
Zhang, V. V. Lobanenkov and B. Ren (2007). "Analysis of the vertebrate insulator 
protein CTCF-binding sites in the human genome." Cell 128(6): 1231-1245. 
Kosak, S. T. and M. Groudine (2004). "Gene order and dynamic domains." Science 
306(5696): 644-647. 
59 
 
Kosak, S. T., J. A. Skok, K. L. Medina, R. Riblet, M. M. Le Beau, A. G. Fisher and H. 
Singh (2002). "Subnuclear compartmentalization of immunoglobulin loci during 
lymphocyte development." Science 296(5565): 158-162. 
Kramer, H., M. Niemoller, M. Amouyal, B. Revet, B. von Wilcken-Bergmann and B. 
Muller-Hill (1987). "lac repressor forms loops with linear DNA carrying two 
suitably spaced lac operators." EMBO J 6(5): 1481-1491. 
Krebs, J. E. and M. Dunaway (1998). "The scs and scs' insulator elements impart a cis 
requirement on enhancer-promoter interactions." Mol Cell 1(2): 301-308. 
Lebkowski, J. S. and U. K. Laemmli (1982). "Evidence for two levels of DNA folding in 
histone-depleted HeLa interphase nuclei." J Mol Biol 156(2): 309-324. 
Li, G., X. Ruan, R. K. Auerbach, K. S. Sandhu, M. Zheng, P. Wang, H. M. Poh, Y. Goh, 
J. Lim, J. Zhang, H. S. Sim, S. Q. Peh, F. H. Mulawadi, C. T. Ong, Y. L. Orlov, S. 
Hong, Z. Zhang, S. Landt, D. Raha, G. Euskirchen, C. L. Wei, W. Ge, H. Wang, 
C. Davis, K. I. Fisher-Aylor, A. Mortazavi, M. Gerstein, T. Gingeras, B. Wold, Y. 
Sun, M. J. Fullwood, E. Cheung, E. Liu, W. K. Sung, M. Snyder and Y. Ruan 
(2012). "Extensive promoter-centered chromatin interactions provide a 
topological basis for transcription regulation." Cell 148(1-2): 84-98. 
Li, G. L., X. A. Ruan, R. K. Auerbach, K. S. Sandhu, M. Z. Zheng, P. Wang, H. M. Poh, 
Y. Goh, J. Lim, J. Y. Zhang, H. S. Sim, S. Q. Peh, F. H. Mulawadi, C. T. Ong, Y. 
L. Orlov, S. Z. Hong, Z. Z. Zhang, S. Landt, D. Raha, G. Euskirchen, C. L. Wei, 
W. H. Ge, H. E. Wang, C. Davis, K. I. Fisher-Aylor, A. Mortazavi, M. Gerstein, T. 
Gingeras, B. Wold, Y. Sun, M. J. Fullwood, E. Cheung, E. Liu, W. K. Sung, M. 
Snyder and Y. J. Ruan (2012). "Extensive Promoter-Centered Chromatin 
Interactions Provide a Topological Basis for Transcription Regulation." Cell 
148(1-2): 84-98. 
Li, Y., W. Huang, L. Niu, D. M. Umbach, S. Covo and L. Li (2013). "Characterization of 
constitutive CTCF/cohesin loci: a possible role in establishing topological 
domains in mammalian genomes." BMC Genomics 14: 553. 
Liberman, L. M. and A. Stathopoulos (2009). "Design flexibility in cis-regulatory control of 
gene expression: synthetic and comparative evidence." Dev Biol 327(2): 578-
589. 
Lieberman-Aiden, E., N. L. van Berkum, L. Williams, M. Imakaev, T. Ragoczy, A. Telling, 
I. Amit, B. R. Lajoie, P. J. Sabo, M. O. Dorschner, R. Sandstrom, B. Bernstein, M. 
A. Bender, M. Groudine, A. Gnirke, J. Stamatoyannopoulos, L. A. Mirny, E. S. 
Lander and J. Dekker (2009). "Comprehensive mapping of long-range 
interactions reveals folding principles of the human genome." Science 326(5950): 
289-293. 
Ling, J. Q., T. Li, J. F. Hu, T. H. Vu, H. L. Chen, X. W. Qiu, A. M. Cherry and A. R. 
Hoffman (2006). "CTCF mediates interchromosomal colocalization between 
Igf2/H19 and Wsb1/Nf1." Science 312(5771): 269-272. 
MacArthur, S., X. Y. Li, J. Li, J. B. Brown, H. C. Chu, L. Zeng, B. P. Grondona, A. 
Hechmer, L. Simirenko, S. V. Keranen, D. W. Knowles, M. Stapleton, P. Bickel, 
M. D. Biggin and M. B. Eisen (2009). "Developmental roles of 21 Drosophila 
transcription factors are determined by quantitative differences in binding to an 
overlapping set of thousands of genomic regions." Genome Biol 10(7): R80. 
Magistri, M., M. A. Faghihi, G. St Laurent, 3rd and C. Wahlestedt (2012). "Regulation of 
chromatin structure by long noncoding RNAs: focus on natural antisense 
transcripts." Trends Genet 28(8): 389-396. 
60 
 
Mallin, D. R., J. S. Myung, J. S. Patton and P. K. Geyer (1998). "Polycomb group 
repression is blocked by the Drosophila suppressor of Hairy-wing [su(Hw)] 
insulator." Genetics 148(1): 331-339. 
Markstein, M., P. Markstein, V. Markstein and M. S. Levine (2002). "Genome-wide 
analysis of clustered Dorsal binding sites identifies putative target genes in the 
Drosophila embryo." Proceedings of the National Academy of Sciences 99(2): 
763. 
Markstein, M., R. Zinzen, P. Markstein, K. P. Yee, A. Erives, A. Stathopoulos and M. 
Levine (2004). "A regulatory code for neurogenic gene expression in the 
Drosophila embryo." Development 131(10): 2387-2394. 
McKnight, S. L., R. C. Kingsbury, A. Spence and M. Smith (1984). "The distal 
transcription signals of the herpesvirus tk gene share a common hexanucleotide 
control sequence." Cell 37(1): 253-262. 
Mercola, M., X. F. Wang, J. Olsen and K. Calame (1983). "Transcriptional enhancer 
elements in the mouse immunoglobulin heavy chain locus." Science 221(4611): 
663-665. 
Meshorer, E. and T. Misteli (2006). "Chromatin in pluripotent embryonic stem cells and 
differentiation." Nat Rev Mol Cell Biol 7(7): 540-546. 
Mirkovitch, J., M. E. Mirault and U. K. Laemmli (1984). "Organization of the higher-order 
chromatin loop: specific DNA attachment sites on nuclear scaffold." Cell 39(1): 
223-232. 
Mitchell, J. A. and P. Fraser (2008). "Transcription factories are nuclear 
subcompartments that remain in the absence of transcription." Genes Dev 22(1): 
20-25. 
Morcillo, P., C. Rosen, M. K. Baylies and D. Dorsett (1997). "Chip, a widely expressed 
chromosomal protein required for segmentation and activity of a remote wing 
margin enhancer in Drosophila." Genes Dev 11(20): 2729-2740. 
Mortazavi, A., B. A. Williams, K. McCue, L. Schaeffer and B. Wold (2008). "Mapping and 
quantifying mammalian transcriptomes by RNA-Seq." Nat Methods 5(7): 621-
628. 
Muller, H. P. and W. Schaffner (1990). "Transcriptional enhancers can act in trans." 
Trends in Genetics 6(9): 300-304. 
Muller, H. P., J. M. Sogo and W. Schaffner (1989). "An enhancer stimulates transcription 
in trans when attached to the promoter via a protein bridge." Cell 58(4): 767-777. 
Muller, M. M., T. Gerster and W. Schaffner (1988). "Enhancer sequences and the 
regulation of gene-transcription." European Journal of Biochemistry 176(3): 485-
495. 
Nabirochkin, S., M. Ossokina and T. Heidmann (1998). "A nuclear matrix/scaffold 
attachment region co-localizes with the gypsy retrotransposon insulator 
sequence." J Biol Chem 273(4): 2473-2479. 
Nakagomi, K., Y. Kohwi, L. A. Dickinson and T. Kohwi-Shigematsu (1994). "A novel 
DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1." 
Mol Cell Biol 14(3): 1852-1860. 
Namciu, S. J., K. B. Blochlinger and R. E. Fournier (1998). "Human matrix attachment 
regions insulate transgene expression from chromosomal position effects in 
Drosophila melanogaster." Mol Cell Biol 18(4): 2382-2391. 
Neuberger, M. S. (1983). "Expression and regulation of immunoglobulin heavy chain 
gene transfected into lymphoid cells." EMBO J 2(8): 1373-1378. 
Noordermeer, D., M. R. Branco, E. Splinter, P. Klous, W. van Ijcken, S. Swagemakers, 
M. Koutsourakis, P. van der Spek, A. Pombo and W. de Laat (2008). 
61 
 
"Transcription and chromatin organization of a housekeeping gene cluster 
containing an integrated beta-globin locus control region." PLoS Genet 4(3): 
e1000016. 
Noordermeer, D., E. de Wit, P. Klous, H. van de Werken, M. Simonis, M. Lopez-Jones, 
B. Eussen, A. de Klein, R. H. Singer and W. de Laat (2011). "Variegated gene 
expression caused by cell-specific long-range DNA interactions." Nat Cell Biol 
13(8): 944-951. 
Ogawa, N., and Biggin, M. D. (2012). "High-throughput SELEX determination of DNA 
sequences bound by transcription factors in vitro." Methods Mol Biol 786: 51-63. 
Ong, C. T. and V. G. Corces (2014). "CTCF: an architectural protein bridging genome 
topology and function." Nat Rev Genet 15(4): 234-246. 
Osborne, C. S., L. Chakalova, K. E. Brown, D. Carter, A. Horton, E. Debrand, B. 
Goyenechea, J. A. Mitchell, S. Lopes, W. Reik and P. Fraser (2004). "Active 
genes dynamically colocalize to shared sites of ongoing transcription." Nat Genet 
36(10): 1065-1071. 
Palstra, R. J., M. Simonis, P. Klous, E. Brasset, B. Eijkelkamp and W. de Laat (2008). 
"Maintenance of long-range DNA interactions after inhibition of ongoing RNA 
polymerase II transcription." PLoS One 3(2): e1661. 
Pepke, S., B. Wold and A. Mortazavi (2009). "Computation for ChIP-seq and RNA-seq 
studies." Nat Methods 6(11 Suppl): S22-32. 
Peric-Hupkes, D., W. Meuleman, L. Pagie, S. W. Bruggeman, I. Solovei, W. Brugman, S. 
Graf, P. Flicek, R. M. Kerkhoven, M. van Lohuizen, M. Reinders, L. Wessels and 
B. van Steensel (2010). "Molecular maps of the reorganization of genome-
nuclear lamina interactions during differentiation." Mol Cell 38(4): 603-613. 
Phillips-Cremins, J. E., M. E. Sauria, A. Sanyal, T. I. Gerasimova, B. R. Lajoie, J. S. Bell, 
C. T. Ong, T. A. Hookway, C. Guo, Y. Sun, M. J. Bland, W. Wagstaff, S. Dalton, 
T. C. McDevitt, R. Sen, J. Dekker, J. Taylor and V. G. Corces (2013). 
"Architectural protein subclasses shape 3D organization of genomes during 
lineage commitment." Cell 153(6): 1281-1295. 
Pickersgill, H., B. Kalverda, E. de Wit, W. Talhout, M. Fornerod and B. van Steensel 
(2006). "Characterization of the Drosophila melanogaster genome at the nuclear 
lamina." Nat Genet 38(9): 1005-1014. 
Plon, S. E. and J. C. Wang (1986). "Transcription of the human beta-globin gene is 
stimulated by an SV40 enhancer to which it is physically linked but topologically 
uncoupled." Cell 45(4): 575-580. 
Pope, B. D., T. Ryba, V. Dileep, F. Yue, W. S. Wu, O. Denas, D. L. Vera, Y. L. Wang, R. 
S. Hansen, T. K. Canfield, R. E. Thurman, Y. Cheng, G. Gulsoy, J. H. Dennis, M. 
P. Snyder, J. A. Stamatoyannopoulos, J. Taylor, R. C. Hardison, T. Kahveci, B. 
Ren and D. M. Gilbert (2014). "Topologically associating domains are stable units 
of replication-timing regulation." Nature 515(7527): 402-+. 
Robin, J. D., A. T. Ludlow, K. Batten, M. C. Gaillard, G. Stadler, F. Magdinier, W. E. 
Wright and J. W. Shay (2015). "SORBS2 transcription is activated by telomere 
position effect-over long distance upon telomere shortening in muscle cells from 
patients with facioscapulohumeral dystrophy." Genome Res 25(12): 1781-1790. 
Robinson, S. I., D. Small, R. Idzerda, G. S. McKnight and B. Vogelstein (1983). "The 
association of transcriptionally active genes with the nuclear matrix of the chicken 
oviduct." Nucleic Acids Res 11(15): 5113-5130. 
Roulet, E., S. Busso, A. A. Camargo, A. J. Simpson, N. Mermod and P. Bucher (2002). 
"High-throughput SELEX SAGE method for quantitative modeling of 
transcription-factor binding sites." Nat Biotechnol 20(8): 831-835. 
62 
 
Schaffner, W., G. Kunz, H. Daetwyler, J. Telford, H. O. Smith and M. L. Birnstiel (1978). 
"Genes and spacers of cloned sea urchin histone DNA analyzed by sequencing." 
Cell 14(3): 655-671. 
Serfling, E., M. Jasin and W. Schaffner (1985). "ENHANCERS AND EUKARYOTIC 
GENE-TRANSCRIPTION." Trends in Genetics 1(8): 224-230. 
Serfling, E., A. Lubbe, K. Dorsch-Hasler and W. Schaffner (1985). "Metal-dependent 
SV40 viruses containing inducible enhancers from the upstream region of 
metallothionein genes." EMBO J 4(13B): 3851-3859. 
Shopland, L. S., C. R. Lynch, K. A. Peterson, K. Thornton, N. Kepper, J. Hase, S. Stein, 
S. Vincent, K. R. Molloy, G. Kreth, C. Cremer, C. J. Bult and T. P. O'Brien (2006). 
"Folding and organization of a contiguous chromosome region according to the 
gene distribution pattern in primary genomic sequence." J Cell Biol 174(1): 27-38. 
Siebenlist, U., R. B. Simpson and W. Gilbert (1980). "E. coli RNA polymerase interacts 
homologously with two different promoters." Cell 20(2): 269-281. 
Simonis, M., P. Klous, E. Splinter, Y. Moshkin, R. Willemsen, E. de Wit, B. van Steensel 
and W. de Laat (2006). "Nuclear organization of active and inactive chromatin 
domains uncovered by chromosome conformation capture-on-chip (4C)." Nat 
Genet 38(11): 1348-1354. 
Small, D., B. Nelkin and B. Vogelstein (1985). "The association of transcribed genes with 
the nuclear matrix of Drosophila cells during heat shock." Nucleic Acids Res 
13(7): 2413-2431. 
Splinter, E., H. Heath, J. Kooren, R. J. Palstra, P. Klous, F. Grosveld, N. Galjart and W. 
de Laat (2006). "CTCF mediates long-range chromatin looping and local histone 
modification in the beta-globin locus." Genes Dev 20(17): 2349-2354. 
Stathopoulos, A. and M. Levine (2002). "Whole-Genome Expression Profiles Identify 
Gene Batteries in Drosophila." Developmental Cell 3(4): 464-465. 
Stathopoulos, A. and M. Levine (2005). "Genomic Regulatory Networks and Animal 
Development." Developmental Cell 9(4): 449. 
Stathopoulos, A., M. Van Drenth, A. Erives, M. Markstein and M. Levine (2002). "Whole-
genome analysis of dorsal-ventral patterning in the Drosophila embryo." Cell 
111(5): 687-701. 
ten Bosch, J. R., J. A. Benavides and T. W. Cline (2006). "The TAGteam DNA motif 
controls the timing of Drosophila pre-blastoderm transcription." Development 
133(10): 1967. 
Theveny, B., A. Bailly, C. Rauch, M. Rauch, E. Delain and E. Milgrom (1987). 
"Association of DNA-bound progesterone receptors." Nature 329(6134): 79-81. 
Tiwari, V. K., L. Cope, K. M. McGarvey, J. E. Ohm and S. B. Baylin (2008). "A novel 6C 
assay uncovers Polycomb-mediated higher order chromatin conformations." 
Genome Res 18(7): 1171-1179. 
Udvardy, A., E. Maine and P. Schedl (1985). "The 87A7 chromomere. Identification of 
novel chromatin structures flanking the heat shock locus that may define the 
boundaries of higher order domains." J Mol Biol 185(2): 341-358. 
van Steensel, B. and S. Henikoff (2000). "Identification of in vivo DNA targets of 
chromatin proteins using tethered dam methyltransferase." Nat Biotechnol 18(4): 
424-428. 
Verschure, P. J., I. van Der Kraan, E. M. Manders and R. van Driel (1999). "Spatial 
relationship between transcription sites and chromosome territories." J Cell Biol 
147(1): 13-24. 
63 
 
Weber, F., J. de Villiers and W. Schaffner (1984). "An SV40 'enhancer trap' incorporates 
exogenous enhancers or generates enhancers from its own sequences." Cell 
36(4): 983-992. 
Wiesendanger, B., R. Lucchini, T. Koller and J. M. Sogo (1994). "Replication fork 
barriers in the Xenopus rDNA." Nucleic Acids Res 22(23): 5038-5046. 
Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein 
and R. Axel (1979). "Transformation of mammalian cells with genes from 
procaryotes and eucaryotes." Cell 16(4): 777-785. 
Wold, B., M. Wigler, E. Lacy, T. Maniatis, S. Silverstein and R. Axel (1979). "Introduction 
and expression of a rabbit beta-globin gene in mouse fibroblasts." Proc Natl Acad 
Sci U S A 76(11): 5684-5688. 
Wurtele, H. and P. Chartrand (2006). "Genome-wide scanning of HoxB1-associated loci 
in mouse ES cells using an open-ended Chromosome Conformation Capture 
methodology." Chromosome Res 14(5): 477-495. 
Yaffe, D. and O. Saxel (1977). "Serial passaging and differentiation of myogenic cells 
isolated from dystrophic mouse muscle." Nature 270(5639): 725-727. 
Yee, S. P. and P. W. Rigby (1993). "The regulation of myogenin gene expression during 
the embryonic development of the mouse." Genes Dev 7(7A): 1277-1289. 
Zeng, M. e. a. (2015). in review. 
Zhang, Y., T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson, B. E. Bernstein, C. 
Nusbaum, R. M. Myers, M. Brown, W. Li and X. S. Liu (2008). "Model-based 
analysis of ChIP-Seq (MACS)." Genome Biol 9(9): R137. 
Zhao, Z., G. Tavoosidana, M. Sjolinder, A. Gondor, P. Mariano, S. Wang, C. Kanduri, M. 
Lezcano, K. S. Sandhu, U. Singh, V. Pant, V. Tiwari, S. Kurukuti and R. Ohlsson 
(2006). "Circular chromosome conformation capture (4C) uncovers extensive 
networks of epigenetically regulated intra- and interchromosomal interactions." 
Nat Genet 38(11): 1341-1347. 
Zinzen, R., K. Senger, M. Levine and D. Papatsenko (2006). "Computational Models for 
Neurogenic Gene Expression in the Drosophila Embryo." Current Biology 16(13): 
1358-1365. 
 
  
64 
 
 
Chapter III: Transcriptional topology 
III.1: Introduction: What we knew about transcriptional topology at the beginning 
of this project 
 Transcriptional topology, the portion of chromatin topology involved in 
transcriptional regulation, has been conceptually differentiated from chromatin topology 
since the “looping model” of enhancement came to prominence (Muller, Sogo et al. 
1989) but genes, their location, and their activity have been studies with respect to 
chromatin outside of enhancement alone.  MARs (DNA regions associating with the 
nuclear matrix) marking boundaries of active chromatin domains was a popular field in 
the 80s (see (Mirkovitch, Mirault et al. 1984)), and it was known that active genes 
associate with MARs in a variety of organisms (Robinson, Small et al. 1983; Ciejek, Tsai 
et al. 1983; Small, Nelkin et al. 1985; Gasser and Laemmli 1986), and even that MARs 
in some case overlapped enhancers.  In the 2000s, people began to study chromatin 
conformation and its effects on genes more closely, noting that some genes are able to 
“loop out” of place upon activation (Chambeyron and Bickmore 2004), and that gene-
poor and gene-rich regions separate (Shopland, Lynch et al. 2006), or that only certain 
classes of genes do this (Simonis, Klous et al. 2006).  Along with this line of thinking 
came the notion of the “transcription factory,” previously noted through microscopy as 
rare foci of pol2 (Jackson, Hassan et al. 1993; Iborra, Pombo et al. 1996) actively 
transcribing genes (Verschure, van Der Kraan et al. 1999), as a method for groups of 
related genes to be expressed, and perhaps a primary mode of transcription. 
Transcription factories are according to some definitions architecturally unchanging 
elements since genes can move to and from transcription factories (Osborne, Chakalova 
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et al. 2004) and their existence does not depend on transcription itself (Mitchell and 
Fraser 2008; Palstra, Simonis et al. 2008).   
 The contemporary genome-wide chromatin literature talks much about a 
potentially related concept called a “topologically active domain” (TAD), a region of 
chromatin containing active genes capable of interacting with each other and bounded 
by CTCF and cohesin (Dixon, Selvaraj et al. 2012; Li, Huang et al. 2013).  It is unknown 
how much the modern TAD has in common with earlier understanding of separate gene-
rich and gene-poor areas; whether it explains all or only some.  In addition to containing 
active genes, TADs seem to have a role in the timing of cell replication (Pope, Ryba et 
al. 2014) and are also associated with Lamin-associated domains (Peric-Hupkes, 
Meuleman et al. 2010).  The TAD is by no means the smallest unit of chromatin within 
which genes preferentially interact, which may be understandable since the TAD was 
defined by the 1MB-resolution Hi-C method, while other domains, sometimes 
confusingly called “smaller TADs,” are found with more highly sensitive measures like 
5C and with more computational processing (Phillips-Cremins, Sauria et al. 2013; 
Filippova, Patro et al. 2014). 
 All of the above now appears quite relevant to this study since most genes that 
connect to far-distal elements connect to elements within their neighborhood of about 
150kb.  A gene’s neighborhood must be important with respect to what most genes 
connect since all of those connections are within that neighborhood, and the above bulk-
scale or microscopy assays showing active elements connecting to other active 
elements are likely related to a subset of the larger CIGs I report.  Others have reported 
that there are some active-gene-poor and some active-gene-rich areas (“ridges”) and it 
has even been claimed that certain meta-classes of genes such as transcription factors 
are more likely to be in gene-poor areas versus in gene-rich areas like lineage-specific 
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genes are (Lercher, Urrutia et al. 2002). However, a similar paper found that 
developmentally related genes could actually be in either type of area (Versteeg, van 
Schaik et al. 2003). 
 Then there are the cases of known, validated E:P “looping” interactions. 
Considering this background, pol2 ChIA-PET data are expected to identify physical 
interactions of several different functional classes.  I am most likely seeing many classic 
E:P “looping” interactions, but I am also surely seeing interactions that are primarily 
involved in the nuclear architecture.  Such interactions can be mediated by known DNA-
site specific chromatin factors such as CTCF (Splinter, Heath et al. 2006; Kim, Abdullaev 
et al. 2007; Handoko, Xu et al. 2011; Ong and Corces 2014), ZNF143 (Bailey, Zhang et 
al. 2015), or YY1 (Harr, Luperchio et al. 2015; Zeng 2015), as well as less sequence-
specific factors (Galande, Purbey et al. 2007) and likely less-known factors and RNA 
components (Magistri, Faghihi et al. 2012) as well.  In chapter III, I focused on the 
general aspects of topology that are consistent across ChIA-PET experiments.  In this 
chapter, I will focus on the topological interactions that are different between genes of 
different expression classes. 
III.1.1: State-to-state changes  
 Globally, chromatin interactions are not thought to change much (Simonis, Klous 
et al. 2006; Hakim, Sung et al. 2011). Nevertheless, some E:P interactions have been 
shown to be transient and dependent on transcription (Cheutin, O'Donohue et al. 2003; 
Kosak and Groudine 2004; Meshorer and Misteli 2006).  One experimentally-driven 
hypothesis is that rearrangement of CRMs can only occur within certain native active 
chromatin domains (Noordermeer, Branco et al. 2008).  I will report in this chapter on the 
changes in detectible interactions between two developmental states, but a caveat is 
that these interactions may well be invisible to us before genes are active, since the 
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ChIA-PET experiments I undertook only detect interactions that co-occur with ChIPpable 
factors associated with transcription.  Therefore, ChIA-PET cannot tell us where 
connectivity changes, only where the active use of connected elements may change 
from state to state. 
III.1.2: Housekeeping genes 
 The notion of the housekeeping gene has been prevalent since the discovery of 
genes themselves.  Since certain enzymes, structural elements, and other core parts of 
the universal cellular machinery must be expressed at roughly similar levels in every cell, 
the reasoning goes, these genes don’t need to be regulated.  Housekeeping genes are 
often used as a foil or control for developmental genes, which are regulated and 
differentially expressed in different cell types.  
 The promoters of some housekeeping genes were investigated during the course 
of researching promoter and transcription biochemistry, but because of the technologic 
limits of the day, highly-expressed genes had to be studied and genes involved in 
disease and development were investigated first.  It was probably the fact that TATA is 
prevalent in the promoters of developmental genes that led to it being the first promoter 
motif discovered in mammals (Goldberg 1989), a bias that was noticed by the 
researchers of the time (Breathnach and Chambon 1981).  In contrast, the TATA-less 
genes were generally regarded as housekeeping genes with low expression levels and 
multiple 5’ ends (Dynan 1986). 
 Perhaps it was because the promoters of housekeeping genes seemed more 
complicated to study than that of the developmental genes, or perhaps because many 
were expressed at a modest level, or perhaps because developmentally regulated genes 
have traditionally been more scientifically exciting, but for a type of gene that is often 
used as a conceptual foil or experimental foil, housekeeping genes have fallen by the 
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wayside in terms of direct research.  One reason that surely has played a part in this 
lack of research is that, somewhere along the line, “being regulated” became 
synonymous colloquially with “has enhancer(s).”  Housekeeping genes, thought to have 
steady expression levels, are assumed to maintain these steady expression levels by 
virtue of a constitutively active promoter.  Meanwhile, developmental genes, which have 
varying levels of expression, need CRMs in order to modulate their levels of transcription 
over development and in different tissues.   
 A few people have managed to study the regulation of housekeeping genes, 
though.  One person who studied a vital housekeeping gene, DFHR, was Dr. Peggy 
Farnham, despite the difficulties of obtaining funding for something assumed not to 
happen (B. Wold, pers. comm.).  Dr. Farnham found that it did, indeed, have enhancers 
(Farnham and Schimke 1985).  However, Dr. Farnham attributed this need for 
enhancers to the fact that DFHR was known to be differentially regulated in the cell cycle 
and did not attempt to question whether housekeeping genes broadly had enhancers.  
Likewise, in the case of string in Drosophila, in which the gene appeared at the level of 
tissues to be broadly expressed but was in fact differentially regulated at the level of 
cells, enhancers were found, but again were written off as a peculiarity of the particular 
gene studied.  Enhancers continued to be studied almost exclusively in the context of 
developmental genes over the next decade, and the preponderance of developmental 
gene enhancer literature and absence of housekeeping gene expression literature 
sometimes seemingly led many to forget the formal possibility that housekeeping genes 
in general might have enhancers. 
 Is it really possible for any gene, much less most genes, to truly be unregulated 
in any way in every cell type?  Some cell types like immune cells with their rearranged 
genomes or neurons and spermatocytes with their uniquely stripped-down metabolic 
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requirements surely contain a large number of “housekeeping” genes with varied levels 
of expression relative to the other tissues in the body.  Furthermore, even genes that are 
known to be regulated by enhancers can appear to drive native expression patterns with 
their proximal promoters alone, as was once the case with myogenin (Yee and Rigby 
1993), so the lack of apparent necessity, in assay, for CRMs does not disprove their 
existence. 
III.2: Results 
III.2.1: Connectivity and amount of gene expression 
Does connectivity, as measured by ChIA-PET, predict level of gene expression?  Since the 
presence of pol2 is required to detect a ChIA-PET connection and is correlated with active 
genes (Mortazavi, Williams et al. 2008), a positive correlation is expected and is observed.  
Further, this correlation is quantitative, with the most highly expressed being the most 
likely to have detectible connections (Fig. III-1).  Surprisingly, this is not due to the source 
ChIP being pol2; it is also true of myogenin ChIA-PET (Fig. III-1, bottom).  From a related 
perspective, larger CIGs are more likely than smaller CIGs to contain highly expressed 
genes (Fig. III-8). 
III.2.2: Gene-distal interactions 
 Are the majority of gene-to-distal interactions multiple, as in the case of the β-
globin LCR, or are genes regulated by many enhancers, either timing-specific or tissue-
specific, each?  I have shown that the majority of captured ChIA-PET interactions are one-
to-one (Fig. II-9), and this likely suggests that most genes, which are modestly expressed, 
connect to one distal element, but I also discovered large sets of more complex 
interactions.  First, there are hundreds of instances of individual distal elements 
connecting to multiple genes (Fig. III-3A), which was perhaps less expected than the 
pattern of multiple distal elements connecting to one gene (Fig. III-3B).  Distal elements, 
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whether they connect with only one gene or multiple genes, all connect to the nearest 
annotated active gene, even the 25% of elements that connect to multiple genes (Fig. III-2, 
right).  The majority of genes without a ChIA-PET connection are not detectably expressed 
(Fig. III-1, compare Figures I-3 to III-4).  I used available C2C12 active and repressive 
chromatin mark data, and skipped over genes that lack any of the active or repressive 
chromatin marks assayed, opposed to connected genes, which have active marks as 
expected (data not shown).  However, due to the relatively little data on repressive marks 
in our laboratory collection or the literature, I cannot comment on the biochemistry 
underlying gene-skipping, other than to say that it is consistent with a previous microscope 
experiment’s claim that inactive genes “loop out” of transcription factories (Mitchell and 
Fraser 2008). 
III.2.3: Connectivity and changes in gene expression 
 I next wanted to know how ChIA-PET connections changed over time.  It has been 
reported that E:P interactions do change with transcription, but also that many are 
constant across tissue types (Simonis, Klous et al. 2006).  In order to determine how 
change in gene expression relates to ChIA-PET, I chose to create four well-defined 
trajectories of gene expression – up, flat, down, and off – to analyze with respect to each 
other, while leaving behind genes that are ambiguously expressed or that have an 
ambiguous trajectory (Fig. III-4).  The change in ChIA-PET connectivity from myoblast to 
myocyte correlates highly with the change in gene expression (Fig. III-5).  This could mean 
that flat genes are unlikely to change their architecture, while developmentally regulated 
genes might.  Alternatively, heeding the cautions from Fig. II-5, the architecture could 
remain constant while increased input from CRMs could cause the increase in gene 
expression.  Another, less likely, possibility is that high expression at one promoter 
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somehow bleeds over into surrounding genomic area, increasing the number of ChIA-PET 
connections returned. 
III.2.4: Distal degree shows a preference for gene type 
 To further quantify ChIA-PET connectivity within the up, flat, down, and off groups, 
I measured the degree.  The degree of a gene is not as closely correlated with its 
expression (data not shown) as edge weight is (Fig. III-5).  When measuring specifically 
the distal degree (distal connection number per gene) in linear regression versus gene 
expression, it became clear that while distal degree is weakly correlated with expression 
level (data not shown), it is strongly correlated with gene trajectory, specifically, the 
upregulated genes (Fig. III-7, top).  Flat genes have no such correlation (data not shown).    
 I have shown that the amount of ChIA-PET connectivity is partially related to the 
quantity of a gene’s expression.  However, I wanted to determine if the striking results in 
the upregulated set of genes were due to expression change alone, or if they showed 
evidence of being connected in a qualitatively different way from other genes.  To further 
explore the distinction between upregulated and flat genes, I asked how for each trajectory 
group distal connectivity is distributed with respect to RNA amount.  For each RNA 
abundance class, I quantified the global myocyte distal degree.  There is a strong 
distinction (P<10-5) for medium- and high-abundance upregulated genes to have a higher 
distal degree than flat genes of the same abundance (Fig. III-7, bottom). 
III.2.5: Promoter-promoter connections 
            Almost a third of pol2 ChIA-PET interactions are gene-gene interactions, which in 
our data define gene vertices centered at transcription start sites (see Materials and 
Methods).  In two contemporary studies, the authors suggested that such ChIA-PET 
connections reflect, and may even cause, co-regulation (Chepelev, Wei et al. 2012; Li, 
Ruan et al. 2012; Kieffer-Kwon, Tang et al. 2013). My differentiation system is well-suited 
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to test this with XX G-G connections overall, YY containing at least one significantly up- or 
down-regulated gene, and ZZ containing genes of substantial trajectory >50FPKM.  I 
interrogated my data in several different ways to ask if, globally, G-G connectivity predicts 
co-regulation of the paired genes.  I found no statistically significant correlation overall 
between pairs of genes with respect to their expression levels (data not shown) when I 
confined the analysis to active genes, since unexpressed genes aren’t expected to 
connect (and therefore will give a false positive significant result when included in the null 
hypothesis). Similarly, there was no significant correlation between expression trajectory of 
pairs of connected gene vertices (data not shown).  However, the G-G landscape isn’t 
completely random.  Flat genes, the most expressed gene type, are connected equally 
with each other, and with upregulated or downregulated, while the two differential classes 
are almost never connected (Fig. III-6, left versus center bars). 
 Although there was no global evidence of co-regulation associated globally with 
gene-gene pol2 connectivity, inspection of several loci of known biological interest led me 
to ask whether a more narrowly defined set of development genes, isolating the most 
extreme expression differences, are overrepresented in certain expression patterns.  I 
compared the activity of genes which directly or indirectly connect to super-differential 
“seed” genes to all genes within the 2Mb window available to the ChIA-PET connections 
of the “seed” genes (Fig. III-6, top).  I found that members of the group of 252 extremely 
upregulated muscle genes are more likely to be close to other myogenic genes than other 
groups of genes, but even taking this into consideration, they were also more likely to 
connect to other upregulated genes (Fig. III-6, bottom).  A similar analysis with 
downregulated genes just barely failed statistical significance, perhaps because of low n, 
and there was no such result with flat genes (data not shown).  This suggests that only the 
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small subsets of developmentally regulated genes are candidates for co-regulation, while 
the majority of G-G interactions reflect co-expression. 
 For large graph analysis, one interpretation is that the additive effect of enhancers 
causes high expression.  Another interpretation is that expression at some modestly and 
steadily expressed genes may be a byproduct of being physically connected to an 
important gene.   
III.3: Discussion/Conclusions 
 First, I reported that the number of multiple gene and distal interactions was 
unexpectedly high based on the founding ChIA-PET paper (Fullwood, Liu et al. 2009), and 
then I explored the likewise unexpected number of gene-gene interactions.  Separating 
connected genes according to their behavior, I showed that flat, presumptively 
“housekeeping” genes connect to all classes of genes with equal frequency.  This applies 
to direct and indirect connections.  In contrast, upregulated and downregulated genes 
never connect directly to each other, and rarely are connected indirectly.  Upregulated and 
downregulated genes share several MRFs (in C2’s, myoD; elsewhere, myf5 and mrf4 too), 
and they show slight genomic separation (Fig. III-6).  Perhaps their CRMs must be 
spatially separated from each other to avoid cross-activation, or maybe the result is an 
“accident” of evolutionary gene groups being linked on the chromosome. 
 Next, I explored connectivity as a function of expression amount and as a function 
of behavior class.  The amount of expression appears to predict whether or not a gene will 
have detectible long-range interactions, and trajectory predicts how many long-range 
interactions there will be.  Developmentally specific genes can be predicted by ChIA-PET 
edge changes, and this, plus the small number of connected, unexpressed genes, predicts 
that “poised” pol2-containing structures are minimal and perhaps rare. 
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 A final main conclusion not anticipated by prior ChIA-PET studies is that 
upregulated myogenic differentiation genes are significantly more likely to be connected to 
multiple distal elements than are genes in the large “housekeeping” group.  This is strongly 
observed for both highly and moderately active genes, and suggests a subset of myogenic 
genes are an ancient conserved gene class that is regulated differently than the simple, 
ubiquitously expressed housekeeping genes or developmental genes that are in gene 
deserts. 
What about transcription factories?  
 The notion of the transcription factory has been raised in conjunction with ChIA-
PET (Li, Ruan et al. 2012).  However, the definition of “transcription factory” is not used 
consistently at all in the literature.  The original “transcription factory” was an immobile 
area of high RNA polymerase II density visible under the light microscope after staining 
for the protein (Jackson, Hassan et al. 1993; Iborra, Pombo et al. 1996).  It was 
hypothesized that these loci were stationary areas containing transcriptional machinery 
where multiple genes could physically interact in order to be transcribed (Jackson, Iborra 
et al. 1998; Cook 1999; Francastel, Walters et al. 1999).   
 However, others, having studied this phenomenon in conjunction with a few well-
known developmental gene loci, particularly the alpha-globin/beta-globin locus, tied a 
“co-regulation” requirement into the definition, rather than the more agnostic “co-
expression” requirement.  It was, in fact, a preliminary version of my analysis in Fig. II-6 
(Fisher-Aylor 2011) that drove the observations in one of the most recent papers in 
which I am credited as a minor author (primarily for my contributions to the ChIA-PET 
protocol of using EGS to stabilize protein-protein interactions, but also for our discovery 
of the prevalence of gene-to-gene, possibly promoter-to-promoter, interactions, and for 
this analysis) – an author who did not have any editorial input to the paper to my dismay 
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– that ChIA-PET interactions represent “co-regulation” (Li, Ruan et al. 2012).  That work 
claimed that an unexpected number of promoters connected to each other and (using “a 
novel statistical analysis” they coined specifically to support this result in their datasets) 
that differential genes were likely to be connected to each other, and the senior authors 
of the paper opted for the connectivity of like genes to be a principal conclusion.  My own 
complete analysis arrived at a much less strong emphasis on the connectivity of genes 
according to their expression types, though.  There are indeed a large number of gene 
vertices connecting to gene vertices (perhaps promoters connecting to promoters) and 
enrichment over expectation for like genes to connect to one another, at least in the 
myocyte state (Fig. III-6); the smaller-n myoblast analysis yielded results that hovered 
around statistical significance but did not pass my preferred stringent P-value cutoff of 
0.005 (data not shown).  However, genes of like expression, whether defined by 
magnitude of or change in RNA output, connecting to one another are not at all what the 
majority of the ChIA-PET data show.  Most genes are expressed similarly in both 
timepoints (perhaps housekeeping genes); most genes, regardless of type, connect to 
these flat expressed genes (Fig. III-6; other analyses not shown).  This makes sense, 
given that I have determined how important gene neighborhood is to connectivity, and 
given what we know overall about gene neighborhoods. 
 While transcription factories may be a primary mode of transcription for some 
genes, it has been noted that there are only a limited number of them per cell (Osborne, 
Chakalova et al. 2004).  If all genes use transcription factories, chromatin must 
rearrange at a higher order of chromatin coiling than current methods can detect since 
the first of the high-throughput assays suggest that globally, chromatin interactions do 
not change much (Simonis, Klous et al. 2006; Hakim, Sung et al. 2011). 
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Figures for Chapter III 
 
Figure III-1: Most unexpressed genes have no ChIA-PET connectivity, and the 
more highly expressed a gene is, the more likely it is to be connected in ChIA-
PET. The percent of gene-vertices at each expression level that are connected in pol2 
(red) or myogenin (green) ChIA-PET.  For a proper comparison to the single myogenin 
dataset, the experiment-matched single myocyte pol2 replicate dataset was used. 
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Figure III-2: Distal elements connect to the nearest active genes. Distal vertices 
(leftmost, non-orange ovals which correspond to the colors in the pie chart) are shown 
connecting to genes (orange ovals) in different configurations.  All distal vertices that 
connect to an active gene within the 10kb-2Mb range visible to ChIA-PET are connected 
to the nearest active gene (light green, dark green).  There is no evidence of distal 
vertices skipping over an active gene without connecting to it (black).   
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Figure III-3: One-to-many interactions in ChIA-PET data. This set of figures 
represents the multiplicity of distal to gene interactions. Cartoon: blue circles represent 
distal vertices; orange circles represent gene vertices; the single starred vertex in each 
cartoon represents the “founder” type of vertex for which the connections are being 
tallied in the accompanying graph.  Blue bars: myoblast pol2 edges; red bars: myocyte 
pol2 edges.  (A) The number of distal vertices that connect to multiple gene vertices.  (B) 
The number of gene vertices that connect to multiple distal vertices.  (C) The number of 
gene vertices that connect to multiple other gene vertices.  (D) The number of distal 
vertices that connect to multiple other distal vertices.   
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Figure III-4: Gene functional classes as defined in this work.  (A) The myoblast vs. 
myocyte RNA levels of connected up (red), down (blue), flat (gray), and off (black) gene 
classes. There are 990 gene-vertices that fall between these stringent categories and 
that are left out of the expression category analysis.  All FPKM values of 0 were replaced 
with a very small fraction so they could be plotted on the graph’s axes. 
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Figure III-5: Change in connectivity predicts developmental classes of genes.  (A) 
Gene-vertices with myoblast (blue) and myocyte (red) preferential expression have 
highly variable average edge weight between the two developmental states. (B) Fold 
change from myoblast to myocyte summed edge weight for two downregulated (blue) 
and two upregulated (orange) sets of gene-vertices are significantly different from the flat 
(gray) and off (white) gene-vertices, which do not change much in terms of ChIA-PET 
connectivity during the developmental transition. 
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Figure III-6: The number of unique upregulated (red), flat (gray), downregulated (blue), 
or off (white) genes that are directly connected to, indirectly connected to, or within 2Mb 
of 252 highly upregulated seed genes.  In the upper cartoon, the red circle is an example 
upregulated seed gene and the orange circles represent the different reported 
categories of gene-vertices. 
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Figure III-7: Upregulated genes have more connected distal vertices than flat 
expressed genes.  (A) Visualization of a linear regression.  Genes are divided 
according to the number of distal vertices to which they connect (x-axis), and also by 
their expression pattern: upregulated (red), downregulated (blue), flat (gray), or off 
(white). (B) Controlling for expression level, upregulated genes (red) have more 
connected distal elements than flat genes (gray). 
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Figure III-8: Highly expressed genes are more associated with large CIGs than 
with small CIGs. The distribution of myocyte RNA levels according to the total number 
of vertices in a gene-vertex’s myocyte CIG (CIG size class).  Small CIGs (2-4 vertices): 
pink; medium CIGs (5-16 vertices): dark red; large CIGs (17+ vertices): red.  A single 
asterisk marks a significant difference between CIG classes (P<0.05) in both K-S and T-
tests.  A double asterisk represents a highly significant difference in both K-S and T-tests 
(P>1*10^-7).  The median RNA levels for gene-vertices in CIGs of each size class 
(vertical lines) are not significantly different from each other. 
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Figure S-1: Lack of correlation between connected promoters.  (A) The amount of 
myocyte RNA for one gene-vertex vs. the other in every gene-gene pair. (B) The change 
in RNA for one gene-vertex vs. the other in every gene-gene pair.  Data points have 
been colored according to the paired gene classes: gray: flat-flat; pink: flat-up; light blue: 
flat-down; red: up-up; dark blue: down-down. 
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Chapter IV: Conclusions 
IV.1: Introduction 
In this thesis, I have described results that are true in all of the ChIA-PET 
datasets I have analyzed regardless of the factor ChIPped, the developmental timepoint, 
or the numerous different analysis approaches that I used.  There are two primary 
principles which in my opinion can explain most of the other ChIA-PET results I 
described in this thesis.  First, physical connectivity between transcription factor- or pol2-
occupied elements in the genome is, in terms of the DNA backbone, primarily local; 
there are fewer than one percent the number of 100kb edges as the number of 10kb 
edges in every dataset, and fewer than two hundred high-confidence, reproducible 
edges over 150kb.  Second, the amount of gene expression measured by RNA-Seq is 
highly correlated with the likelihood that a gene will have a ChIA-PET connection.  
Developmental genes might show slightly different patterns of engagement, and the 
implications for how genes of average expression profiles might be expressed is that 
most may differ only in degree (they have fewer enhancers), not in type (only operated 
by a basal promoter and mostly not having enhancers), though of course much exciting 
gain-of-function and loss-of-function experimental work is required to substantiate these 
final two hypotheses. 
IV.2: Connectivity of active elements is much more prevalent than expected and 
most connections are local (<50kb) 
 When the genome-wide assay ChIP-Seq was invented, one of the first surprises 
when studying tissue-specific transcription factors was how often they occupied sites in 
the genome (Cao, Yao et al. 2010; Kwan G, Kirilusha A, Fisher-Aylor K, unpublished).  
For example, MyoD and Myog occupy more than 14,000 sites in the genome, even 
though there are only a few hundred muscle-specific genes (also see Fig. I-2).  In an 
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analogous surprise, when I used a genome-wide assay to determine how many active 
genes and occupied distal elements were physically connected to each other, I found 
connectivity almost everywhere there were areas of widespread DNase accessibility.  
This means that the majority of active genes, no matter what type of expression they 
have, show physical connectivity to active elements that are near to them.  Although 
there very well may be some notable exceptions to this, it appears, based on these data, 
that what a gene connects to is determined in large part by its genomic neighborhood.  It 
is possible that there are two different approaches to transcription between genes in 
gene-dense, highly inter-engaged areas and in areas that are gene-poor or otherwise 
sparse in CRMs. 
IV.3: Most ChIA-PET connectivity occurs sequentially rather than simultaneously 
 One surprise to me in the ChIA-PET data was how little connectivity varied when 
counting the relationship between vertices and edges across the genome.  Although by 
large the ChIA-PET data consists of simple connections in gene desert areas and 
extremely large interacting graphs in gene dense areas, the relationship between 
vertices and edges remains essentially constant.  This likely relates to the first principle 
that shorter edges are more common than longer (Fig. II-7).  However, it is likely 
possible to take this into account in a way that could determine if there are different 
modes of interactivity in the genome.  In order to do this, the existing edge and vertex 
data could be used to create different models of interaction, such as cooperative binding 
of multiple elements to a gene, independent binding of multiple elements to a gene, or 
binding of elements to a gene in a way that is mutually exclusive.  Treating these three 
models as, in effect, null hypotheses for which to create P values on a graph by graph 
basis would help determine if there are any loci that exhibit classic examples of 
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cooperative, independent, or mutually exclusive activation of a promoter and if so, 
whether this co-occurs with different classes of genes.   
IV.4: Possible implications for the regulation of developmental and housekeeping 
genes 
Although most detected interactions in the genome are simple, there are 
nevertheless many thousand instances of one element connecting to multiple other 
elements.  In congruence with the knowledge that many developmental genes used 
differently across time and tissue type have multiple enhancers, with these enhancers 
often being identified as active in only one tissue/at only one time, there are hundreds of 
examples in ChIA-PET of one gene connecting to multiple distal elements.  However, 
there are also hundreds of cases (though fewer cases than the reverse) of one distal 
element connecting to multiple different genes.  There were a very small number of 
known examples of this phenomenon before the very recent advent of high-throughput 
connectivity assays, and many known examples involved developmentally related 
genes.  My data show that many enhancers are even shared between genes with 
different expression patterns; for example, the majority of genes in CIGs containing 
myogenic genes are expressed at a steady level over development, though I rarely 
found instances of genes with opposite expression patterns in the same CIGs as each 
other. 
Most expressed genes are expressed at a low and steady level, and a subset of 
these genes can be thought of as “housekeeping genes”: genes which are on in all cell 
types (or almost all, if one thinks critically about gene expression in cells such as sperm 
and eggs) because their products are necessary for a cell’s basic existence.  However, 
many steadily expressed genes have detectible connections to distal elements in both 
cell states.  While it is possible that some of these connections are structural and not 
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otherwise regulatory, it is also possible that most genes, regardless of what their product 
is used for and when, might be regulated by enhancers. 
In this myogenic system, I did detect two ways in which myogenic genes engage 
with distal elements in subtly different ways from other genes.  First, myogenic genes 
are slightly more likely than predicted by gene neighborhood to engage with other 
myogenic genes, although the majority of genes a myogenic gene connects to are 
steadily expressed.  Second, myogenic genes are more likely than flat genes of the 
same expression levels to engage with multiple distal elements.  Together, these 
observations predict that developmentally active genes may be regulated in a subtly 
different way from other genes, but in a way that differs in degree rather than type.  
Perhaps most promoters require input from an enhancer, while developmentally 
regulated genes require more enhancers in order to change their expression levels 
across time and tissue. 
IV.5: Take-away lessons for other biologists 
 In the process of completing this larger ChIA-PET project, I have determined 
some useful relationships and rules for bioinformatics that do not fit within my larger 
narrative.  First, from analyzing tissue-specific transcription factors in two different 
systems, Twist in very early fly embryos and Myogenin in C2C12 mouse muscle, I found 
that 400 base pairs is likely the average width of a CRM (S. Pepke, K. Fisher, A. 
Ozdemir, and A Kirilusha, data not shown).  As expected, since these two observations 
agreed despite how different the systems were, an analysis of genome-wide DNase in 
this system (C2C12), which looks at many different types of factors simultaneously, also 
found that 400 base pairs was a good estimate of the average CRM (Ramirez, R 
unpublished).   
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In studying transcription factors genome-wide, it is often unclear how to assign a 
particular instance of occupancy to a gene that it might express.  Typically, an occupied 
site is assigned to its nearest promoter, sometimes including rules such as the promoter 
being downstream, or the enhancer being within a certain distance of a gene (such as 
the 2KB window where most enhancers fall).  My analysis shows that connectivity can 
be predicted reasonably well using RNA-seq and a genome-wide footprinting assay such 
as DNase or ATAC-seq.  This is because while most unexpressed genes are not 
connected, expressed genes connect to many elements that are close to them.  It is 
appropriate in the absence of connectivity data to assign a region occupied by an active 
transcription factor to the nearest gene that is expressed within about 50 kb (Fig. II-7, 
Fig. III-2).  The only caveat to doing this is that in areas that are gene dense or highly 
occupied by transcription factors, the site in question may additionally connect to other 
genes and elements (Fig. III-2).   
ChIP-Seq signal size cannot correlate to amount of factor occupancy, as is a 
common erroneous assumption.  In addition to the more likely possibility that sample 
heterogeneity could also cause differences in signal size from locus to locus, it is a fact 
that sequence content affects ChIP-Seq results.  All samples that are processed on 
Illumina sequencers, and likely on other types of high throughput sequencers as well, go 
through a PCR step, called library building, which is necessary in order to obtain enough 
material to sequence.  However, this means that since one library building method is 
typically used as the standard method, most libraries will exhibit the same bias which is 
derived from the temperature and time setting of the PCR protocol itself.  In the case of 
Illumina platform sequencing, the PCR protocol appears to have been chosen so that all 
libraries of 200 base pair fragments return an average sequence content of 65% G/C, 
which is the overall sequence content of most mammalian genomes, including human. 
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However, this does a disservice to any 200-bp segments of DNA that are more A/T or 
G/C rich than the mammalian average.  This may explain partially why some factors in 
our system that occupy A/T rich motifs, such as SRF and MEF2, have been difficult to 
ChIP.  It also explains why some of the existing data sets for factors that bind A/T rich 
elements, such as anterior-posterior patternin transcription factors in early Drosophila 
development (for review, see MacArthur, Li et al. 2009), contain a modified library-
building protocol.  Other factors might be difficult to CHIP because the areas they 
occupy are difficult to shear into 200 bp fragments.  This likely occurs for factors that 
bind in or near repressed regions of the chromosome because all current ChIP-Seq 
fragmentation methods, including sonication, preferentially cleave active areas of the 
DNA (Auerbach, Euskirchen et al. 2009).  Therefore, if a factor that needs to be ChIPped 
is thought to be repressive (therefore not easily accessible to any current fragmentation 
protocol) or binds an extremely A/T or G/C rich motif or area, it will likely be necessary to 
change the conventional ChIP-Seq protocol.  
IV.6: Paths forward 
 ChIP-Seq showed us that the well-studied instances of the functional MyoD or 
Myog binding near muscle-specific genes were not incorrect, they just did not appear to 
be as unique as they previously had been assumed to be.  Likewise, the previously 
characterized functional connections in this system are supported by ChIA-PET, but do 
not appear special or unique.  Highly expressed and differential genes appear to be 
connected to an exceptionally high degree; however, constitutively expressed and 
modestly expressed genes also connect to active elements nearby, including elements 
occupied by muscle-specific transcription factors.  Based on these observations, it is 
quite possible that enhancers are more prevalent than previously thought.  However, it 
would be jumping to conclusions to conclude that a ChIA-PET edge represents a 
95 
 
functional interaction (Li, Ruan et al. 2012).  The current claims by my contemporaries 
who are doing ChIA-PET that ChIA-PET-unconnected elements are far apart from each 
other are not substantiated by any evidence.  Despite suggestions otherwise, which are 
based on a careful selection of loci and an experimental protocol which involved a non-
conventional step to bloat the nucleus and presumably tear apart weak connections, the 
absence of an edge in ChIA-PET tells you nothing scientifically about connectivity (Fig. 
II-5). 
 These uncertainties lead to several obvious scientific questions.  What does 
connectivity look like where it is invisible to ChIA-PET?  Which connected elements can 
be considered classic enhancers?  Which connections are functional, as opposed to 
incidental?  The first of these questions can be answered by classic 3C and FISH 
assays, and in my opinion, the most interesting loci to study first would be the MYOG 
loci which do not show ChIA-PET connectivity in the preceding myoblast state.  It is 
entirely possible that the connections that seemingly appear upon differentiation are 
already established in the myoblast state but are invisible to ChIA-PET because they 
lack pol2.  This specific question relates to a deeper one: is physical association with a 
promoter a cause or an effect of transcription factor occupancy, and is the answer the 
same for every occupied site?  A second related question is when, during the course of 
development, are physical connections established?   The current view of the field that 
makes the most sense to me is that some connections, such as those thought to occur 
in classic CTCF insulation, are established early in development in order to mark large 
active areas of chromatin, but that the interactions that occur within these domains are 
primarily transient enhancer to promoter interactions (Kim, Abdullaev et al. 2007; 
Chepelev, Wei et al. 2012).  Some of these questions could be addressed using 4C or 
DNA-FISH at a well-studied and massively up-regulated large genomic locus, like the 
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area around Myog the gene.  Preliminary experiments of both kinds have been executed 
by my colleague Say-Tar Goh and suggest that the connections within this locus already 
exist in the myoblast state.  To take the question further and ask when these 
connections are formed, the same experiment could be performed in developmentally 
earlier cells, such as 10T1/2 or multipotent mesenchymal cells.   
 Another open question is which elements that connect to genes are functionally 
connected to these genes.  This is a complex question that can only be answered using 
several different types of experiments, both gain-of-function and loss-of-function.  An 
overview of current classic enhancer assays based on high-throughput genomics data, 
both published and unpublished, suggests that between 50 to 80% of transcription factor 
occupied elements (predicted by ChIP-Seq) increase the activity of a generic promoter 
(Ozdemir, Fisher-Aylor et al. 2011; ENCODE consortium unpublished; Desalvo, G 
unpublished). In this system, preliminary evidence suggests that about 50% of occupied 
elements are definitely enhancers, and this is independent of ChIA-PET connectivity.  
However, gain-of-function assays such as this mean little when they are negative.  For 
example, an element might regulate the promoter to which it is connected in the cell but 
not the promoter used in the enhancer assay.  Other elements, such as the intronic MCK 
enhancer (Tai, Fisher-Aylor et al. 2011), only function in one orientation, although it is 
not the promoter.  Because of this, it is necessary to use loss-of-function assays also in 
order to determine how transcription initiation truly occurs.  With CRISPR this is now 
economically feasible.  Occupied and connected sites should be deleted, first one-by-
one and then in combination, in order to determine which loci affect gene expression.   
 One of the more interesting types of ChIA-PET edges to investigate is the 
surprisingly prevalent promoter-to-promoter edges ((Li, Ruan et al. 2012), Fig. II-8).  One 
of the reasons I created the Myog ChIA-PET was to determine which characteristics of 
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pol2 ChIA-PET were specific to pol2 itself.  The fact that numerous promoter-to-promoter 
edges still occur in the Myog ChIA-PET as well as other characteristics that might have 
been suspected to be pol2 specific, such as the phenomenon of more highly expressed 
genes being more likely connected, makes it more likely that these edges are 
characteristic of active genes.  However, since Myog is found at promoters as well as 
enhancers, it would be useful to determine whether these phenomena exist using a 
factor for ChIA-PET that occupies enhancers but not promoters.   
 However, it has been found in the past that promoters can connect to other 
promoters and in some cases can alter one another functionally.  One of the first 
experiments done upon the discovery of enhancers found a promoter in an enhancer 
trap experiment (Weber, de Villiers et al. 1984) and then demonstrated that this 
promoter acted as a functional enhancer (Serfling, Lubbe et al. 1985).  Possibly related 
are the phenomena that a few unexpressed genes show physical connections (Fig. III-1 
(Osborne, Chakalova et al. 2004; Sanyal, Lajoie et al. 2012; Noordermeer and Duboule 
2013).  Perhaps some of these instances result from inactive promoters acting as 
enhancers rather than enhancers interacting with a promoter before it is expressed, as is 
commonly assumed.  These two possibilities are not mutually exclusive.  Genes are 
thought to cycle between off and on (Ross 1994, Wijarde 1995, Milot 1996, Kimura 
2002, Levsky 2002, Osborne 2004), so even if promoters were only able to act as 
enhancers when they themselves are unexpressed, it is possible that this is indeed 
happening in the system. Another possibly related phenomenon is that of pol2 pausing.  
Many unexpressed genes have paused pol2 (Zeitlinger, Stark et al. 2007) especially 
genes that are tissue specific (Hendrix, Hong et al. 2008).  These paused promoters can 
act as insulators (Core and Lis 2009), so perhaps they could act as other types of CRM 
as well.  Nor is it necessarily true that promoters and enhancers are as different as we 
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thought from the perspective of transcription biochemistry. When it was first noticed that 
general transcription factors and pol2 were sometimes found at enhancers (Koch, 
Fenouil et al. 2011), particularly using strong fixatives (Kwan, G and Fisher-Aylor, K 
unpublished data), it was assumed that they were a result of indirect binding to the 
enhancer via a connected promoter.  However, recent experiments suggest that some, 
or perhaps even most, enhancers produce non-coding RNA; in other words, enhancers 
could at an extreme be stray, non-coding promoters.  When different genome-wide 
measurements of RNA were used, it appeared that, at an extreme, transcription 
occurred almost everywhere in the genome that was active, coding or not (Consortium 
2012; Djebali, Davis et al. 2012).  The same group that proposed enhancers may be 
stray promoters found that enhancer RNAs might contribute structurally to the 
transcription initiation complex (Lis, Core et al. 2015).  A way to determine in this system 
how important promoter-promoter connections are to gene expression would involve 
knocking out one promoter at a time and determining what, if any, change in expression 
occurs in the putatively connected promoters as a result (for example, using CRISPR to 
create a line of C2s missing one promoter, then using RNA-Seq on the myoblasts and 
myocytes of the new line compared with our existing C2 RNA-Seq to identify possibly 
affected promoters).  
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Chapter V: Materials and Methods 
V.1: Cell growth 
 C2C12 cells were grown and differentiated according to the standard protocol 
(see supplemental materials and methods).  The myoblast cells were harvested at less 
than 40% confluence, and the myocyte cells were harvested 60 hours after the start of 
differentiation. 
V.2: ChIA-PET 
 C2C12 cells for ChIA-PET were fixed in 1.5mM EGS/1% formaldehyde (see 
supplemental materials and methods). The DNA was sheared to an approximate length 
of 375 bp., and sheared chromatin was ChIPped using an RNA polymerase II antibody 
(4H8; Millipore) according to the standard ChIP-Seq protocol (Johnson et al. 2007; 
supplemental materials and methods) with the following modifications: the sonicate from 
5*10^7 nuclei were used for each ChIP reaction (with 5ug of antibody), and all incubation 
times were doubled.   After ChIPping, the nuclei from seven individual ChIPs were 
pooled for one ChIA-PET samples, and were shipped on-bead to Singapore for library 
building.  Two individual ChIA-PET biological and technical replicates were sequenced 
for each sample.  Libraries were sequenced on the Illumina platform using custom 
primers as previously described (Fullwood, Liu et al. 2009).  
V.3: DNase-seq 
 DNase-seq experiments and primary analysis were performed by Ricardo 
Ramirez in the laboratory of Ali Mortazavi at UC Irvine, with minor changes in 
experimental protocol in two biological replicates on C2C12 exponentially growing cells 
and on 60 hr horse serum treated C2C12 cells (Ko et al. 2013).  This section was 
authored in party by Ricardo Ramirez.  Approximately a total of ~600M (130-160M reads 
per replicate) Illumina Hi-seq 2500 single 50bp DNase-seq reads sequenced.  DNase-
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seq reads were mapped to the mm9 reference genome using Bowtie (Langmead et al. 
2009).  Hotspot version 4 (Thurman et al. 2012; John, S et al. 2011) was used to 
determine DHS peaks for each replicate and the intersection of Hotspot calls (FDR < 
1%) was performed in the subsequent analysis.  High quality DNase-seq data was 
determined by the efficiency (fraction of mapped reads in Hotspot calls) or SPOT score 
as calculated by Hotspot, with data ranging between 48-68% for all replicates. These 
Hotspot calls were used in the “3kb”/low-resolution version of the analysis (which is not 
the primary version reported in this work, but was one of several used to substantiate 
and test the conclusions). 
 DNaseI footprinting was performed using the Wellington method (Piper et al. 
2013) for each cell type by combining DHS reads for both replicates.  Approximately 300 
million DHS reads were used to compute DNaseI wFootprints genome-wide for each cell 
type respectively.  The resulting footprints were used in the “Wellington” analysis, which 
is the primary analysis reported in this work. 
V.4: ChIA-PET raw data processing 
 After sequencing, the raw data were stripped of chimeric reads and reads without 
linkers (Fullwood et al. 2009).  Non-chimeric paired reads were then mapped to the mm9 
genome at 100% match, and pairs of reads closer together than 10kb or farther apart 
than 2Mb were discarded.  
 Paired-reads with concordant half-linkers were mapped onto the UCSC mm9 
genome using bowtie 0.12.7 and no mismatches (Langmead et al. 2009). Reads were 
then processed with ERANGE 3.3 (Mortazavi, Williams et al. 2008), and paired-reads 
that mapped uniquely on the same chromosome more than 4.510 kb and less than 2 Mb 
apart were discarded. Connections mapping between different chromosomes were not 
analyzed.  Such interchromosomal interactions primarily fell into areas with many 
103 
 
repeats or areas without evidence of chromatin accessibility.  Many such interactions 
may represent intrachromosomal interactions spanning chromosomal rearrangements in 
this unsequenced cell line, which might also be pseudotetraploid because similar 
C2C12s (not the same because the Wold C2C12 lineage is different than the one 
deposited in the cell bank ACTT) are pseudotetraploid (Casas-Delucchi, Brero et al. 
2011; supplemental S1).  However, when considering only the interchromasomal PETs 
that fell within CIG vertices (which are so sparse they number in the low hundreds even 
when accepting interchromosomal edges supported two PETs in only one library), I 
noticed that the most highly connected regions in the conventional intrachromosomal 
analyses were the regions with the most likelihood of containing interchromosomal 
edges as well. 
V.5: Construction of ChIA-PET candidate vertices 
To create a set of candidate vertices upon which the ChIA-PET data was 
mapped, Wellington calls from myocyte and myoblast DNase data were expanded to +/-
500bp around their peaks, then pooled together with all annotated Gencode M1 (Coffey, 
Kokocinski et al. 2011; Derrien, Johnson et al. 2012; Harrow, Frankish et al. 2012; 
Frankish, Uszczynska et al. 2015) PC and LNC TSS’s.  TSS’s were expanded to -600bp 
and +400bp based on an in-house analysis which found the majority of DHS signal at 
annotated promoters between -600 and +400 of the TSSs.  Any overlapping regions 
regardless of their source were merged together.  The resulting regions are referred to in 
this work as “candidate vertices” and the analysis based on these vertices as the 
“Wellington” analysis. 
Two different analyses were also performed to ensure whether and which 
elements of the ChIA-PET analysis were predicated on assumptions we made early in 
the analysis process.  First, to capture more ChIA-PET ends (at the expense of lower 
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resolution), we created candidate vertices using HotSpot calls for myoblast and myocyte 
DNase data.  Overlapping regions were merged together into one region, and all regions 
that were narrower than 3kb were expanded to +/-1.5kb around their midpoint.  Second, 
to determine if and which elements connected by ChIA-PET were being left out of the 
analysis due to the requirement to be near DNase hypersensitive regions, I used 
ERANGE on the 25bp PET ends (unpaired) – from the second technical replicates of 
pol2 ChIA-PET for myoblast and myocyte – with no background library to call “pileups” of 
ChIA-PET reads.  These regions became candidate vertices with no expansion and no 
addition of annotated TSSs in what I termed the “data-driven” analysis.  The “data-
driven” analysis had the additional benefit of having highly connected vertices that were 
less than 1kb wide.  These two medium-confidence (“3kb”) and extremely high-
confidence (“data-driven”) analyses showed essentially the same answer for all of the 
analyses that I have included in this thesis, which is the reason I am so confident that 
the results I report here represent general characteristics of ChIA-PET data. 
V.6: Construction of CIGs 
 The subset of accepted ChIA-PET raw paired-end tags previously described 
were mapped onto each set of candidate vertices using the following rules.  Pairs falling 
within the same vertex as each other, or where only one mate fell into a candidate 
vertex, were discarded.  An edge is defined as a pair of vertices that is spanned by a 
pair of partnered raw reads; edges supported by fewer than 2 individual sets of PETs 
were discarded.  In order to focus only on edges that are most likely to be signal instead 
of noise, one final intersect set of edges was constructed for each of the two timepoints: 
these sets require that an edge be present in each of the two biological/technical 
replicate ChIA-PET datasets, and the final edge weight is the average of its weight in the 
two individual replicates.  We normalized the edge weights by the average length of the 
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end-point vertices to make edges comparable between vertices of different widths.  CIGs 
were defined as fully connected sub-graphs of the parent set of candidate vertices.  The 
final ChIA-PET (“*.matrix”) datasets submitted displays all edges, connected vertices, 
and CIGs on a vertex-by-vertex basis.   
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Chapter Supplemental I 
Differentiation and fiber type-specific activity of a muscle creatine kinase intronic 
enhancer 
Phillip WL Tai, Katherine I Fisher-Aylor, et al. (2011), Skeletal Muscle 1:25 
 
S1.1 Abstract 
Hundreds of genes, including muscle creatine kinase (MCK), are differentially 
expressed in fast- and slow-twitch muscle fibers, but the fiber type-specific regulatory 
mechanisms are not well understood.  
 Modulatory region 1 (MR1) is a 1-kb regulatory region within MCK intron 1 that is 
highly active in terminally differentiating skeletal myocytes in vitro. A MCK small intronic 
enhancer (MCK-SIE) containing a paired E-box/myocyte enhancer factor 2 (MEF2) 
regulatory motif resides within MR1. The SIE's transcriptional activity equals that of the 
extensively characterized 206-bp MCK 5'-enhancer, but the MCK-SIE is flanked by 
regions that can repress its activity via the individual and combined effects of about 15 
different but highly conserved 9- to 24-bp sequences. ChIP and ChIP-Seq analyses 
indicate that the SIE and the MCK 5'-enhancer are occupied by MyoD, myogenin and 
MEF2. Many other E-boxes located within or immediately adjacent to intron 1 are not 
occupied by MyoD or myogenin. Transgenic analysis of a 6.5-kb MCK genomic fragment 
containing the 5'-enhancer and proximal promoter plus the 3.2-kb intron 1, with and 
without MR1, indicates that MR1 is critical for MCK expression in slow- and 
intermediate-twitch muscle fibers (types I and IIa, respectively), but is not required for 
expression in fast-twitch muscle fibers (types IIb and IId).  
 In this study, we discovered that MR1 is critical for MCK expression in slow- and 
intermediate-twitch muscle fibers and that MR1's positive transcriptional activity depends 
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on a paired E-box MEF2 site motif within a SIE. This is the first study to delineate the 
DNA controls for MCK expression in different skeletal muscle fiber types.  
S1.2 Background 
 Muscle creatine kinase (MCK) is among the most abundant transcripts in striated 
muscle [1]. In differentiating muscle cell cultures, the onset of MCK expression occurs 
shortly after proliferating myoblasts exit the cell cycle [2] and begin to express 
differentiation-specific transcription factors [3]. In mouse embryos, MCK expression is 
initiated after the activation of myogenic transcription factors. MCK mRNA is first 
detectable in embryonic day 13 (E13) cardiac and skeletal muscles, and its expression is 
maintained throughout adulthood [4]. The expression of MCK between different 
anatomical muscle groups is quite variable; for example, MCK protein as well as its 
enzymatic product, creatine phosphate, are about two or three times higher in fast-twitch 
muscles than in slow-twitch muscles [5,6]. Fiber type-specific muscle regulatory factors 
(MRFs) have been studied in several other skeletal muscle genes, such as in MLC2v, 
MLC1/3f and aldolase genes [7-10] and even more extensively in slow and fast troponin 
I genes [11-16]. These studies have provided important clues that implicate a variety of 
transcriptional control mechanisms in muscle fiber type-specific gene expression. 
Aspects of these mechanisms are both similar to and different from those that regulate 
MCK expression in fast- and slow-twitch fiber types.  
 While MCK gene expression has been extensively studied [17-22], some of its 
regulatory regions have yet to be fully characterized. Currently, the 5'-enhancer (-1,256 
to -1,050) is the best characterized of the known regions [18,20,23-28]. It has the ability 
(1) to drive high-level transcription of reporter genes in skeletal and cardiac muscle in 
both transgenic mice and cell culture and (2) to function with heterologous promoters 
[29]. Deletion and mutation analyses within this region in cultured skeletal myocytes and 
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in transgenic mice have defined seven control elements: muscle-specific (CArG) and 
serum response element promoters, activator protein 2 (AP-2), Six4/5, AT-rich, left and 
right E-boxes and myocyte enhancer factor 2 (MEF2) [23,24]. The MCK proximal 
promoter (-358 to +1) has also been thoroughly studied. It is active in skeletal and 
cardiac myocytes in culture and can function independently of the 5'-enhancer. The 
proximal promoter is also active in transgenic skeletal muscle, and the combination of 
both the 5'-enhancer and the proximal promoter exhibits significant synergy in both cell 
culture and transgenic mice. The proximal promoter contains at least four active 
transcription factor binding sites: p53, E-box, CArG, and MPEX, a recently discovered 
sequence that recruits both Myc-associated zinc finger protein (MAZ) and Krupple-like 
factor 3 (KLF3) [30-33]  
Studies involving the systemic delivery of expression constructs via adeno-
associated vector type 6 vectors and transgenic mice have demonstrated that the MCK 
5'-enhancer and proximal promoter confer transcriptional activity several orders of 
magnitude higher in muscles containing primarily fast-twitch fibers, such as the tibialis 
anterior (TA) and quadriceps, than in muscles containing slow-twitch fibers, such as the 
diaphragm and soleus [22,34,35]. In contrast, the ratio of endogenous MCK protein 
levels in fast- to slow-twitch skeletal muscles is only about 2:1 [5,6,36]. The discrepancy 
between gene construct expression levels and endogenous MCK levels suggests that 
MCK gene transcription in slow-twitch fiber types is partially governed by regulatory 
elements located elsewhere in the MCK locus. This hypothesis is supported by previous 
transgenic tests of an approximately 6.5-kb mouse MCK gene region (-3,349 to +3,236) 
that was used to express dystrophin in mdx mice [37]. While fiber-type expression ratios 
were not included in these studies, the detection of dystrophin in all fibers implied that 
one or more subregions within the -3,349 to +3,236 sequence in addition to the 5'-
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enhancer and proximal promoter play major roles in MCK expression in slow- and 
intermediate-twitch muscle fibers.  
 The MCK gene locus also contains a less well-characterized 1-kb control region 
called modulatory region 1 (MR1), which resides within the +740 to +1,721 portion of the 
gene's first intron. In previous and very preliminary studies, MR1 was shown to promote 
muscle-specific transcription in skeletal myocyte cultures and in transgenic skeletal 
muscle [19,22,38]. We began the present study by comparing MR1 sequences among 
six mammalian species and discovered that MR1 is highly conserved throughout its 
sequence. Most of the conserved motifs are not sequences known to bind muscle gene 
transcription factors, but a 95-bp subregion within MR1, the MCK small intronic enhancer 
(MCK-SIE), was shown to contain conserved and functional E-box and MEF2 control 
elements, and chromatin immunoprecipitation (ChIP) assays and ChIP-Seq analyses 
demonstrate that the MCK-SIE's E-box and MEF2 elements interact with 
MyoD/myogenin and MEF2, respectively. The MCK-SIE exhibits much higher 
transcriptional activity than the entire MR1 in differentiated skeletal muscle cultures, and 
the SIE's elevated activity is due to removing it from the repressive effects of highly 
conserved regions flanking the MCK-SIE's 5'- and 3'-borders.  
 Upon discovering the enhancer-like properties of the MCK-SIE, and recalling that 
MCK transgenes containing only the 5'-enhancer and proximal promoter regions express 
relatively poorly in slow- and intermediate-twitch fibers, we hypothesized that expression 
of MCK in these fiber types may require the MCK-SIE-containing MR1 region. We 
therefore generated transgenic mouse lines that carry the 6.5-kb MCK regulatory region 
with or without MR1. Comparison of transgene fiber-type expression patterns between 
these lines supports our hypothesis. Interestingly, while E-box and MEF2 elements are 
common to other important regulatory regions in the MCK-SIE and the rat slow upstream 
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regulatory element (SURE) region in slow troponin I, the key DNA control elements that 
ensure slow-twitch muscle fiber expression in the SURE region [11,13,14,39], are not 
present in the MCK-SIE (see Discussion).  
S1.3 Results 
S1.3.1 Sequence analysis of the intron 1 modulatory region MR1 reveals multiple 
highly conserved sequence motifs  
To begin our characterization of mouse MR1 and its role in MCK gene 
expression, a 1,081-bp region (+740 to +1,721) was aligned to the MR1 regions of five 
other mammalian species (human, cat, dog, bovine and pig) to reveal the presence of 
potentially functional control elements (Figure 1 and Additional file 1, Figure S1). This 
comparison revealed several MR1 subregions containing many highly conserved 
sequence motifs, which were then compared to a transcription factor binding motif library 
deposited in the TRANSFAC database [40]. Of particular interest was a 95-bp region 
(+901 to +995) that was subsequently proven to exhibit the properties of a transcriptional 
enhancer (Figure 1). The MCK-SIE exhibits high sequence conservation and contains 
four motifs known to control the transcription of many muscle genes: two core E-boxes 
(CAnnTG) [41,42], a MEF2 site and an overlapping MAF half-site and AP-1 site (Figure 
1). Among six mammalian species, 11 to 12 bp of the more 5'-E-boxes conform to the 
14-bp MyoD/myogenin consensus binding site: [C/G]N[A/G]2 CA[C/G]2 TG[C/T]2 N[C/G] 
[17] and 10 to 12 bp of the more 3'-E-boxes conform to the consensus binding 
sequence. Since the dog and mouse E-box sequences are located further 5' than in the 
other species (Figure 1), and since the distance between the 5'-E-box and MEF2 site 
varies from 16 to 40 bp, the precise distances between the four MCK-SIE control 
elements may not be functionally important. The MEF2 motif in all six species conforms 
fully to the MEF2 consensus sequence ([G/T][C/T]TA[A/T]3 ATA[A/G][A/C/T]) [43]. In 
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addition, a region located near the 5'-E-box contains partially overlapping sequences 
that match perfectly with proven MAF and AP-1 binding sites [44]. The clustering of 
these motifs seems significant, since the combination of a paired E-box and MEF2/AT-
rich motif has been observed in many muscle promoters, including the MCK 5'-enhancer  
[45, 46] 
 
 
Figure 1.  Modulatory region 1 (MR1) contains a highly conserved subregion 
containing known myogenic control element motifs.  Sequence alighment of MR1 
reveals a highly conserved 95-bp subregion, muscle creatine kinase (MCK) small 
intronic enhancer (MCK-SIE), that contains five putative control elements: an E-box motif 
pair, a myocyte enhancer factor 2 (MEF2) consensus motif and partially overlapping 
sequences that match proven MAF half-site and activator protein 1 (AP-1) sequences 
(see also Additional file 1 Figure S1).  Bases that are identical in all six species (Homo 
sapiens, Felis catus, Bos taurus, Sus scrota, Canis familiaris and Mus musculus) are 
shown in black, while bases conserved between at least three species are shown in 
gray.  The 3’-E-box is present in all six species, but is slightly more 5’ in the mouse and 
further 5’ in the dog.  Conformation of mouse control element sequences to the 
MyoD/myogenin and MEF2 consensus sequences are indicated below the mouse 
sequence (+ = conforms, - = differs).  
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Figure S1. A six-species sequence alignment of modulatory region 1 (MR1), which 
demonstrates the conserved nineteen subregions throughout the region. The MR1 
sequences of six mammalian species (human, cat, dog, bovine, pig and mouse) were 
aligned to reveal sequence conservation. Bases that are fully conserved between the six 
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species are highlighted in black, while those conserved in three to five species are 
highlighted in gray. Gaps in the sequence alignment are represented as hyphens. The 5' 
and 3' flanks of MR1, as defined in this study, are marked with red right-angled arrows. 
Nineteen conserved subregions (A-S, annotated by orange barbed lines) were tested for 
transcriptional activity (see Additional file 2, Figure S2). The two E-box elements, the 
MAF/activator protein 1 (AP-1) site and the myocyte enhancer factor 2 (MEF2) 
consensus sequence investigated in this study are outlined in green. The 1,081-bp MR1 
region (+740 to +1,721) extends slightly more 5' and 3' than the originally described 
mouse MR1 sequence (+748 to -1,607) [29]. 
S1.3.2 MR1 is required for high-level MCK gene expression in differentiated 
skeletal muscle cells, and it contains a highly active SIE  
 To address the function of MR1 in MCK gene expression, the MR1 region was 
deleted from the entire 6.5-kb MCK sequence (Figure 2A, constructs 1 and 2 
[6.5MCKCAT and 6.5MCKΔMR1-CAT]), and the effect of the deletion was examined in 
differentiated skeletal myocytes (MM14). To gauge the relative change in transcriptional 
activity caused by the loss of MR1, we compared 6.5MCKΔMR1-CAT to a construct that 
contains a deletion of the well-characterized MCK 5'-enhancer (Figure 2A, construct 4 
[6.5MCKΔEnh-CAT]). Expression from each test plasmid was normalized to the activity 
of a muscle-specific MCK enhancer-driven alkaline phosphatase (AP) reference 
construct.  
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Figure 2. MR1 is a positive regulator of MCK transcription. (A) MM14 skeletal 
myocytes were cotransfected with an MCK enhancer-alkaline phosphatase (AP) 
reference plasmid and test gene plasmids containing the chloramphenicol acetyl 
transferase (CAT) reporter gene driven by the full-length 6.5-kb MCK construct 
(6.5MCK-CAT, #1), the 6.5-kb construct with MR1 deleted (6.5MCKΔMR1-CAT, #2), the 
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6.5-kb construct with the MCK-SIE deleted (6.5MCKΔSIE-CAT, #3) or, for comparison, 
the 6.5-kb construct with the 5'-enhancer deleted (6.5MCKΔEnh-CAT, #4). Test 
construct activities are represented as the average values of relative CAT over AP 
activity normalized to the activity of 6.5MCK-CAT. (B) MR1 is composed of regions that 
promote transcription in MM14 cultures. Constructs containing the "full-length" MR1 
(MR1-PP-CAT, #2), a construct lacking the MCK-SIE (MR1ΔSIE-PP-CAT, #3) or just the 
MCK-SIE (SIE-PP-CAT, #4) were generated to test the functional activity of the MCK-
SIE. Activities of these test constructs were normalized to activities of the proximal 
promoter alone (PP-CAT, #1). The activity of the 5'-enhancer (5'Enh-PP-CAT, #5) is 
provided for comparison. Each experiment was performed in at least twelve plates in 
three separate experiments, and activities are averages of those experiments. Error bars 
represent ±1 standard deviation.  
 
 Deletion of MR1 results in an approximately fivefold lower transcriptional activity 
in differentiated MM14 cultures than that produced by the entire 6.5-kb MCK gene 
construct (P < 0.01) (Figure 2A, constructs 1 and 2), whereas deletion of the MCK gene 
5'-enhancer results in a greater than 10-fold decrease (P < 0.01).  
 To determine whether the MCK-SIE is critical for MCK gene transcription, it was 
deleted from the 6.5MCK-CAT construct and the resulting 6.5MCKΔSIE-CAT was tested 
in differentiated skeletal muscle cultures (Figure 2A, construct 3). The deleted construct 
exhibited a 60% decrease in transcriptional activity in skeletal myocytes (P < 0.01), 
demonstrating that, in the context of the 6.5-kb MCK genomic sequence, the MCK-SIE is 
likely responsible for much of the positive transcriptional activity of MR1.  
S1.3.3 MCK-SIE is active in differentiated skeletal muscle cells when placed 5' of 
the MCK proximal promoter  
 To facilitate further analysis of MR1 regulatory functions, subsequent studies 
were carried out in the context of MR1 placed 5' of the highly conserved MCK proximal 
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promoter (Figure 2B (MR1-proximal promoter-chloramphenicol acetyl transferase (MR1-
PP-CAT)), construct 2). This test construct frees MR1 from transcriptional effects of the 
highly active MCK 5'-enhancer, which could lead to dampened effects of mutations or 
deletions within MR1. Importantly, it also avoids potential confounding effects due to 
cotranscriptional or posttranscriptional events, such as altered splicing efficiency or 
altered elongation efficiency, which could occur in conjunction with testing MR1 function 
within its 3' intron 1 location in the native MCK gene. In agreement with the decreased 
activity observed when MR1 is deleted from the 6.5-kb sequence (Figure 2A), MR1-PP-
CAT exhibits transcriptional activity in skeletal myocyte cultures that is approximately 
threefold greater than that of the proximal promoter alone (Figure 2B, compare 
constructs 1 and 2). MR1's positive activity when moved 5' of the transcription start site 
also indicates that it has the properties of an enhancer.  
Since the MCK-SIE had the greatest potential for explaining the positive activity 
of MR1 (Figure 2A), we tested its capacity to act as an enhancer independent of other 
MR1 sequences. Deletion of the MCK-SIE from MR1 reduces transcriptional activity to a 
level similar to that of the proximal promoter alone (Figure 2B, construct 3). Conversely, 
when the MCK-SIE was placed directly upstream of the proximal promoter (Figure 2B, 
MCK-SIE-PP-CAT, construct 4), a greater than 10-fold increase in transcription (P < 
0.01) relative to the MR1-PP-CAT construct was observed. In fact, the MCK-SIE 
synergizes with the proximal promoter, as does the 5'-enhancer (Figure 2B, 5'Enh-PP-
CAT, construct 5).  
S1.3.4 Two E-box motifs and a MEF2 site are required for full transcriptional 
activity of the MCK-SIE in skeletal myocytes  
 To determine the transcriptional activity of the MCK-SIE conserved binding site 
motifs, the 5'- and 3'-E-boxes and MEF2 motifs were subjected to both deletion and 
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mutation analyses (Figure 3A) in the context of the MCK-SIE-PP-CAT construct (Figure 
2B, construct 4). In skeletal myocytes, deletion or mutations of the 5'-E-box resulted in 
approximately 30% reductions in transcriptional activity, whereas deletion or mutations 
of the 3'-E-box resulted in approximately 65% reductions (Figure 3B), and deletion of 
both E-boxes caused a nearly 90% decrease in transcriptional activity. Deletion or 
mutations of the single MEF2 consensus motif also caused an approximately 90% 
reduction in transcriptional activity (Figure 3B). These data imply that both E-boxes 
contribute to the MCK-SIE's transcriptional activity, but that the 3'-E-box provides most 
of the activity. Since mutation of the MEF2 site leads to about the same loss in activity 
as mutation of both E-boxes, and since E-box binding factors are known to synergize 
with MEF2, it may be that the bulk of the MCK-SIE's transcription activity is derived from 
a single highly active MEF2-MyoD/myogenin complex.  
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Figure 3. Two E-boxes and a MEF2 site are critical for activity of the MCK-SIE. (A) 
Deletions and mutations tested in MCK-SIE. The currently accepted consensus motifs 
for the E-box and MEF2 motifs are shown. Proven MAF half-site and AP-1 control 
element sequences are also indicated. Stars indicate sequences that were 
experimentally proven to recruit the labeled factors and do not represent consensus 
binding motifs. The wild-type mouse sequences of these elements within the MCK-SIE 
(Wt), the deletion sequences (Del) and two mutation sequences (M1 and M2) used in 
this study are shown on successive lines. Base pair deletions are indicated as hyphens, 
point mutations are shown as changed bases and asterisks indicate unchanged bases. 
(B) Mutational analysis of control elements within the MCK-SIE. The E-box, MAF/AP-1 
and MEF2 motifs in the MCK-proximal promoter-CAT (MCK-SIE-PP-CAT) (diagrammed 
with elements in their relative positions) were deleted (gray bars) or subjected to two 
mutations (white bars) within core bases (Figure 2A) and were tested for transcriptional 
activity in differentiated MM14 skeletal myocyte cultures. The relative activities of these 
constructs were compared to the MCK-SIE-PP-CAT construct (scaled to equal 1.0) and 
PP-CAT alone (black bars). Each construct was tested in twelve plates in three separate 
experiments, and activities shown are averages of those experiments. Error bars 
represent ±1 standard deviation.  
 
 The possibility that other control elements may reside in the MCK-SIE is raised 
by the highly conserved TGCTGAC[T/g]T[G/a]G sequence that begins several base 
pairs 3' of the 5'-E-box (Figure 1). The TGCTGA portion is a perfect match to MAF half-
sites [47,48], and the TGACTTA sequence in the mouse MCK-SIE is a perfect match to 
a fully functional noncanonical AP-1 site [49,50]. Deletion and mutations that should 
have abolished the binding of either MAF or AP-1 (Figure 3A) had little to no effect on 
transcriptional activity (Figure 3B). This does not negate the possibility that MAF and/or 
AP-1 interactions within the MCK-SIE region play a role in MCK gene expression in vivo, 
but such interactions are not important for the MCK-SIE's transcriptional activity in 
differentiating skeletal myocyte cultures.  
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S1.3.5 Both MyoD and myogenin bind to the MCK-SIE in differentiated skeletal 
myocytes  
 On the basis of the rapid onset of MCK expression during differentiation, the 
transcriptional activity of MR1 in myocyte cultures (Figure 2B) and the presence of two 
active E-box elements within this region (Figure 3B), it seemed likely that MyoD and/or 
myogenin associate with the MCK-SIE. ChIP analysis of differentiating skeletal myocyte 
cultures was thus employed to determine whether the E-box pair recruits MyoD, 
myogenin or both MRFs in vivo.   
 One caveat of ChIP data interpretation is that control elements cannot be 
distinguished with respect to transcription factor binding when they bind the same factors 
and are close enough that both sites will be present on many of the same randomly 
sheared chromatin fragments. This would certainly be the case for the MCK-SIE E-box 
pair, where the separation is only 46 bp. Thus, primers that flank the entire MCK-SIE 
were used to detect MyoD- and myogenin-immunoprecipitated chromatin. This issue is 
also pertinent to ChIP discrimination between occupancy of the MCK-SIE E-box pair and 
other MCK E-boxes with proven transcriptional activity. These are centered at -1,175 
and +1,152 within the MCK 5'-enhancer and at -246 within the proximal promoter [26]. 
Therefore, in addition to using primers that amplify the MCK-SIE, primers for the 5'-
enhancer were used as a positive control, since this region is known to contain two 
functional E-boxes that bind MyoD and myogenin [17,51,52].  
 Three "negative" control primers were used to rule out the possibility of cross-
enrichment from factors binding to non-MCK-SIE regions (Figure 4A). The first 
"negative" control primer set amplifies intron 1 of the MAP/microtubule affinity-regulating 
kinase 4 (Mark4) gene. This sequence is roughly 40-kb 3' of the MCK-SIE on mouse 
chromosome 19 and is within a 1-kb region that entirely lacks the core E-box binding 
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motif CAnnTG; thus it should serve as a truly negative control for MyoD and myogenin 
occupancy of the MCK-SIE. The second "negative" control primer pair spans the exon 
1/intron 1 boundary and amplifies a 217-bp region located 690 bp upstream of the MCK-
SIE, 242 bp downstream of the active promoter E-box and 1,149 bp downstream of the 
active MCK 5'-enhancer right E-box (Figure 4A). The mouse exon 1/intron 1 boundary 
region contains two nonconserved E-boxes and also has four nonconserved E-boxes 
located 52, 67, 97 and 310 bp downstream of its 3'-border. None of these E-boxes have 
been tested for transcriptional activity, but they are likely to be transcriptionally inactive 
as they are not conserved in other mammals. Nevertheless, this would not preclude their 
occupancy by MyoD/myogenin or their function in mouse muscle cells; thus examining 
this subregion was also of interest in itself. The third "negative" control primer pair spans 
a 209-bp region starting at exon 2 (Figure 4A). It contains one nonconserved E-box and 
two other nonconserved E-boxes which are located 36 bp and 638 bp upstream of its 5'-
border. MyoD/myogenin binding to any of these exon 2 E-boxes would thus cause an 
enrichment that would be detected by the exon 2 primer pair. Conversely, if MyoD and/or 
myogenin occupy the MCK-SIE, and if the negative control regions are not occupied, 
enrichments of the MCK-SIE and of the MCK 5'-enhancer (positive control) should be 
significantly greater than those at any of the negative control regions.  
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Figure 4. MyoD and myogenin are enriched at the MCK-SIE in skeletal myocytes. 
(A) Diagram of the 6.5-kb MCK regulatory region with the three known active regulatory 
regions: the 5'-enhancer, PP, MR1 (white boxes), the MCK-SIE (light gray box) exons 1 
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and 2 (black boxes) and other regions (gray), including the 33.7-kb Mark4 gene (located 
approximately 40 kb 3' of the MCK-SIE and transcribed in the opposite direction). E-box 
CAnnTG core motifs (arrowheads) occur throughout the 6.5-kb sequence. Among the 
thirty-five total E-boxes are two functional E-boxes within the 5'-enhancer, one functional 
E-box within the proximal promoter and two E-box motifs within the MCK-SIE (longer 
arrows). The less frequent MEF2 motifs (full diamonds) are found only in the 5'-enhancer 
and MCK-SIE and as a possible nonconsensus MEF2 site (open diamond) in the 
proximal promoter. The chromatin immunoprecipitation (ChIP) primer pairs (black lines) 
that span the 5'-enhancer sequence were used as positive controls for MyoD and 
myogenin binding to functional E-boxes. Negative controls consist of genomic regions 
containing either no core E-box motifs (region within the Mark4 intron 1 (M4, dagger)) or 
core E-box motifs with no proven transcriptional function (MCK gene exon 1/intron 1 
boundary (two E-boxes) and exon 2 (one E-box); see Results, section-5). (B) MyoD and 
myogenin bind MCK gene E-box motifs. ChIP analyses using antibodies for MyoD, 
myogenin, MEF2 and control immunoglobulin G (IgG) were performed using chromatin 
from differentiated MM14 cell myocytes. The graph shows data from one of three ChIP 
experiments that is representative of the enrichment detected at each position by 
antibodies to myogenin (black bars), MyoD (gray bars) or MEF2 (white bars) over 
nonspecific rabbit IgG as determined by quantitative polymerase chain reaction (qPCR) 
assay. Error bars represent ±1 standard deviation of triplicate samples. (C) 
Electrophoretic mobility shift assay (EMSA) of MEF2 binding to the MCK-SIE MEF2 
control element. Nuclear extracts from differentiated MM14 cultures were incubated with 
a 32P-labeled probe containing the MCK-SIE-MEF2 sequence with no competitor (lane 
1), wild-type MEF2 competitor (lane 2), two different mutant MEF2 competitors (lanes 3 
and 4), pan-MEF2 antibodies (lane 5), transcriptional enhancer factor 1 (TEF-1)-specific 
antibodies (lane 6) or nonspecific rabbit IgG (lane 7). Arrows indicate the MEF2-
containing complex and free probe. (D) MEF2 ChIP-Seq occupancy at the 6.5-kb MCK 
regulatory region in differentiated C2 C12 cells shows that MEF2 is present at all three 
control regions. The 6.5-kb region is shown in schematic at the top (5'-enhancer, 
proximal promoter and MR1 are shown in white; MCK-SIE is shown in gray). Sequences 
that match the MEF2 canonical motif (CTAWWWWTAG) at the 80%, 85% and 100% 
thresholds are mapped throughout the 6.5-kb region. The sequenced and mapped ChIP 
signals (reads per million (rpm)) for the two pan-MEF2 antibodies 1 and 2 and the 
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control (input DNA) are indicated as black histograms (scale shown at the right). Two 
different ChIP-Seq region finders (Model-based Analysis of ChIP-Seq data and 
Enhanced Read Analysis of Gene Expression) define the sequence range in which 
MEF2 is predicted to bind (see Materials and methods), and these are shown below 
each signal track as black bars. Conservation across the regions is shown from the 
University of California Santa Cruz (UCSC) Genome Browser plot of phastCons scores 
for the 20 default placental mammals.  
 
 Accordingly, ChIP analysis showed that antibodies for both MyoD and myogenin 
enriched the 5'-enhancer several-fold over nonspecific immunoglobulin G (IgG) (Figure 
4B), and both antibodies also enriched the MCK-SIE region. In contrast, neither antibody 
enriched the exon 2 and Mark4 genomic regions significantly above nonspecific IgG. 
This demonstrates that MyoD and myogenin bind neither to nonconserved, and 
presumably nonfunctional, E-box motifs in the regions surrounding the MCK-SIE, nor to 
chromatin regions that lack E-boxes. There is a slight enrichment at the exon 1/intron 1 
boundary. However, this could be caused by cross-enrichment due to MyoD and 
myogenin occupancy of the nearby and functional proximal promoter E-box [26], the 5'-
enhancer, the MCK-SIE or any combination of these regions. Nevertheless, the 
enrichment due to MyoD and myogenin occupancy of the MCK-SIE region is probably 
not due to spurious enrichment from amplification of longer sheared chromatin 
fragments that include the 5'-enhancer or proximal promoter, because the enrichment 
signal from the exon 1/intron 1 region would then be higher than that of the MCK-SIE, 
and it is not. MyoD and myogenin thus occupy proven functional E-boxes in the 5'-
enhancer and the MCK-SIE in differentiated skeletal myocytes, and they do not appear 
to occupy E-boxes in regions flanking the MCK-SIE. An additional consistent observation 
in these studies is that myogenin exhibits an approximately twofold higher occupancy of 
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the 5'-enhancer than MyoD, whereas both MRFs exhibit equivalent occupancy of the 
MCK-SIE.  
S1.3.6 MEF2 interaction with the MCK-SIE in vitro and in vivo 
 As demonstrated in Figure 3B, the MEF2 site contributes strongly to the 
transcriptional activity of the MCK-SIE region. Since members of the MEF2 superfamily 
of transcription factors (MEF2A, MEF2B, MEF2C and MEF2D) [53] have previously been 
shown to play important roles in muscle gene transcription, we asked whether any of the 
MEF2 family members were associated with the MCK-SIE in vivo. In initial ChIP 
analysis, several different MEF2 antibodies unexpectedly failed to enrich the MCK-SIE 
or even the 5'-enhancer (Figure 4B) (see Discussion). Furthermore, antibodies to 
octamer binding protein 1 (Oct-1) and transcriptional enhancer factor 1 (TEF-1), two 
factors known to transactivate AT-rich motifs in muscle promoters [54,55] and known to 
be present in myocyte cultures, also failed to precipitate the MCK-SIE when used in 
ChIP assays (data not shown). This led us to question whether MEF2 in our cell culture 
model was detectable by immunoassays.  
 To establish that differentiated MM14 cultures contain MEF2 protein, that MEF2 
protein is recognized by the pan-MEF2 antibody used in our ChIP study and that MEF2 
can indeed bind to the MCK-SIE, we analyzed MEF2 binding by electrophoretic mobility 
shift assay (EMSA). 32P-labeled MCK-SIE-MEF2 sequence probes were generated and 
incubated with MM14 nuclear extracts. Gel electrophoresis with the MCK-SIE-MEF2 
probe revealed a single intense band, which implied that either a single or multiple 
factors of similar size were bound to the MCK-SIE-MEF2 probe (Figure 4C). Wild-type 
competitor oligonucleotides completely abolished this band, whereas two 
oligonucleotides containing different mutations of the MCK-SIE-MEF2 motif had no 
effect. Furthermore, a partial supershift of the band was caused when the probe was 
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incubated with nuclear extracts in the presence of a pan-MEF2 antibody, suggesting that 
the band of interest contains MEF2. The partial shift likely occurred because the entire 
complex might not be fully and stably accessible by the antibody to produce a consistent 
supershift. These results argue that MEF2 proteins are present in the nuclei of 
differentiated MM14 muscle cells, that MEF2 is capable of binding to the MCK-SIE probe 
and that MEF2 antibodies, which did not precipitate MCK-SIE-enriched sequences in 
ChIP analysis, were capable of binding MEF2 oligonucleotide complexes in EMSA 
studies of similarly differentiated muscle cultures.  
 Since TEF-1 also binds AT-rich motifs in muscle gene promoters and has been 
shown to bind the MCK 5'-enhancer [55], we asked whether TEF-1 binds to the MEF2 
sequence in the MCK-SIE. Incubation with TEF-1-specific antisera did not supershift or 
abolish the "MEF2 complex," whereas it did supershift a TEF-1-specific complex (data 
not shown). A nonspecific IgG also failed to alter the mobility or intensity of the MEF2-
specific band (Figure 4C). The absence of detectable MEF2 binding in our ChIP study 
(Figure 4) is therefore not likely to be due to competitive in vivo occupancy of the MEF2 
site by TEF-1.  
As MEF2 occupancy of the MCK 5'-enhancer has been reported in mouse 
embryos and in the B22 myogenic cell line following Brahma-related gene 1 and MyoD 
induction [42], it seemed possible that unknown differences between the myogenic 
states of the different cell culture models might affect the ability to detect MEF2 
occupancy in the MCK locus. Fortunately, ChIP-Seq analyses aimed toward identifying 
genome-wide MEF2 binding events in terminally differentiated muscle cells were being 
performed in parallel studies by the Wold group (personal communication, B. Wold). We 
therefore collaborated in analyzing the MCK locus. Initial ChIP-Seq experiments in C2 
C12 skeletal muscle cells also failed to detect significant MEF2 ChIP signals at the MCK 
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locus or at several other MEF2 target loci, thus suggesting that MEF2 might be 
inefficiently cross-linked to DNA under standard ChIP conditions. Since members of the 
MADS family of transcription factors, of which MEF2 is a member, often depend 
significantly on protein-protein interactions with other DNA-bound factors, and since the 
MyoD family of factors interact with MEF2 through protein-protein interactions [56], we 
reasoned that chromatin fixation conditions designed to more efficiently stabilize these 
interactions might improve ChIP detection (see Materials and methods).  
 Following the modified fixation procedure, a standard sequencing readout from 
this material revealed distinct MEF2 signals at the MCK-SIE and at the 5'-enhancer 
(Figure 4D). These signals were very similar in biological replicate chromatin samples 
that had been immuno-enriched by MEF2 antibodies directed against nonoverlapping 
epitopes (data not shown). Enrichment over background was more than 10-fold at both 
sites (P < 2e-13 for Model-based Analysis of ChIP-Seq data (MACS) and P < 8e-7 for 
Enhanced Read Analysis of Gene Expression (ERANGE)), and no other site in the MCK 
locus was significantly occupied, except for the dispersed signals observed throughout 
the MCK proximal promoter sequence. Enrichment of MEF2 within the proximal 
promoter, which contains no sequences that match the canonical motif (although one 
with 80% similarity is present (Figure 4D)), could be due to any of several possibilities 
(see Discussion). The observed MEF2 ChIP-Seq peaks overlap regions of high-
sequence conservation among placental mammals at the 5'-enhancer, the proximal 
promoter and the MCK-SIE regions as determined by phastCons scores, which predict 
evolutionarily conserved elements using a 30-species vertebrate sequence alignment 
and phylogenetic tree information (Figure 4D).  
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S1.3.7 MR1 contributes to MCK gene expression in slow- and intermediate-twitch 
fiber types in adult mice  
 Previous investigations of MCK gene regulation in transgenic mice have 
suggested that the 5'-enhancer and the proximal promoter are highly active in 
anatomical muscles with predominantly fast-twitch fibers (type IIb and type IId (also 
called type IIx or type IId/x fibers)) such as the TA muscle. Conversely, the activity levels 
of the 5'-enhancer and the proximal promoter were at least 10-fold lower in muscles from 
the same transgenic mice that contained a high proportion of slow-twitch muscle fibers 
(type I) or intermediate-twitch muscle fibers (type IIa) such as soleus [26,27]. Since the 
endogenous levels of MCK protein in fast vs. slow muscle fibers differ by only about 
threefold [5], the previous transgenic studies implied that regulatory regions in addition to 
the 5'-enhancer and proximal promoter are required for full MCK expression in slow-
twitch fibers. This led us to hypothesize that MR1 may contribute to MCK expression in 
type I and type IIa fiber types. To test this possibility, we generated transgenic mouse 
lines containing either the 6.5-kb MCK genomic region driving the β-galactosidase (β-
gal) reporter gene (6.5MCK-β-gal) or the same construct lacking MR1 (6.5MCKΔMR1-β-
gal). Adult transgenic mice were killed, and TA and soleus muscles were dissected and 
cryosectioned. Sections were then X-gal-stained to detect β-gal transgene expression. 
To identify the specific fiber types expressing β-gal, we adopted a method of visualizing 
the four distinct fiber types on a single sample section by immunofluorescence tagging of 
myosin heavy chain (MYHC) isotypes as described by Gregorevic et al. [57] (see 
Discussion for rationale of MYHC vs. histochemical fiber typing). Sister sections were 
thus immunostained with monoclonal antibodies that recognize the MYHC isoforms 
found in slow-twitch muscle fibers (type I), intermediate-twitch muscle fibers (type IIa) 
and fast-twitch muscle fibers (type IIb) (Figures 5A and 5B). Type IId fibers were 
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identified based on the absence of immunostaining with all of the above-mentioned 
monoclonal antibodies [58]. It should be noted that the distribution of fiber twitch types 
assessed by MYHC isotype expression within the anatomical muscles examined among 
different transgenic lines was qualitatively similar (data not shown). Thus introduction of 
the transgenes themselves did not alter the distribution of fiber twitch types. Whether 
expression levels of the wild-type 6.5MCK-β-gal and 6.5MCKDMR1-β-gal transgenes 
are differentially affected by the metabolic states within individual muscle fiber types 
remains to be determined.  
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Figure 5. MR1 is important for MCK expression in slow- and intermediate-twitch 
skeletal muscle fibers. (A) Sister sections of tibialis anterior (TA) and soleus muscles 
from mice carrying the 6.5MCK-β-gal or the 6.5ΔMR1-β-gal transgenes, immunostained 
with myosin heavy chain (MYHC) fiber type-specific monoclonal antibodies (panels 1, 3, 
5, 7, 9 and 11) or activity stained for β-galactosidase (β-gal) expression (panels 2, 4, 6, 
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8, 10 and 12). Antibodies for different isoforms and fluorophore-labeled secondary 
antibodies mark the fiber types as follows: slow-twitch fibers (type I), blue; intermediate-
twitch fibers (type IIa), red; and fast-twitch fibers (types IIb and IId), green and black, 
respectively (the black appearance of type IId fibers is due to the absence of any type 1, 
IIa, or IIb antibody binding). Purplish fibers contain both types I and IIa MYHCs (see 
Figure 5B, soleus), and fibers with weak red or green staining probably contain mixtures 
of type IId (no color) + type IIa or type IId + type IIb, respectively (see Figure 5B, TA). 
Sister sections were stained for β-gal expression (false colored gold). Bars are 0.5 mm. 
(B) Higher magnification sections indicate differences in β-gal expression between fiber 
types in transgenic lines with and without MR1. Individual fibers, outlined in white or 
black to show relative differences in X-gal staining between fiber types (type I = K, L and 
O; type IIa = C, D, G, I and J; type IId = B, F, H and M; and type IIb = A and E), can be 
cross-referenced to β-gal expression in sister sections.  
 
 Comparisons between immunostained and X-gal-stained sister cross-sections of 
the TA and soleus muscles of mice carrying the 6.5MCK-β-gal transgene showed β-gal 
expression in all fiber types, but there was a clear difference in the distribution of X-gal 
staining intensities among fiber types in the predominantly fast-twitch TA muscles 
compared to the predominantly slow- and intermediate-twitch soleus muscles (Figure 
5A, panels 2 and 4). As a general rule in TA muscle, type IIb fibers exhibit greater X-gal 
staining than type IId fibers, and type IIa fibers exhibit the least staining (Figure 5B, TA 
X-gal panel, fiber staining intensities: A > B > C), whereas in the soleus, type IId and 
type IIa fibers exhibit the greatest X-gal staining and type I fibers stain the least (Figure 
5B, soleus X-gal panel, fiber staining intensities: H > I > K).  
 Interestingly, fibers that show similar MYHC expression can also vary in X-gal 
staining intensity (compare TA fibers C with D and soleus fibers I with J and K with L). 
However, the overall trend found within the same transgenic mouse and even within the 
same anatomical muscles is that the 6.5MCK-β-gal transgene is more active in individual 
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fast-twitch muscle fibers than in intermediate- and slow-twitch fibers. These β-gal/fiber-
type staining patterns were consistent among all mice tested (n = 7) in the single 
6.5MCK-β-gal-transgenic line.  
 Four transgenic mouse lines that contain the 6.5-kb regulatory region lacking 
MR1 (6.5MCKΔMR1-β-gal) exhibit a strikingly different β-gal expression profile. In the 
TA, there is weaker relative X-gal staining in regions of the TA that are dominated by 
type IIa fibers (Figure 5A; compare panels 5, 6, 9 and 10 with panels 1 and 2). At higher 
magnification, this difference can be directly correlated with low levels of X-gal staining 
in type IIa fibers (Figure 5B, TA panels, fiber G and others) and reduced staining in 
some type IId fibers (Figure 5B, TA panels, fiber F and others). However, in the same TA 
muscle, type IIb fibers (Figure 5, fiber E and others) stain intensely for β-gal. In the 
soleus muscle, X-gal staining is relatively weak throughout the section in comparison to 
similarly treated TA muscle sections (Figure 5A, panels 7, 8, 11 and 12 vs. panels 3 and 
4). At higher magnification, both type I and type IIa muscle fibers show very weak X-gal 
staining (Figure 5B, soleus panels, fibers N, O and others), while the few fibers that 
express β-gal are type IId fibers (Figure 5B, soleus panels, fiber M and others). These 
observations were consistent among all mice tested (n = 7) from the four independent 
6.5MCKΔMR1-β-gal-transgenic lines. This suggests that MR1 contributes strongly to the 
expression of MCK in type I and type IIa fibers, and perhaps weakly in type IId fibers, but 
that MR1 is not absolutely required for high-level MCK expression in type IIb fibers.  
 Expression levels from the wild-type 6.5MCK-β-gal and 6.5MCKΔMR1-β-gal 
transgenes were also examined in protein extracts from entire anatomical muscles 
containing different proportions of fast and slow fibers. Extensor digitorum longus (EDL) 
muscles (primarily fast-twitch fibers) and soleus muscles (primarily slow-twitch and 
intermediate-twitch fibers) were dissected from four or five mice each from the most 
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highly active lines carrying each transgene, and β-gal specific activity was determined. In 
all mice from each transgenic line, EDL extract activities were significantly higher than 
those from the soleus. However, because absolute expression levels typically differ 
between individual transgenic mouse lines, owing to variable transgene integration sites 
and copy numbers [25-27], the β-gal-specific activity levels were then normalized for 
each line by dividing the EDL levels by the soleus levels. The ratio was three times 
higher in extracts from the 6.5MCKΔMR1-β-gal-transgenic mice (data not shown). In 
combination with the much lower transgene expression levels observed within the 
individual type I and type IIa fibers of 6.5MCKΔMR1-β-gal-transgenic mice (Figure 5), 
the quantitative data are consistent with the conclusion that the MR1 region plays a 
relatively more important role in MCK gene expression in muscles containing slow and 
intermediate fiber types than in muscles containing primarily fast fibers.  
S1.4 Discussion 
 In this study, we characterized the MCK intronic region MR1 [22] and found that it 
contains regulatory elements that provide positive transcriptional activity in skeletal 
muscle cells. Our results argue that MR1 is crucial for the "full" activity of the 6.5-kb 
MCK regulatory region in differentiated skeletal muscle cultures (Figure 2), and they 
recapitulate those of an earlier study that demonstrated MR1's ability to drive 
transcriptional activity in a position-independent manner [22]. Additionally, we found that 
MR1's positive transcriptional activity is conveyed by a highly conserved 95-bp sequence 
designated the MCK-SIE (Figure 1). When separated from its flanking MR1 regions, the 
MCK-SIE synergizes with the proximal promoter to provide transcriptional activity 
equivalent to that of the highly active MCK 5'-enhancer (Figure 2B) [22]. Interestingly, 
however, the MCK-SIE requires the 358-bp MCK proximal promoter for its activity, 
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whereas the 5'-enhancer exhibits high activity with the 80-bp MCK basal promoter as 
well as with the proximal promoter (data not shown).  
 The MCK-SIE's high activity is largely due to the paired E-box and MEF2 motifs, 
since their mutation or deletion caused a significant decrease in transcription, while 
mutations affecting the AP-1/MAF half-site motifs did not (Figure 3). Although a 
TRANSFAC database search of the mouse MCK gene's 1-kb MR1 region revealed 
many possible transcription factor binding motifs, and although many of these overlap 
with conserved sequences (Additional file 1, Figure S1), deletion of other conserved 
regions did not disclose a correlation with positive transcriptional activity (Additional file 
1, Figure S1, and Additional file 2, Figure S2). While it is also possible that some aspects 
of MR1-mediated MCK expression are regulated by nonconserved control elements, as 
we have shown is the case for Six4/5 and MAZ elements in the 5'-enhancer and 
proximal promoter [24,32] and as has been shown for other genes [59,60], pursuing this 
possibility did not seem as immediately fruitful as investigating the SIE's E-box and 
MEF2 mechanisms. Nevertheless, our studies do not preclude positive transcriptional 
contributions from other MR1 and SIE sequences.  
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Figure S2. The functional consequence of individual deletions of the conserved 19 
subregions throughout MR1. (A) Conserved regions within MR1 (gray blocks in part A, 
gray bars in part B) were deleted from MR1-proximal promoter-chloramphenicol acetyl 
transferase (MR1-PP-CAT) and tested for transcriptional activity in skeletal myocytes 
(gray bars). (B) MM14 cells were transiently transfected with constructs containing each 
of the 19 different conserved motif deletions, and cells were harvested as described in 
the Figure 2 legend. Relative CAT activity was normalized with the MCK 5'-enhancer 
alkaline phosphatase (AP) reference plasmid and compared to the intact MR1-PP-CAT 
(black bar) and to the PP-CAT (white bar). Expression levels of MR1-PP-CAT were 
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scaled to equal 1.0. Asterisks indicate constructs that did not result in a statistically 
significant change in transcriptional activity.  
 
 Several ChIP studies have indicated the ability of E-box motifs in skeletal muscle 
gene promoters to recruit the basic helix-loop-helix factors MyoD and myogenin, and 
EMSA studies have proven E-box binding by Myf5, MRF4 and E12/47 as well [45]. 
Analysis of early phases of muscle differentiation also suggests that MyoD may bind 
muscle gene promoters as a "pioneering" factor [3] that facilitates histone acetylation 
[45]. As differentiation progresses, MyoD is then replaced by myogenin at the same 
regulatory regions. This was shown to be the case for the MCK 5'-enhancer in E10.5 to 
E14.5 mouse limb muscles [51]. This transition may be facilitated by decreased levels of 
Suv39h1, a histone H3 lysine 9-specific methyltransferase that represses myogenin 
expression via histone and MyoD methylation [61]. However, in our ChIP studies of 
MM14 muscle cultures harvested four days after the initiation of differentiation, a time at 
which 90% of the myonuclei are in MYHC-positive cells, both MyoD and myogenin were 
detected at the 5'-enhancer as well as at the MCK-SIE (Figure 4B). These data 
demonstrate that a rapid and complete MyoD-to-myogenin binding transition is not 
observed in the cell culture system used in our study. However, it may be informative 
that we found the ratio of myogenin to MyoD enrichment of the 5'-enhancer to be 
consistently greater than that of the MCK-SIE, where about equal ChIP signals were 
detected. The biological relevance of this difference in enrichment is not yet understood.  
 Our MCK-SIE ChIP data for differentiating MM14 cultures are generally 
consistent with ChIP-Seq studies that have probed the entire genomic occupancy of 
MyoD in differentiated mouse C2 C12 myocytes [52] in that both studies detected enriched 
MyoD occupancy of the MCK-SIE, proximal promoter and 5'-enhancer. Our data are also 
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consistent with a temporal ChIP-Seq data set showing no MyoD or myogenin occupancy 
of the MCK-SIE in replicating C2 C12 cells and highly enriched occupancy by both factors 
in fully differentiated cultures (A. Kirilusha, G. Kwan and B. Wold, personal 
communication). On the basis of our mutagenesis studies, the MCK-SIE 3'-E-box 
appears to be the more active site, since its deletion caused a greater reduction of 
transcriptional activity (Figure 3B). This might be attributed to the mouse 3'-E-box's 
being a closer match (12 of 14 bp) to the overall E-box consensus sequence than the 5'-
E-box (11 of 14 bp) (Figure 1C). Alternatively, the closer proximity of the 3'-E-box than 
the 5'-E-box to the MEF2 site may improve the synergistic interactions between 
MyoD/myogenin and MEF2 and may lead to greater activity of the 3'-E-box In either 
case, it is not known whether one or both E-boxes preferentially associate with MyoD or 
myogenin in vivo or whether this might change under different physiological conditions. 
Ideally, this question could be addressed by ChIP analysis, but because the two E-boxes 
are only 46 bp apart, their individual occupancies cannot be definitively resolved on the 
basis of currently available data. Our MCK locus-specific MyoD/myogenin ChIP data 
also concur with the global ChIP-Seq MyoD data [52] with respect to occupied and 
unoccupied E-boxes in the sense that the strongly preferred sequence for occupied E-
boxes in differentiated C2 C12 muscle cultures is CAG/cCTG. All of the occupied E-boxes 
in our study conformed to this sequence, and no unoccupied E-boxes within the MCK 
regions studied had the preferred sequence. It is also worth emphasizing that even 
though dozens of CAnnTG consensus E-boxes occurred within the 6.5-kb MCK genomic 
region, and while some of these occurred in clusters of two or three E-boxes within a 
100-bp region (Figure 4A), neither our study nor the more comprehensive global ChIP-
Seq study (personal communication, B. Wold) detected significant MyoD binding at the 
vast majority of these E-boxes. This indicates that the mere presence of one or more 
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nearby E-box motifs within transcriptionally active muscle gene promoters does not 
imply their functionality. Conversely, since our laboratory has proven the function of E-
boxes within all three of the MCK genomic regions in which ChIP and ChIP-Seq 
detected significant MyoD binding, the data suggest that the detection of reproducible 
MyoD ChIP peaks of this type in muscle genes is strongly indicative of transcriptional 
function of the associated E-boxes. While the ChIP studies implicate MyoD and 
myogenin as binding to the MCK-SIE and 5'-enhancer E-boxes, it is important to point 
out that cell culture studies are not necessarily indicative of the MRFs that occupy these 
E-boxes in adult skeletal muscle fibers. In the latter context, it is likely that these E-boxes 
may be primarily occupied by MRF4, since it appears to be the predominant MRF in 
adult skeletal muscle [62,63].  
 The MCK-SIE MEF2 site is also critical for transcriptional activity, as removing 
this sequence is even more deleterious than removing the individual E-boxes (Figure 
3B). Consistent with this, we found that MEF2 binds this sequence in vitro by EMSA 
using nuclear extract from MM14 myocytes (Figure 4C). Furthermore, ChIP-Seq studies 
of differentiated C2 C12 muscle cells identified enriched MEF2 occupancy at both the 5'-
enhancer and the MCK-SIE (Figure 4D), and the fold enrichments at these sites relative 
to the negative control were more than 10-fold. A diffuse signal over the proximal 
promoter region was also observed, and this signal may reflect either that binding to a 
nonconsensus MEF2 site or that MEF2 association with MyoD/myogenin bound to a 
proximal promoter E-box located at -247 bp provides positive transcriptional activity both 
in vitro and in vivo [25,27]. Alternatively, MEF2 enrichment at the proximal promoter may 
be due to the secondary binding of MEF2 complexes formed at the 5'-enhancer and/or 
the MCK-SIE physically contacting the promoter. Such long-distance interactions of 
enhancer-affiliated factors with promoter DNA via cross-linking with initiation complex 
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proteins have been readily detected in standard ChIP reactions during chromatin 
conformation capture [64].  
 Overall, we conclude that MEF2 interacts in vivo with the MCK-SIE complex. The 
strong dependency of MCK-SIE function on the presence of the MEF2 control element 
(Figure 3B) also supports the hypothesis that MEF2 likely binds directly at this site. The 
functional synergy of this MEF2 site with E-box control elements bound by MyoD and 
myogenin is reminiscent of the behavior of an analogous E-box pair and MEF2 site in 
the MCK 5'-enhancer [23] and is consistent with a model of cobinding involving MEF2 
and MRFs [46,56,65], although simultaneous occupancy by both factors in vivo is 
inferred and has not been directly measured.  
 Interestingly, all four isoforms of MEF2 (MEF2A, MEF2B, MEF2C and MEF2D) 
are present in myocyte cultures [53], but MEF2B is not present in adult mouse muscle 
[66,67]. The MCK-SIE sequence does not predict which, if any, MEF2 isoforms bind 
preferentially [53], and the antibodies used in our ChIP assays cross-reacted with all 
MEF2 isoforms. Thus, it is possible that the MEF2 site may be occupied by any of the 
MEF2 isoforms present in differentiated skeletal muscle cultures. It is also plausible that 
the MEF2 site can be occupied by other non-MEF2 factors that recognize AT-rich motifs. 
For example, AT-rich motifs similar to the one found in the MCK-SIE are known to bind 
nuclear factors such as Oct-1, TEF-1 and MHox [24,51,55,68-72], and the MCK 5'-
enhancer's MEF2 and AT-rich motifs have been shown to recruit MEF2, Oct-1 and TEF-
1. In this regard, even though the MCK 5'-enhancer and MCK-SIE contain similar paired 
E-box/MEF2 motifs, the MCK-SIE fails to bind TEF-1 by EMSA analysis (Figure 4C), 
whereas the 5'-enhancer MEF2 element binds TEF-1 [55]. Although the functional 
consequences of this difference are unknown, these data imply that the MEF2 site-
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mediated transcriptional activity of the MCK-SIE and MCK 5'-enhancer may differ in 
terms of their interactions with non-MEF2 factors.  
 An intriguing facet of MR1's regulatory function is the discovery that it contains 
transcriptionally repressive sequences flanking the highly positive MCK-SIE. These MR1 
regions can repress the MCK-SIE's activity via the combined or individual effects of at 
least 15 highly conserved 9- to 24-bp sequences (Figure 2B and Additional file 1, Figure 
S1, and Additional file 2, Figure S2). When MR1 constructs containing individual 
deletions of these motifs were tested in skeletal muscle cultures, most of the deletions 
resulted in two- to fourfold increases in transcriptional activity (Additional file 2, Figure 
S2), suggesting that these conserved regions act to repress transcriptional activity. The 
only deletion that resulted in a significant decrease in activity overlapped the MEF2/AT-
rich motif within the MCK-SIE region (Additional file 1, Figure S1, and Additional file 2, 
Figure S2). Interestingly, deletion F, which encompassed the MCK-SIE's conserved 5'-E-
box, did not cause decreased activity when tested in the context of the entire MR1 
region (Additional file 2, Figure S2), but did lead to decreased activity in the context of 
the isolated MCK-SIE (Figure 3B). This may be due to the compensatory functions of 
other control elements within the entire MR1.  
 Our studies have also begun to address the in vivo function of MR1 in MCK gene 
expression. Comparisons between a transgenic mouse line that contains the 6.5-kb 
sequence driving β-gal and several lines from which the MR1 region has been deleted 
revealed differences in transgene expression that indicated a correlation between MR1 
function and muscle fiber type. Transgenic lines expressing the 6.5MCKΔMR1-β-gal 
transgene expressed very low levels of β-gal in slow- and intermediate-twitch fibers (type 
I and type IIa), while expression levels in fast-twitch fibers (type IIb and type IId) 
remained high (Figure 5). Although only one wild-type 6.5MCK-β-gal-transgenic line was 
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derived in our own study, an independent transgenic study that employed the same 6.5-
kb MCK genomic sequence to express the transcriptional enhancer factor domain family 
member 1 (TEAD1) transcription factor demonstrated high-level transgene expression in 
the soleus (slow- and intermediate-twitch muscle fibers) as well as in EDL (fast-twitch 
muscle fibers) [73].  
 Our transgenic analysis of MCK gene regulation has focused on correlations 
between transgene expression levels and fiber types defined according to their MYHC 
isotype expression profiles. Since MCK functions in an energy transport pathway that is 
important for optimal contractile function, it might also have been informative to identify 
fiber types based on metabolic markers such as succinate dehydrogenase and 
nicotinamide adenine dinucleotide phosphate levels that could be detected via 
histochemical assays and then to correlate these fiber types with transgene expression 
levels. This was not done for purely technical reasons, as MYHC immunostaining 
provided more precise distinctions between fiber types and because the ability to detect 
four fiber types in a single cryosection facilitated correlations between fiber types and β-
gal levels in adjacent sections. Furthermore, since the original investigators of muscle 
fiber types based on MYHC immunostaining were very careful to ascertain that individual 
fibers were designated as the same fiber type by both the histochemical and 
immunostaining protocols [58], it seems likely that our study would have reached similar 
conclusions regarding the role of MR1 in MCK gene expression with either fiber-typing 
technique.  
 There is clearly a functional relationship between Myhc types and MCK gene 
expression patterns [6,74], but the underlying basis of this regulatory linkage is not 
known. In this regard, however, the distribution of MYHC isotypes in different anatomical 
muscle is not altered in MCK-deficient mice; rather, the lack of MCK appears to be 
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compensated by an increase in mitochondrial creatine kinase (CK) [75]. Recently, it has 
also been shown that the expression patterns of myosin isoforms and enzymes involved 
in muscle fiber energy metabolism can be uncoupled by mutations that affect glycogen 
storage and sarcoplasmic calcium release mechanisms [76]. These reports suggest that 
MCK transgene expression would not be anticipated to exhibit a strict correlation with 
muscle fiber types as assessed solely by MYHC fiber typing. This possibility may 
partially explain why the MCK-driven β-gal levels observed in transgenic TA and soleus 
muscles were not uniform among all fibers of each MYHC-defined type (Figure 5B). 
These nonuniformities in transgene expression within specific fiber types do not appear 
to be regulated by MR1, since they are observed in fibers carrying the intact 6.5-kb MCK 
genomic region as well as in those in mice carrying the 6.5MCKΔMR1 transgene. 
Nevertheless, the MR1 region clearly plays an important role in regulating the steady-
state levels of MCK gene expression in different anatomical muscles and in different 
fiber types. In this regard, it has yet to be determined whether MR1 or the MCK-SIE 
alone can drive expression in slow- and intermediate-twitch muscle fibers independently 
of the 5'-enhancer. It is also not known which physiological signals impinge on the MCK-
SIE and on the flanking repressive regions within MR1.  
 Transgenic analysis of fiber type-specific muscle gene expression has also been 
carried out with the MLC2v, MLC1/3f, aldolase A and slow troponin I muscle genes [7-
10,14]. Similarly to our studies with MCK, E-boxes and MEF2 control elements have 
been identified within their key regulatory regions. In particular, the slow troponin I SURE 
region contains the critical E-box, MEF2, and a CACC motifs, which in isolation confer 
pan-muscle expression. Interestingly, the inclusion of a more upstream region within 
SURE, which contains a bicoid-like motif that recruits the general transcription factor 3 
(GTF3)/muscle transcription factor II I repeat domain-containing protein 1 (MusTRD1), 
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restricts activity to slow-twitch muscle [11,14]. A related mechanism may modulate the in 
vivo activity of the MCK-SIE, leading to the contribution of MR1 to expression in slow-
twitch fibers. However, neither the bicoid-like motif (GTTAATCCG) [14] nor the GTF3 
consensus DNA binding sequence (GTC GA GATTAG BGA ) [11] is found in or immediately 
adjacent to the MCK-SIE. In contrast, the fast-twitch activity of the MCK 5'-enhancer may 
be partially due to recruitment of the Six4 transcription factor, since the MEF3 site in the 
aldolase A pM promoter is necessary but not sufficient to drive transcription in some 
fast-twitch muscle fibers [77].  
 The contribution of multiple enhancer regions to the expression of striated 
muscle genes in different fiber types may be a common mechanism. For example, 
transgenic analysis has demonstrated that the troponin I (fast) enhancer intronic 
regulatory element (TnIfast IRE), in isolation, results in fast twitch fiber-specific 
expression in the adult plantaris muscle, where TnIfast IRE elements yield the highest 
levels of expression in type IIb fibers, intermediate levels in type IId, very low levels in 
type IIa fibers and no expression in type I fibers [16], while the endogenous TnIfast gene 
is expressed at similar levels in all fast-twitch fiber types [15]. The MCK gene MR1 
region, although its activity contributes to expression in slow and intermediate fibers, 
appears analogous to TnIfast IRE in that both regulatory regions provide relatively 
restricted fiber-type expression patterns and both genes require the contribution of 
multiple fiber-specific enhancers to achieve pan-skeletal muscle expression. The MCK 
MR1 and 5'-enhancer regulatory regions thus appear to share common mechanisms of 
transcription with several fast- and slow-twitch muscle genes.  
S1.5 Conclusions 
 This study identifies a regulatory region within the MCK gene's intron 1 that plays 
a major transcriptional role in slow- and intermediate-twitch muscle fibers. This activity 
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was shown in vitro to be dependent on the MCK-SIE region, which contains a paired E-
box and MEF2 motif. Each motif was shown to be required for full MCK-SIE 
transcriptional activity, and ChIP studies showed that they recruit MyoD, myogenin and 
MEF2, respectively. It was also shown that the MCK-SIE is flanked by repressive 
regulatory regions containing multiple different negative control elements. The 
mechanisms and functional purposes of these remain to be determined.  
S1.6 Materials and methods 
S1.6.1 Sequence analysis 
 Sequences spanning the TATA box to exon 2 of the MCK gene of Homo sapiens 
(human [AC005781.1]), Felis catus (cat [GenBank: AC135221.3AC135221.3]), Canis 
familiaris (dog [GenBank: AC137538.2]), Bos taurus (bovine [GenBank: AC137535.2]), 
Sus scrofa (pig [GenBank: AC139878.2]) and Mus musculus (mouse GenBank: 
[AC118017.15]) were obtained from compiled genomic sequences in the Entrez 
Genome Project database and subjected to sequence alignment using ClustalW [78]. 
The intron 1 sequences of both mouse and human were independently analyzed for 
putative control element motifs using Match http://www.gene-regulation.com/cgi-
bin/pub/programs/match/bin/match.cgi webcite) (Contact B. Wold for specifics: 
http://woldb@caltech.edu webcite, a matrix search algorithm that scours the TRANSFAC 
database of transcription factors and their experimentally proven binding sites. 
Parameters were set to select for vertebrate-only matrices with a 90% core binding 
similarity to broaden the rate of positive hits. 
S1.6.2 Plasmid constructs 
 A 6.5-kb construct of the mouse MCK gene (-3,349 to +3,230) [37] was cloned 
upstream of the CAT reporter gene 6.5MCK-CAT [26]. The 6.5MCKΔMR1-CAT 
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construct was generated from the 6.5MCK-CAT construct by introducing ClaI restriction 
sites 5' and 3' of MR1 (+740 and +1,724) using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene, http://www.genomics.agilent.com/ webcite), according to 
the manufacturer's directions. MR1 was then deleted by digestion of the plasmid with 
ClaI and religation of the remaining vector. The 6.5MCKΔEnh-CAT construct was 
generated by site-directed mutagenesis to delete the MCK 5'-enhancer (-1,256 to -
1,040).  
 The MR1 region was polymerase chain reaction-amplified from the existing 6.5-
kb construct with primers containing the restriction sites SphI (5') and BstI (3'). The MR1 
amplicon was cloned upstream of the proximal promoter by replacing the 5'-enhancer in 
the e-358-CAT reporter construct [27] using SphI and BstI. The mouse MCK PP region 
used in these studies extends from -358 to +7. All other deletions and mutations 
described in this study were generated using the QuikChange Site-Directed 
Mutagenesis Kit.  
S1.6.3 Transient transfections and reporter gene assays 
 MM14 skeletal myoblasts were cultured as described previously [79]. Collagen-
coated 100-mm dishes were inoculated with about 1 × 105 log phase cells/dish and were 
allowed to proliferate under growth conditions (85% Ham's F10C nutrients + gentamicin, 
15% horse serum and 2 ng/mL basic fibroblast growth factor (bFGF) added at 
approximately 12-hour intervals) for about 24 hours. Myoblasts were cotransfected using 
a standard calcium phosphate method [23] at about 3 × 105 cells with test constructs 
driving the expression of the CAT reporter gene and an AP reference plasmid, which 
contains the 5'-enhancer placed 5' of the basal promoter sequence (-80 to +7). 
Transfected MM14 cultures were induced to differentiate four hours after beginning the 
transfection by aspirating the growth medium, rinsing once with saline G, incubating for 2 
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minutes at room temperature in 15% glycerol 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid-buffered saline, rinsing again with saline G and then 
adding 10 mL of differentiation medium (98.5% Ham's F10C nutrients + gentamicin, 
1.5% horse serum and 1 μM insulin) [79]. Relative enzymatic activities of CAT and AP 
were determined from extracts as described in previous studies [25]. Since the MCK 
enhancer-AP reference plasmid is expressed only in differentiated muscle cells, it 
provides a control for plate-to-plate variability in transfection efficiency and extent of 
muscle differentiation in skeletal myocyte cultures.  
S1.6.4 ChIP assays 
 ChIP assays were performed using a modification of the Fast-ChIP method as 
described previously [32,80] with the following nuances: 100-mm dishes were plated 
with about 1 × 105 log phase MM14 cells/dish and grown to near confluence (about 4 × 
106 cells/dish), then allowed to differentiate in proliferation medium without additional 
bFGF for four to six days prior to harvesting. All cultures contained more than 90% 
terminally differentiated myocytes as assessed by immunostaining a parallel culture with 
the myosin-specific antibody MF-20. This procedure produced more than 7 × 106 
differentiated myonuclei per 100-mm dish. Cells were sonicated with 16 rounds of 15-
second pulses with 45 seconds of rest between pulses (four minutes total) on a Model 
100 Sonic Dismembrator (Fisher Scientific, http://www.fishersci.com/ webcite) at the 
highest setting. Antibodies used for immunoprecipitation described in this study were as 
follows: anti-myogenin (M-225) sc-576 X, anti-MyoD (M-318) sc-760 X, anti-MEF2A (C-
21) sc-313 and normal rabbit IgG sc-2027 (Santa Cruz Biotechnology, 
http://www.scbt.com/ webcite). The primers used in ChIP analyses were MCK 5'-
enhancer: 183 bp forward: 5'-GCCCATGTAAGGAGGCAAGGCC-3', reverse: 5'-
CACCAGGGACAGGGTTATTTTTAGAGC-3', MCK exon 1/intron 1 boundary: 217 bp 
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forward: 5'-GGGTCACCACCACCTCCACAG-3', reverse: 5'-
GCCTTGCAAGGAGGGGACACTTG-3', MCK-SIE: 168 bp, forward: 5'-
CTTGAGGCCCAGAGCCTGGCTG-3', reverse: 5'-
GAGACCCAAAGCCCTTGAAGCTGCTAC-3', MCK exon 2: 207 bp, forward: 5'-
GTCCCAAAGGCCGCCACCATG-3', reverse: 5'-GGGTTGTCCACCCCAGTCTGG-3' 
Mark4 gene region: 205 bp, forward: 5'-GGATGCCATGCCTGGTGGCCAT-3', reverse: 
5'-GCCATGCAGCTTTCACGCAGAGG-3'.  
S1.6.5 EMSA 
 EMSA was carried out as previously described [32]. Nuclear extracts from 
differentiated skeletal muscle cultures were prepared as previously described [81] using 
a cocktail of several protease inhibitors (P8340; Sigma, St. Louis, MO, USA). Total 
protein in the extracts was quantitated by using the Bradford method [82]. Incubations 
with antisera or unlabeled oligonucleotide competitors were carried out at room 
temperature for 20 minutes prior to the addition of probe. The 5' to 3' sequences of the 
double-stranded probes or competitors with introduced mutations of the sequence 
underlined are  
MEF2 (MCK-SIE):  
AGGAGCATCTAAAAATAGCCACAAAG 
 
MEF2 (MCK-SIE)-M1:  
AGGAGCATC  
CG 
AAAA  
CG 
GCCACAAAG  
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MEF2 (MCK-SIE)-M2:  
AGGAGCATC  
AT 
AAAA  
AT 
GCCACAAAG.  
Antibodies used for EMSA were anti-MEF2A (pan-MEF2, C-21) (Santa Cruz 
Biotechnology), anti-TEF-1 (BD Transduction Laboratories, 
http://www.bdbiosciences.com/home.jsp webcite) and IgG normal rabbit sc-2027 (Santa 
Cruz Biotechnology, http://www.scbt.com/ webcite).  
S1.6.6 ChIP-Seq assays 
 ChIP assays for MEF2 ChIP-Seq were performed according to the protocol 
described by Johnson et al. [83] with the modifications described in the paragraph 
below. C2 C12 cells were grown at low density on Nunclon 14-cm-diameter plates (Fisher 
Scientific, http://www.fishersci.com/ webcite) in 20% fetal bovine serum 
(FBS)/Dulbecco's modified Eagle's medium (DMEM) (#11965; Invitrogen 
http://www.invitrogen.com/site/us/en/home.html webcite with penicillin and streptomycin 
and passaged at no more than 50% confluence. Upon reaching confluence, 
differentiation was induced by switching to 2% horse serum/1 μM insulin/DMEM. After 60 
hours of differentiation, the cells were cross-linked with 1% formaldehyde (Avantor 
Performance Materials, http://www.avantormaterials.com/ webcite) and 0.025% 
glutaraldehyde (Polysciences, Inc. http://www.polysciences.com/ webcite) for 10 
minutes. A total of 2 × 107 cells were fragmented to about 100 to 300 bp using 30-
second, 12-W cycles on a Misonix 3000 sonicator 
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http://www.fishersci.com/ecomm/servlet/fsproductdetail?aid = 2819374&storeId = 10652 
webcite for a total sonication time of 15 minutes. The sheared chromatin was 
immunoprecipitated using 100 μL of sheep anti-mouse IgG M280 beads (Invitrogen) and 
5 μg of MEF2 monoclonal antibody (clone B4) from Santa Cruz Biotechnology or 200 μL 
of sheep anti-rabbit IgG M280 beads and 10 μg of MEF2 polyclonal antibody (clone 
H300) from Santa Cruz Biotechnology. Illumina libraries for sequencing were made 
using their ChIP-Seq library kit (Illumina, Inc., http://www.illumina.com/ webcite) as 
described by the manufacturer, except that a 10-cycle amplification was performed 
before gel selection according to the method of Johnson et al. (library 2) [83]. Library 
sequencing was performed for 36 cycles on an Illumina Genome Analyzer (Illumina, 
Inc.), and the resulting reads were mapped to the mouse MM9 genome by using Bowtie 
software [84]. Mapped reads that permitted up to two mismatches to the reference 
genome were displayed on the University of California Santa Cruz (UCSC) Genome 
Browser. ChIP-Seq signals were called using the ChIP-Seq module within the ERANGE 
version 3.2 software package [85] and were also mapped using the MACS peak caller 
[86].  
S1.6.7 Transgenic mice 
 The 6.5-kb MCK gene sequence and the sequence with MR1 deleted were 
cloned upstream of the β-gal reporter gene to generate the 6.5MCK-β-gal and 
6.5MCKΔMR1-β-gal constructs, respectively. DNA for microinjection was prepared by 
enzymatic digestion to linearize the plasmids and gel-purified by freeze-and-squeeze 
columns (Bio-Rad Laboratories, http://www.bio-rad.com/ webcite). Transgenic mice were 
produced using eggs from C57BL/6J × C3H crosses through the University of 
Washington Transgenic Resource Program. Founders were crossed to C57BL/6J to 
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generate F1s. Lines of mice analyzed were either F1s or the progeny of F1s (N2 or N3) 
that were back-crossed with C57B/6J.  
S1.6.8 Dissections 
 Adult mice (1+ months) were killed according to methods approved by the 
University of Washington Institutional Animal Care and Use Committee. TA and soleus 
muscles were dissected and mounted in a 2:1 mixture of optimal cutting temperature 
compound and 10% gum tragacanth in cryomold cassettes. Cassettes were then frozen 
in liquid nitrogen-cooled isopentane. Tissues contained in blocks were cryosectioned at 
a thickness of 6 μM at -25°C using a Leica cryostat http://www.leica-microsystems.com/ 
webcite, mounted onto glass slides at room temperature and then stored at -80°C.  
S1.6.9 X-gal staining 
Slides were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 
15 minutes at 4°C and washed in 100 mM sodium phosphate (pH 7.3), 2 mM MgCl2 , 
0.01% sodium oxycholate and 0.02% Nonidet P-40 and stained in a standard X-gal 
reagent solution [87] for 4 hours. After staining, slides were fixed for 15 minutes in 10% 
formalin and mounted in gelvatol (Sigma-Aldrich, http://www.sigmaaldrich.com webcite). 
Images were obtained using a Zeiss Axiovert 200 microscope 
http://www.zeiss.com/micro webcite with a Zeiss AxioCam MRm camera (Zeiss), and 
acquired using AxioVision software (Zeiss). Images were then uniformly false-colored 
using Adobe PhotoShop version 7 software (Adobe Systems, http://www.adobe.com/ 
webcite).  
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S1.6.10 Immunofluoresence 
Monoclonal antibodies specific for myosin isoforms MYHC1, MYHC2A and 
MYHC2B were produced from cultures of hybridoma lines BA-D5, SC-71 and BF-F3, 
respectively [58]. These antibodies stain type I, type IIa and type IIb fibers, respectively. 
Cultures were grown to high density in DMEM High Glucose (HyClone Laboratories, 
http://www.hyclone.com/ webcite) supplemented with 10% FBS (Gemini Bioproducts, 
http://www.gembio.com/ webcite)) and penicillin-streptomycin (Sigma). Cultures were 
then switched to serum-free medium and incubated for two or three days. The medium 
was collected, centrifuged and filter-sterilized (0.22 μm Stericup; Millipore, 
http://www.millipore.com/ webcite) and monoclonal antibodies were concentrated by 
HiTrap column chromatography (GE Healthcare Biosciences, 
http://www.gelifesciences.com/ webcite). High-protein concentration fractions as 
determined by the Bradford method [82] were pooled and dialyzed (Slide-A-Lyzer 
Dialysis Cassettes; Pierce Biotechnology, http://www.piercenet.com/ webcite), and then 
stored at -20°C. Slides were treated with blocking buffer (1% bovine serum albumin and 
0.05% Tween 20 in PBS) and incubated with about 10 μg/mL BA-D5, SC-71 and BF-F3 
for 1 hour, washed three times for five minutes in blocking buffer and incubated with goat 
anti-mouse secondary antibodies IgG2b Alexa Fluor 350, IgG1 Alexa Fluor 594 and IgM 
Alexa Fluor 488 (Invitrogen) for 30 minutes. Slides were washed as before, rinsed in 
PBS and mounted in gelvatol. Images were acquired as described above.  
S1.7 Abbreviations 
AP: alkaline phosphatase; bFGF: basic fibroblast growth factor; β-gal: β-
galactosidase; BRG1: Brahma-related gene 1; CAT: chloramphenicol acetyl transferase; 
ChIP: chromatin immunoprecipitation; ERANGE: Enhanced Read Analysis of Gene 
Expression; KLF3: Krupple-like factor 3; Mark4: MAP/microtubule affinity-regulating 
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kinase 4 gene; MAZ: Myc-associated zinc finger protein; MEF2: myocyte enhancer 
factor 2; MCK and MCK: muscle creatine kinase gene and protein; MCK, MCK-SIE: 
MCK small intronic enhancer; MR1: modulatory region 1; MYHC: myosin heavy chain; 
Oct-1: octamer-binding protein; TA: tibialis anterior muscle.  
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Chapter Supplemental II 
High resolution mapping of Twist to DNA in Drosophila embryos: Efficient 
functional analysis and evolutionary conservation 
Anil Ozdemir*, Katherine I Fisher-Aylor*, et al. (2011), Genome Research 21(4): 566-577 
 
SII.1 Abstract 
 Cis-regulatory modules (CRMs) function by binding sequence specific 
transcription factors, but the relationship between in vivo physical binding and the 
regulatory capacity of factor-bound DNA elements remains uncertain. We investigate 
this relationship for the well-studied Twist factor in Drosophila melanogaster embryos by 
analyzing genome-wide factor occupancy and testing the functional significance of Twist 
occupied regions and motifs within regions. Twist ChIP-seq data efficiently identified 
previously studied Twist-dependent CRMs and robustly predicted new CRM activity in 
transgenesis, with newly identified Twist-occupied regions supporting diverse 
spatiotemporal patterns (>74% positive, n = 31). Some, but not all, candidate CRMs 
require Twist for proper expression in the embryo. The Twist motifs most favored in 
genome ChIP data (in vivo) differed from those most favored by Systematic Evolution of 
Ligands by EXponential enrichment (SELEX) (in vitro). Furthermore, the majority of 
ChIP-seq signals could be parsimoniously explained by a CABVTG motif located within 
50 bp of the ChIP summit and, of these, CACATG was most prevalent. Mutagenesis 
experiments demonstrated that different Twist E-box motif types are not fully 
interchangeable, suggesting that the ChIP-derived consensus (CABVTG) includes sites 
having distinct regulatory outputs. Further analysis of position, frequency of occurrence, 
and sequence conservation revealed significant enrichment and conservation of 
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CABVTG E-box motifs near Twist ChIP-seq signal summits, preferential conservation of 
±150 bp surrounding Twist occupied summits, and enrichment of GA- and CA-repeat 
sequences near Twist occupied summits. Our results show that high resolution in vivo 
occupancy data can be used to drive efficient discovery and dissection of global and 
local cis-regulatory logic. 
SII.2 Background 
In animal genomes, cis-acting regulatory modules (CRMs) average ∼300–500 bp 
in size and typically contain one or more binding motif instances for several transcription 
factors (Davidson 2006). DNA binding motif instances can now be readily mapped in 
silico by similarity to a consensus binding motif that has been defined through in vitro 
methods, or they can be derived from careful functional dissection of a few well-studied 
CRMs. However, many transcription factors recognize short sequence motifs that occur 
so frequently in the genome that virtually all gene loci have one or more, raising 
questions about which of these sites is occupied in the cell and what regulatory impact 
that occupancy has. We also know that binding motifs in the best-studied CRMs are 
often clustered (e.g., Ip et al. 1992a; Small et al. 1992; Berman et al. 2002; Markstein et 
al. 2002), presumably to facilitate coordinated and cooperative interaction among factors 
and cofactors and to achieve specificity relative to isolated single motif occurrences. 
However, we do not yet understand the logic by which motif combinations specify the 
functional output of the vast majority of CRMs in the genome (e.g., Lusk and Eisen 
2010), and efficient identification and analysis of many more CRMs are needed to 
uncover these principles.  
 Advances in identifying candidate CRMs are coming from whole-genome 
approaches in which either chromatin immunoprecipitation (ChIP) is employed to find the 
region of DNA bound by a given transcription factor in vivo (e.g., Zeitlinger et al. 2007; 
172 
 
Zinzen et al. 2009), or high-throughput screening assays are utilized to identify promoter 
and CRM functions (e.g., Landolin et al. 2010; Nam et al. 2010), although the latter have 
not yet been widely applied. Global ChIP assays also allow one to define de novo or 
refine binding motifs used by a factor in vivo and to compare this with in vitro defined 
motifs. ChIP-seq is a particular form of genome-wide chromatin immunoprecipitation, 
which can produce high positional resolution of observable DNA binding in vivo 
(Johnson et al. 2007). In particular, the resolution of ChIP-seq data can be used to infer, 
within a given binding region, which specific motif occurrence is likely to account for the 
majority of the observed ChIP signal (Valouev et al. 2008). We refer to the motif 
instances most likely to drive observed binding as candidate “explanatory” sites, and we 
explore the value of making explanatory site models for all ChIP signals to guide detailed 
functional assays.  
 We apply ChIP-seq and ChIP-chip analyses to Twist, a key transcription factor in 
the dorsal-ventral (DV) patterning network of the Drosophila early embryo. Patterning the 
DV axis depends partly on Twist, a bHLH transcription factor present at high levels in 
ventral regions of the embryo (for review, see Chopra and Levine 2009; Reeves and 
Stathopoulos 2009). Many previous studies have contributed to the current picture of a 
developmental gene network that describes embryonic DV patterning, in which more 
than 50 genes and 30 CRMs have been linked (for review, see Stathopoulos and Levine 
2005). Previous published ChIP-chip studies conducted using Twist antibodies have 
demonstrated that its occupancy can be detected in vivo (Sandmann et al. 2007; 
Zeitlinger et al. 2007). Our goals are to relate the global Twist occupancy pattern to 
functional CRM activity, as assayed by transgenesis, and to relate the local ChIP-seq 
profile to specific motif instances and combinations and their contribution to individual 
CRM activity.  
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SII.3 Results 
SII.3.1 Comparison of ChIP-chip and ChIP-seq in the identification of CRMs 
 We performed ChIP-chip and ChIP-seq analysis on sheared chromatin isolated 
from Drosophila embryos from 1 to 3 h in age, using an antibody that is specific to Twist 
protein, and subsequently assessed the overlap between sets of regions identified by 
each approach (see Supplemental Fig. 1A–C and Methods). For ChIP-chip, we used a 
script to call peaks based on a minimum signal score, whereas for ChIP-seq, we used 
the ERANGE software suite to call peaks based on the number, orientation, and ratio of 
short sequence reads relative to a background control. The results from these methods 
were compared at several sensitivity thresholds to accommodate different numbers of 
peaks called by their informatics pipelines (Supplemental Fig. 1D). Given the substantial 
technical and computational differences between ChIP-chip and ChIP-seq, the fact that 
the vast majority of ChIP-seq signals overlap with some ChIP-chip regions lends mutual 
confidence, although a large number of ChIP-chip sites lacked support from ChIP-seq. 
Inspection of multiple ChIP-seq regions for which Twist activity was previously studied in 
detail showed that ChIP-seq regions are generally better resolved and provide superior 
guidance for experimental tests of function that are the central focus of this study 
(Supplemental Table 1).  
SII.3.2 Functional analysis of Twist-occupied regions 
 We quantified how frequently and strongly ChIP-seq regions function as CRMs at 
the same time and place in development as the ChIP assays. To first identify a set of 
known gold-standard Twist CRMs, we applied a conservative standard that allowed only 
CRMs having prior genetic and molecular evidence. Enhancers (i.e., CRMs supporting 
gene expression rather than acting as silencers) along the DV axis were categorized as 
three types: Type I (ventral regions), Type II (ventro-lateral regions), and Type III (dorsal-
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lateral and dorsal regions) (Supplemental Table 2B; for review, see Chopra and Levine 
2009; Reeves and Stathopoulos 2009). Many enhancers of Types I and II require Twist 
for expression based on genetic and molecular genetic evidence, but not until recent 
ChIP-chip analyses was it thought that Twist might function to regulate Type III patterns 
(Zeitlinger et al. 2007). We observed very strong ChIP signals at sog and brk Type III 
CRMs but not at ind, dpp, zen, and tld (Supplemental Table 2B; Supplemental Fig. 2). 
When only Type I and II CRMs were considered, 11 of 15 were present in our medium 
confidence (MC) data set (see Methods). Known CRMs for the four not present (i.e., 
Ady43A, phm, E(spl), and wntD) had below-threshold or no Twist ChIP-seq signal. The 
threshold for calling peaks could, of course, be reduced in order to recapture some (e.g., 
wntD and phm), but at the expense of increasing the false positive rate. Taken at face 
value, this gold standard comparison suggests we miss ∼25% of true positives at the 
threshold selected.  
 Next, we tested 31 new candidate Twist CRMs drawn from the entire ChIP-seq 
set in a standard reporter gene assay (see Supplemental Table 2A). Of the 31 test 
regions, 23 (74%) supported expression; 21 supported expression in a classic dorso-
ventral pattern or a subregion thereof, and 2 supported distinct patterns (i.e., ubiquitous 
or purely anterior-posterior) (Supplemental Fig. 3). The 23 new CRMs were distributed 
throughout the ChIP-seq signal range (Supplemental Fig. 2, “Positive signal”). Peaks 
near genes Cyp310a1, Traf4, mirror (mirr), and Mef2 were clearly defined by the ChIP-
seq data, while the equivalent ChIP-chip data in these regions was much broader and, in 
some cases, gave multiple peaks, making the location of a candidate CRM ambiguous 
(see Fig. 1A–D). While Twist ChIP-seq data led to a high recovery rate of CRM 
detection, surprisingly, only ∼25% of the associated genes including Cyp310a1, Asph, 
and emc (i.e., 3 of 12 assayed) actually required Twist to support expression in embryos. 
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For instance, mirr, Traf4, and Mef2 expression was unaffected in twist mutants, even 
though their Twist-ChIP-seq signals were equally prominent and numerous (data not 
shown; see Discussion).  
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Figure 1. In vivo Twist occupancy supported by Twist ChIP-seq identifies 
functional CRMs. Representative examples of newly identified enhancers (brown boxes) 
and those previously identified (pink boxes) are shown for Cyp310a1 (A), mirr (B), Traf4 
(C), and Mef2 (D). Upper left panels show ChIP-chip data and lower left panels show 
ChIP-seq data for Twist-IP and control samples. In upper right panels, lateral views of 
whole mount in situ hybridizations of the endogenous genes of stage 5–8 embryos are 
shown. In lower right panels, lateral views of whole mount in situ hybridizations of similar 
staged embryos containing either cherry (for Traf4, mirr, and Cyp310a1 enhancers) or 
lacZ (for Mef2 5′ enhancer) reporter constructs.  
 
SII.3.3 Twist recognition motifs in vivo and in vitro 
 Twist belongs to a large bHLH family of DNA-binding factors that recognize a 
core DNA consensus, CANNTG, called an E-box (for review, see Massari and Murre 
2000). Prior work using in vitro and in vivo approaches highlighted a subfamily preferred 
by Twist, led by CATATG (i.e., TA E-box). We asked which, if any, of the 10 possible E-
box recognition motifs (counting reverse complements as the same motif) are selectively 
concentrated within 50 bp of called ChIP-seq signal summits (Fig. 2A). We found that 
CA and GA core E-boxes were most prominent, while GC, TA, and CG were relatively 
minor (Fig. 2A, “Twist ChIP-seq”). Compared with regions sampled from ChIP-seq 
control data or from the entire non-repeat genome, only CA, TA, CG, and GA core E-
boxes were statistically enriched in Twist-occupied regions (Fig. 2A, colored slices). 
When larger radii from the ChIP signal summits were interrogated, the number of E-
boxes of all types increased, and the specific enrichment trend was less apparent (i.e., 
enrichment of CA, TA, CG, and GA core E-boxes). In contrast, when ChIP-chip regions 
were similarly examined (Supplemental Figs. 5, 6), no specific enrichment of any motif 
was detected at any radius from the called Twist peaks. Overall, the enrichment and 
resolution results suggest that the ChIP-seq data could be used to model individual 
binding domains and causal motif instances in them (see below).  
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Figure 2. A comparison of Twist in vivo and in vitro binding preferences. (A) The 
frequency of E-boxes associated with HC twist peaks (±50 bp), SELEX-bound 
sequences, ChIP-seq enriched control regions (±50 bp of summits), and the non-repeat 
dm3 genome was calculated. (B) Twist ChIP-seq data in the vicinity of CRMs shown to 
support expression of the genes rho (Ip et al. 1992b), vnd (Stathopoulos et al. 2002), 
vein (Markstein et al. 2004), and Cyp310a1 (this work). The directionality within ChIP-
seq sequencing reads points to the position of the “explanatory” site. Blue and red ticks 
symbolize individual sequencing reads acquired, which match either the Watson or Crick 
strand.  
 
 Previously published foot-printing data and small-scale SELEX had found that 
the in vitro Twist protein binding consensus is CAYRTG (i.e., core E-box residues YR = 
TA, CG, and CA) (Ip et al. 1992b; Zinzen et al. 2006). To test how Twist in vivo binding 
results relate to in vitro preferences, we determined E-box frequencies in high-
throughput Twist SELEX data, and compared them with our ChIP-seq data (see 
Supplemental Text). For the most part, the same E-boxes were highlighted, except that 
the TA-core E-box motif, which was the most highly bound by Twist in vitro (35.6% 
occupancy by SELEX), was less enriched in vivo (7% by ChIP-seq versus 5.3% 
frequency in the genome). A simple explanation is that there are real differences 
between the in vivo and in vitro binding conditions that affect Twist motif preference. 
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Among alternative explanations, one or more species of bHLH heterodimers might be 
acting in vivo, while only homodimers were assayed in vitro (see Discussion). 
SII.3.4 Motif composition of Twist ChIP-seq regions 
 We examined the positions of all E-box motifs within Twist-ChIP-seq regions 
(Fig. 2B). The ChIP-seq protocol used here is a standard Illumina platform one that 
retains information about whether a sequenced fragment end originated from the 
Watson (red) or Crick (blue) strand (Fig. 2B; Valouev et al. 2008). With appropriate data 
preprocessing to account for fragment length (for review, see Pepke et al. 2009, see 
Methods), the summit location within each peak region can be identified computationally. 
Inspection of known Twist CRMs showed that this agrees well with, on average, 1–2 
dominant binding motif instances within ±50 bp (e.g., see Fig. 2B). A subset of 
previously known Twist-bound regions consists of multiple peaks aggregated together, 
and these are typically associated with multiple Twist motifs (e.g., see Fig. 2B, vnd).  
 We mapped and visualized the position of each motif instance relative to its peak 
summit and calculated the cumulative frequency for each motif type as a function of 
distance from the peak (Fig. 3). Within the top ranked ∼1000 peaks the concentration of 
CAYRTG motifs was stronger than in lower ranked peaks, with CACATG sites, rather 
than CACGTG and CATATG, being most prominent near peak summits (Fig. 3B, top). 
Several criteria, including manual inspection of peaks throughout the ranking and the 
presence of previously studied Twist-dependent CRMs, led us to define a high 
confidence (HC) threshold of 513 regions (FDR 1%; see Methods and Supplemental 
Text); however we also found that binding motif centrality extends to ∼1000 sites in the 
genome, and for most analyses we use this more inclusive set of ∼1000 medium 
confidence (MC) calls (FDR 17%).  
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Figure 3. Motif composition of Twist ChIP-seq regions shows preferential 
concentration of specific E-boxes near summits. (A) Locations of CAYRTG = CACATG 
CATATG and CACGTG E-box instances located within ±250 bp of the ChIP-seq peak 
(ERANGE-shifted called signal summit; see Methods) (y axis), plotted as a function of 
signal intensity rank from highest (1) to lowest (2000) (x axis). 1099 MC ChIP-seq data 
set is shown with a dashed line. CACATG is the most prevalent E-box motif in Twist 
ChIP regions and it shows the strongest central concentration. (B) Direct (top panel) and 
cumulative (bottom panel) motif density plots. In the MC data set, 65% of CACATG 
motifs and 50% of CAGATG occur within ±50 bp of Twist peaks. (C) CAGATG occurs 
more frequently in Twist ChIP-seq regions and is more centrally localized than (D). (D) 
CATATG is the motif most prominent in SELEX data (see text). (E) Other E-boxes 
(defined here as CANNTG motifs where NN is neither CA, GA, nor TA) display a more 
uniform distribution (B,E), though the other CABVTG E-boxes not pictured here (CG, 
GC, and CC) provide a minor central enrichment (see Supplemental Fig. 8). The number 
and distribution of explanatory E-boxes changes with ChIP-seq signal strength, 
suggesting that more E-boxes create a more robust Twist ChIP signal (A; Supplemental 
Fig. 7).  
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 The accumulation of motif instances as a function of distance from the summit, 
over the entire set of Twist ChIP-seq regions, was analyzed (Fig. 3B, bottom). Using the 
K-S test, the P-value for CACATG distribution was defined as <2.2 × 10−16 (D = +0.44), 
meaning that the observed enrichment of CACATG near the peak summit is non-random 
and highly significant. It suggests that the CA-containing E-box drives in vivo binding at 
the majority of sites we called. Five other E-boxes also are enriched near summits, 
though they are less frequent in comparison to CACATG (Fig. 3B, top; Supplemental 
Fig. 8; Supplemental Table 3). In addition, the highest ranking peaks are associated with 
2 or more matches to E-boxes; in particular the CACATG site is prominent (see 
Supplemental Fig.9).  
SII.3.5 CACATG and CATATG motifs are not functionally synonymous  
 For many ChIP regions, detailed inspection of the primary data displayed in 
browser format confirms a single explanatory motif (e.g., vein CRM, Fig. 2B; 
Supplemental Fig. 10). However, some CRMs contain two or more closely spaced sites 
matching the CABVTG consensus, leading us to ask how closely positioned E-boxes 
interact. The rho early embryonic enhancer is such a case, with a highly directional 
single peak with two E-boxes sites (CATATG, T1, and CACATG, T2) separated by only 
5 bp (Fig. 4A). We tested whether a series of enhancer constructs support expression in 
the lateral domain of the embryo, comparing the wild type CRM with Twist motif mutants.  
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Figure 4. Mutagenesis of Twist binding sites at the ChIP-seq peak summit of rho 
enhancer. (A) The 75 bp sequence from the rho minimal enhancer which contains 
binding sites for Twist as well as for the transcription factors Dorsal and Snail. E-box 
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sequences CATATG (T1, dark blue) and CACATG (T2, light blue) are separated by 5 
bp, and Dorsal binding sites (orange) are positioned upstream and downstream of Twist 
sites. A Snail site that overlaps with T2 E-box is shown in green. (B) A diagram of the 
minimal 299 bp rho enhancer showing the relative positions of sites for Twist (dark and 
light blue triangles) and Dorsal (orange circles and filled circles, showing non-canonical 
and canonical sites, respectively). Lower schematic shows color-coded representations 
of the WT or mutant Twist binding sites present in various reporter constructs. Single 
nucleotide mutations were introduced into either T1 or T2 to eliminate binding (black: 
CATATG>GATATG or CACATG>GACATG) or to convert one site to the other (light 
blue: CATATG>CACATG or dark blue: CACATG>CATATG). (C) In situ staining of the 
wild type construct, minimal rho enhancer attached to the evep.lacZ reporter. (D) The 
Rho1Δ2Δ double mutant containing point mutations in both of the E-boxes, T1 and T2, 
supports reporter gene expression that is significantly weakened and more narrow 
compared to wild type (C). (E–G) Single mutations support expression that is weaker 
than wild type (C), more similar to the double mutant (D). (H) When a CATATG E-box is 
present in both the T1 and T2 positions, this change severely affects the expression 
domain of the reporter gene, reducing it to levels comparable to those observed in the 
double mutant Rho1Δ2Δ embryos (D). (I) When a CACATG E-box is present in both the 
T1 and T2 positions, the expression supported is comparable to the wild type (C).  
 
 Within the rho enhancer sequence, we introduced single-nucleotide changes to 
sites T1 and T2 (CANNTG→GANNTG). These subtle changes abrogated expression, 
such that instead of supporting expression in a wide domain (∼6–8 cells), the mutant 
enhancer supports expression in a more narrow domain (∼3–4 cells) (cf. Fig. 4D,C); this 
result is comparable to what others have found previously with more severe changes to 
the T1 and T2 E-box sequence (5 or more changes per site; Ip et al. 1992c). We also 
found that mutation of either site alone supported reporter gene expression, but neither 
was as severe as eliminating both (cf. Fig. 4E,F,G and 4C,D). This suggested that Twist 
binding to both T1 and T2 sites contributes to rho expression.  
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 We then asked whether CA and TA E-boxes are interchangeable. When T1 and 
T2 are both CACATG (i.e., T1 site TA-core was converted into CA-core), reporter 
expression was comparable to wild type (Fig. 4I). In contrast, replacement of both sites 
by the CATATG was not sufficient to support expression over the full spatial domain 
(Fig. 4H); in fact, expression was comparable to the T2 mutant (Fig. 4G). This suggests 
that the CA E-box can function in both positions, while the TA E-box can function in T1 
but not T2.  
SII.3.6 Motif discovery in Twist ChIP-seq regions 
 To uncover possible alternative Twist binding motifs or co-associated motifs for 
Twist-interacting factors, we used MEME, a motif discovery tool (Bailey et al. 2006), to 
search for statistically overrepresented motifs in and near Twist-occupied regions. As 
expected, prominent motifs found by MEME were E-box sequences (Fig. 5A) that 
overlap with CABVTG defined by our previous analyses (Fig. 3). In addition, MEME 
output highlighted residues flanking the E-box, such that a leading-A or lagging-T 
residue is preferred [e.g., CACATG-T (A-CATGTG) or A-CACATG (CATGTG-T)]. In 
contrast, a lagging A was very rare in Twist regions and in the genome at large (Fig. 5A). 
Other in vitro and in vivo bHLH binding studies support the idea that flanking bases may 
influence bHLH DNA binding (Grove et al. 2009; Cao et al. 2010).  
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Figure 5. Motifs associated with Twist in vivo occupancy identified using MEME. 
MEME was run on the narrow 50 bp region surrounding each of the 1099 MC ChIP-seq 
peaks to identify all motifs that are enriched near the point of Twist occupancy. These 
motifs were mapped back to determine their spatial distribution relative to Twist peaks, 
and some motifs showing a non-uniform distribution near Twist peaks were selected. (A) 
Variations on CAYRTG and CAGCTG were returned, together specifying CABVTG (top 
two Weblogos). Note that a leading A residue or a lagging T residue is also suggested, 
which appears preferred by other non-Twist family DNA-binding bHLH factors (K Fisher-
Aylor, S Kuntz, and A Kirilusha, unpubl. obs.; Grove et al. 2009). In addition, two simple 
repetitive sequences (CA and GA) are also significantly enriched at Twist-occupied sites 
(bottom two Weblogos). (B) Venn diagram illustrating the relationship between sets of 
peaks defined as having at least one occurrence of (i) either of the two E-box-like motifs; 
(ii) the CA-repeat-like sequence; or (iii) the GA-repeat-like sequence.  
 
 Several “simple” repeat sequences were significantly overrepresented in the 
Twist-occupied regions: the predominant one was a CA-repeat, and a similar GA-repeat 
sequence was also found (Fig. 5A). Of the 1099 peaks comprising the MC Twist ChIP-
seq data set, 850 contain at least one match to either major E-box in the wide area 
around the peak (±250 bp), and 378 of these (or 44%) also contain at least one CA- or 
GA-repeat sequence (Fig. 5B). It is possible that the CA- and GA-repeats associated 
with Twist ChIP-seq peaks play some role in marking or phasing these regions as 
potentially “open chromatin,” as these same motifs were recently found associated with 
DNA occupied by Trithorax and Polycomb group/recruitment factors (see 
Schuettengruber and Cavalli 2009; and Discussion).  
 Interactions between Twist and other transcription factors might exist, yet not be 
identified by MEME for various reasons. We therefore tested additional motifs already 
known to bind transcription factors that pattern the DV axis in the early Drosophila 
embryo. Dorsal is a maternal transcription factor that functions cooperatively with Twist 
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at some well-studied, closely-spaced sites (e.g., Ip et al. 1992c; Erives and Levine 
2004), but the generality of this pattern across other Twist bound regions is not known. 
We found no significant global correlation between Dorsal motif occurrences and Twist 
peaks in our data. Among other factors (i.e., Su(H), Zelda, RGGNCAG/unknown, and 
Snail), only Snail exhibited significant motif co-enrichment in Twist ChIP regions, while 
Su(H) and RGGNCAG exhibited weak enrichment. The Snail result is neither surprising 
nor definitive because this factor can bind a sequence similar to that of Twist 
(Supplemental Fig. 12). Snail is thought to function as a repressor, at least in part, by 
competitively inhibiting binding of Twist (e.g., Ip et al. 1992b). Perhaps binding of both 
Twist and Snail to CRMs through the CA-core E-box plays a role that is more 
widespread than previously appreciated (see Discussion).  
 Twist-occupied regions were preferentially and significantly concentrated in 
proximal promoters (Fig. 6A), relative to several control samples, while intronic and 
intergenic classes were not enriched. Twist regions were slightly, but not significantly, 
depleted in exons. We tested whether the Twist regions near promoters were, more 
frequently than any others, lacking an explanatory E-box. This would be expected if 
many Twist promoter ChIP signals resulted from capture of indirect looping interactions 
from distant Twist-bound CRMS (e.g., Fullwood and Ruan 2009), rather than from 
primary motif binding, but it was not observed (Fig. 6B). We also asked if specific E-box 
motifs are selectively associated with any specific gene region class. Explanatory motifs 
at promoters showed higher CAGCTG and CACGTG E-box content, relative to intronic 
and intergenic groups, and a reduction in the dominant CACATG motif (Fig. 6B; 
Supplemental Fig. 13). These trends were not due to similar changes in the frequencies 
of GC, CG, or CA dinucleotides in promoters genome-wide (Supplemental Fig. 13). 
Exons also had distinctive signatures, presumably due to protein coding constraints.  
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Figure 6. Enrichment of Twist ChIP-seq summits and explanatory E-box motifs in 
different genic and intergenic locations. (A) Enrichment of Twist ChIP-seq and ChIP-chip 
summits at particular positions in the genome, relative to a genome random sample and 
several sequencing negative controls. The genome was segregated into four mutually 
exclusive categories: promoter proximal (relative to the set of promoters from S. 
Celniker, including 500 bp upstream), exonic, intronic, and intergenic (see Supplemental 
Methods). While the majority of Twist regions fall into intergenic and intronic regions, 
there is a significant overabundance of Twist peaks in promoters relative to the amount 
of promoters in the genome (24%, or 258 of the ChIP-seq peaks). Intergenic and intronic 
Twist occurrences are comparable to that expected from a random genomic sample 
(29%, or 319 intergenic, and 38%, or 420 intronic). The number of summits within exonic 
regions is relatively disenriched (9%, or 102). In order to assess these numbers 
compared to expected values, we also compared the same number of Twist ChIP-chip 
regions (largest by area), the input control DNA regions enriched over Twist, the 
aggregated input DNA, and a random sampling of sequenced reads mapping uniquely to 
the genome (see Supplemental Text). We also report the total amount of the genome 
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falling into each of these categories. The aggregated control and, to a lesser degree, the 
random control reads draw attention to the fact that there are many sequenced reads 
falling into exons. The enriched control does not show the exon bias perhaps because a 
directionality requirement was used; there is a mild enrichment of these sequences in 
the gene flanking category relative to the random genomic sample but a significant 
depletion in the promoter proximal that is likely due to the fact that Twist peaks are 
enriched at promoters. (B) The frequency of explanatory E-box sequences as a function 
of position of Twist-bound peaks in the genome (i.e., promoter proximal, intergenic, 
intronic, and exonic position). The CA, CG, and GA core E-boxes show enrichment in 
promoter, intergenic, and intronic positions; the GC core E-box is specifically enriched in 
the promoter proximal position.  
 
SII.3.7 Evolutionary conservation of ChIP-seq regions and motifs 
 Preferential sequence conservation is a signature of many biologically-significant 
regulatory regions and sequence motif instances. On average, our Twist-occupied 
regions were more conserved over a sequence domain of ∼300 bp compared to random 
genomic background conservation (blue versus red trace, Fig. 7A). In the HC Twist 
ChIP-seq data set of 513 peaks, conservation was highest over the motif when regions 
were centered on the explanatory CABVTG instance, and conservation gradually 
dropped to background levels as a function of distance from the center (green versus 
blue trace, Fig. 7A). Slight preferential conservation is observed in the background 
control sequence when they are aligned using the same set of E-boxes (cyan versus red 
trace, Fig. 7A). This is consistent with E-boxes being targets of a large family of 
transcription factors that exhibit varying degrees of motif preference. Furthermore, this 
regional conservation was less prominent in lower ranked peaks, suggesting that the 
higher ranked peaks are more likely to be functional (see Supplemental Fig. 14).  
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Figure 7. Conservation analysis of sequences defined by Twist binding. (A) 
Averaged conservation profiles using phastCons scores for ChIP-seq regions and 
random genome samples. The blue curve shows average conservation in ChIP-seq 
peak regions is significantly elevated ±150–200 bp from the ChIP-seq signal summit. 
The green curve shows the same data but with regions recentered over the nearest 
CABVTG binding motif within 150 bp of the original summit. For the random sample, 500 
regions containing one of the motifs were selected with the region start point selected at 
random for the uncentered distribution. Here “midpoint” refers to the location in the 
center of the randomly determined region. The error bar shows two standard deviations 
of 30 trials of 500 samples each. A maximum over the motifs is manifest, though 
substantially smaller than within the ChIP-seq peak regions. (B) Histogram of phastCons 
scores for bp occurring within the 6 E-box binding motif candidates (gray) compared to 
that for bp within the ChIP-seq regions, but outside any of the E-box motifs (black). Bp in 
the motif sites are found to be statistically more conserved than bp outside of motifs 
(0.005 significance level). (C) Fraction of sites in various sequence patterns falling within 
the top decile of phastCons scores for a 150 bp radius surrounding ChIP-seq summits 
versus the chi squared statistic for distributions within 150 bp of the summit compared to 
those of region 250–500 bp from the summit. CACATG, CATATG, and GA repeat 
sequences exhibit significantly greater conservation in ChIP-seq regions compared to 
flanking sequence than other motifs (as shown by their clustering at high values of the 
chi squared statistic), though CATATG and GA repeats do not exhibit high absolute 
levels of conservation.  
 
 To assess conservation of E-box sites more quantitatively, we compared the 
distribution of phastCons scores for inferred Twist binding motifs in peak domains (±150 
bp from the ChIP-seq summit) to those for other sequences in the same regions (Fig. 
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7B). E-box motifs were significantly more conserved than the rest of the domain, 
suggesting that they are more functionally relevant than the average sequence around 
them. This supports the view that E-boxes in proximity to detected peaks are not only 
“explanatory” for binding, but that many of these have some function in vivo. The 
function implied by conservation may or may not occur during the embryonic stage at 
which we have made our measurements, and it is even possible that some are 
conserved due to binding by a different bHLH factor during the life of the animal.  
 We examined the degree of conservation of individual E-boxes of interest relative 
to one another and to CA and GA repeats that were found to be prevalent in the ChIP-
seq signals. We sought to distinguish those with functions associated specifically with 
the Twist-occupied CRMs by comparison to flanking sequence, by comparing the 
fraction of conserved (phastCons > 0.9) motif occurrences within ±150 bp of the ChIP-
seq summit to those in flanking regions 250–500 bp away from the summit (Fig. 7C); the 
latter is assumed to be statistically equivalent to genomic background from data in 
Figure 6A. We find that CATATG, CACATG, and GA repeats stand out in terms of the 
change in conservation between peak and flanking sequences. In contrast, CAGATG, 
CACGTG, CACCTG, and CA repeats show minimal change between peak and non-
peak sequences.  
SII.4 Discussion 
 This analysis of in vivo Twist occupancy in the developing Drosophila embryo 
provides general and specific insights into relationships of Twist DNA binding motifs and 
in vivo Twist occupancy with regulatory function. We found that the in vivo consensus 
binding motif, as derived from Twist ChIP-seq data, is CABVTG (Figs. 2 and 5). Within 
that subfamily of E-boxes, CACATG is most prevalent within tested CRMs and is 
occupied preferentially within ChIP-seq defined peaks in general (Supplemental Tables 
192 
 
1 and 2; Fig. 3). Our detailed analysis of the rho enhancer showed that within the Twist-
subfamily of E-boxes, individual members are not always interchangeable, and this 
suggests that they can support different functions (Fig. 4). When we searched for other 
motifs in addition to the E-box sequence that are associated with Twist peaks, we found 
that two repeat sequences, in particular, are associated with Twist ChIP-seq peaks, CA- 
and GA- repeat sequences, and that A/T-rich sequences are generally depleted from the 
region around ChIP signals (Supplemental Fig. 11). E-boxes and the over-represented 
motifs, in particular CACATG, CATATG, and a GA-repeat, are more conserved within 
peaks than background, suggesting that they have significant functions, presumably in 
transcriptional regulation.  
We investigated the relationship between Twist occupancy and CRM regulatory 
activity by conducting functional tests and through analyses of conservation. Because 
the numbers of Twist-occupied sites we detected (500–1100) is large compared to the 
number of known Twist-regulated genes, it was not a foregone conclusion that most 
occupied regions would have any regulatory function. Our observed 74% CRM activity 
rate (23 positive CRMs of 31 tested) is high, and it argues that ChIP occupancy is 
efficiently highlighting functional regulatory DNA segments (Supplemental Table 2A); this 
analysis also captured the majority of gold standard enhancers identified by a number of 
previous studies (Supplemental Table 2B). Results showing preferential conservation of 
the Twist-bound cohort provide additional support for the idea that many other candidate 
regions that we did not test directly for function will also turn out to be CRMs.  
 A natural question is why the remaining ∼25% did not score as active enhancers 
to support gene expression. Simple biological possibilities are that some Twist 
occupancy is not associated with any regulatory activity; that the module's regulatory 
activity is to silence or to insulate, rather than to enhance; that the module is bound but 
193 
 
is not active at this time in development (for review, see Levine and Tjian 2003; Arnosti 
and Kulkarni 2005; Gurudatta and Corces 2009; Cao et al. 2010). There are precedents 
for all these possibilities, although not all have been explicitly shown for Twist. Technical 
explanations are that CRM activity might not have been successfully captured in a 
segment tested, or that the original ChIP region calls include an unrecognized class of 
false positives.  
 Although our ChIP data efficiently identified CRMs, we emphasize that there is a 
distinction between significant in vivo Twist occupancy, as indicated by the ChIP-seq 
data, versus significant regulatory dependence on Twist, which appears to be rarer. 
Lower levels of regulatory dependency are, at present, difficult to measure, and they 
might be common. At the extreme, Twist-binding at most CRMs could be entirely 
opportunistic, arising by protein-protein interactions with other already bound factors and 
cofactors and/or binding to an E-box that has been made accessible by other unrelated 
factors nearby.  
SII.4.2 Incongruity between in vivo and in vitro preferred motifs 
 Our findings suggest that the TA-core and CA-core E-boxes are similarly 
preferential for Twist binding in vitro, but in vivo the Twist ChIP-seq explanatory sites are 
enriched in CA-core E-boxes. If Twist protein sees CA and TA motifs similarly, then the 
in vivo preference might simply reflect general base composition. When we specifically 
tested for this, the magnitude of CA enrichment in Twist bound E-boxes was much larger 
than in the non-coding genome at large (Supplemental Fig. 13). Alternatively, bHLH 
proteins are known to form heterodimers in addition to homodimers, and an explanation 
for CA differences is that Twist binding detected in vivo is a combination of homo- and 
heterodimers (e.g., Murre et al. 1989). The enrichment of CA core E-boxes in vivo could 
reflect a particular Twist–bHLH heterodimer, since ChIP will, in principle, recover any 
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Twist-containing complex. In particular, there is some genetic interaction data that 
suggests that Twist and Daughterless (Da), a bHLH ubiquitously expressed in the 
embryo, may interact to affect patterning in the early embryo (Jiang et al. 1992; 
Gonzalez-Crespo and Levine 1993; Stathopoulos and Levine 2002). Other data with 
forced heterodimers showed that Twist can partner with Da at later stages to influence 
somatic mesoderm specification (Castanon et al. 2001). When we examined overlap 
between our Twist ChIP-seq binding events and that of Da ChIP-chip data available (Li 
et al. 2008), using relaxed criteria for overlap, we found 30% of our high confidence sites 
have some evidence for Da binding at the same locus. When the explanatory E-box 
instances for these regions from our data were interrogated, we found no positive 
correlation with CA core E-boxes and Da, but we did find a positive correlation with GC 
core E-boxes and possible Twist/Da co-occupancy (data not shown). Since other bHLH 
factors in the embryo might also partner with Twist, the specific role, if any, of 
heterodimers in this system will be speculative until the full partnering repertoire for Twist 
is quantified and characterized. It is also possible that post-translational modifications 
and local conditions in the nucleus that differ from the in vitro conditions affect DNA 
binding preferences.  
 Our mutagenesis experiments with the rho CRM further demonstrate that the TA-
core and CA-core E-boxes are not equivalent, at least in some instances. What could be 
different about CA- versus TA-core E-boxes? CACATG and CATATG E-boxes (e.g., T1 
and T2; see Fig. 4) were first identified as Twist-binding sites within the rho early 
embryonic enhancer in 1991 by Ip et al. (1992c) using in vitro footprinting. They showed 
that the CA-core E-box (but not TA-core) can also be bound by the repressor Snail. It is 
therefore possible that the preference we see for CA core E-boxes near ChIP-seq peaks 
indicates that Twist/Snail combined sites have been favorably selected, and that this 
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combination site has a distinct role in regulating the activity of many CRMs in the early 
embryo. In 2002, the CA-core E-box was also found to be overrepresented in a small 
group of CRMs that specifically support expression in ventro-lateral domains of the 
embryo (Stathopoulos et al. 2002), and since then others have studied cooperativity 
between Twist and Dorsal binding (e.g., Erives and Levine 2004; Zinzen et al. 2006; 
Crocker et al. 2008). It might follow that the CA-core E-box is generally required to 
support cooperative interactions with Dorsal or with other collaborating factors, although 
we did not detect Dorsal motifs in most Twist ChIP-seq defined regions.  
 We favor the view that in the majority of regions the Twist motif highlighted by 
ChIP-seq is the one most likely to contribute to regulating gene expression (or other 
unidentified functions), but we cannot dismiss contributions from other E-box sites 
present in the region. Our experiments with the rho enhancer illustrate this, as both E-
boxes CACATG and CATATG, located five nucleotides apart, affect gene expression. 
Within Twist ChIP-seq peaks, we find that TA core E-boxes are less frequent overall and 
only weakly enriched under peaks of binding (±250 bp from the peak summit), and as a 
result they are not often “explanatory” (<±50 bp from the peak summit). Yet these 
accessory TA core E-boxes may also contribute to regulating gene expression, whether 
by binding Twist more transiently or by interacting with some other factor. Because the 
CA core E-box is also bound by Snail, the balance of activation/repression may require 
that a combination of CA and TA core E-boxes is optimal to support expression. 
Furthermore, while Twist bound to the explanatory sites may serve a major role in 
regulating gene expression and these accessory sites may provide less input, even 
marginal input may be crucial to support gene expression patterns in ways that matter 
for viability and selection, even though some of these may also be too subtle for our 
assays to detect.  
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SII.4.3 Simple sequence motifs and chromatin status 
 Apart from the CA- and GA-repeat sequences, no motifs other than the E-boxes 
were found to co-cluster with Twist binding sites in a large fraction of Twist-bound 
regions even when a wider window around the peaks of detected binding was 
interrogated. This does not preclude that other factors function in important combinations 
with Twist, but it suggests that no single transcription factor motif is commonly used in 
the entire Twist-occupied set. Finding specific combinations will require focus on subsets 
of regions selected by other criteria, such as expression pattern of nearby genes, 
performance of CRMs in transgenic assays, or direct binding assays for known or 
suspected accessory factors.  
 We do not know the significance of CA- and GA-simple repeat motifs that are 
enriched in Twist binding regions, but their association in other studies with open 
chromatin regions is suggestive (Auerbach et al. 2009). We hypothesized that GAGA-
binding factor (GAF) which binds to promoters (for review, see Lehmann 2004) might do 
so here in promoter proximal regions through recognition of the GA-repeats. However, 
we did not find an enrichment of GA-repeat sequences associated with promoter 
proximal Twist peaks; the GA-repeats were located in many different positions 
suggesting a broader role than regulation of promoters, such as making DNA regions 
accessible.  
 Depletion of A/T-rich sequences from peaks was striking and it proved to be non-
specific, as it is associated with a multitude of ChIP-seq samples. Further analyses 
showed there is a similar depletion of A/T-rich sequences around ChIP-seq peaks for 
diverse factors and in multiple genomes, including worm, mouse, and human 
(Supplemental Fig. 15; K Fisher-Aylor and B Wold, unpubl. obs.). This depletion was 
also seen when “peaks” of reads were selected from matching control samples of input 
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chromatin (cross-linked, sheared, and reverse cross-linked). The sonication step 
associated with ChIP-seq has recently been shown to enrich for promoter regions, 
DNase I hypersensitive sites, and other “open” chromatin regions (Auerbach et al. 2009), 
but in that work no specific sequence content biases were reported. The depletion of A/T 
rich runs might arise from a role these sequences have been suggested to play in 
nucleosome exclusion and positioning (e.g., Iyer and Struhl 1995; Peckham et al. 2007). 
Our observations of broad A/T depletion arose from a study of motif representation that 
happened to be A-rich (Supplemental Fig. 11), and it suggests that careful examination 
of background input chromatin is needed when evaluating the sequence composition of 
ChIP regions.  
SII.4.4 The conservation profile around explanatory Twist motifs implies CRMs of 
∼300 bp 
 The genomes of Drosophilids are known to exhibit more conservation, in general, 
than many other animal species separated by what are thought to be an equivalent 
length of evolutionary distance. Thus, it has proven difficult to identify putative CRMs 
based on a simple search for increased local conservation of non-coding DNA sequence 
among Drosophilid genomes. Early comparative studies of enhancer regions in 
Drosophila species suggested that local increases in conservation of non-coding 
sequence imply regulatory function (Bergman et al. 2002). More recently, it has been 
suggested that this idea should be narrowed to conservation of specific binding sites 
only within CRMs or even just conservation of site number without strong primary 
sequence conservation (Sosinsky et al. 2007; Ho et al. 2009; Liberman and 
Stathopoulos 2009). Here we provide evidence to support both views: increased general 
conservation of sequence within putative CRMs relative to genomic background, as well 
as higher conservation of particular binding sites (Fig. 7). We asked if there is a genome-
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wide average conservation signature that would characterize candidate CRMs; ChIP-
chip data previously detected a conservation preference but without clarity about the 
dimensions of regions under selective pressure (MacArthur et al. 2009). Our data 
suggests that sequences around these motif instances are preferentially conserved 
compared with genomic background in a window of ∼300 bp on average, a size that 
corresponds well with anecdotal samplings of individual CRMs. We also found evidence 
that the explanatory sites identified by Twist binding are preferentially conserved 
compared with their surroundings, arguing for their biological salience.  
SII.5 Methods 
SII.5.1 Fly stocks and general molecular biology 
 Drosophila melanogaster fly stocks were reared under standard conditions at 
25°C. Transgenic flies were obtained using standard P-element transformation or by 
site-directed integration. Wild type refers to the background yw. P-element 
transformations were achieved in yw flies, while site-directed integration was carried out 
using D. mel stock containing attP insertion at position ZH-86Fb. Enhancer sequences 
were amplified from genomic DNA (primer sequences are available upon request) and 
cloned into eve.promoter-LacZ-attB or eve.promoter-cherry-attB vectors (Liberman and 
Stathopoulos 2009). Anti-sense riboprobes labeled with Digoxigenin-UTP (Roche) were 
used for in situ hybridization to detect transcripts.  
SII.5.2 Chromatin preparation, DNA isolation, amplification, hybridization, and 
sequencing 
 Chromatin was prepared as described previously (Sandmann et al. 2006) from 2 
g of yw embryos of from 1 to 3 h in age. Rat anti-Twist antibody (gift of M. Levine, UC 
Berkeley) was used for both ChIP-chip and ChIP-seq experiments. For ChIP-chip, the 
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resulting DNA library was labeled and hybridized to arrays by NimbleGen Systems, Inc.; 
10 ng of immunoprecipitated (IP) DNA was amplified using the Whole Genome 
Amplification kit (Sigma) according to the manufacturer's instructions. The mock ChIP-
chip sample used preimmune antibody, rather than anti-Twist. For ChIP-seq, 50 ng of IP 
material was used to prepare a library (Johnson et al. 2007), and DNA sequencing of 
samples was performed by the Illumina protocol at Caltech Genome Center. The ChIP-
seq input control was processed equivalently to the Twist ChIP-seq sample, except that 
it was not immunoprecipitated (no antibody or bead processing). Each ChIP-seq library 
was sequenced to a total of 9 million reads.  
SII.5.3 SELEX 
 SELEX experiments using in vitro binding to a column were carried out as 
described (Ogawa and Biggin 2011). See the Supplemental Text for more details, 
including processing of SELEX data.  
SII.5.4 Bioinformatics 
 ChIP-chip and ChIP-seq data processing: Methods used to call ChIP-chip versus 
ChIP-seq peaks are described in detail within the Supplemental Text. In brief, we used 
the ERANGE software suite to call peaks based on the number, orientation, and ratio of 
short sequenced reads relative to a background control. We considered an alternate 
peak caller (MACS), overlap of ChIP-seq regions with ChIP-chip regions, and the 
inclusion of known Twist targets to determine the threshold for calling Twist occupied 
sites (i.e., ChIP-seq signals). We selected a high confidence (HC) set of 513 sites based 
on high inclusion in ChIP-chip regions (87%), MACS regions (72%), and validated Twist 
targets (75%). We also selected a medium confidence (MC) set of 1099 regions based 
on the similarity in motif organization around these peaks (E-box, Fig. 3A).  
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SII.5.5 ChIP-seq summit refinement 
 After ChIP-seq enriched regions were identified by the ERANGE program, post-
processing was performed to refine the summit location by utilizing directional tag 
information. For each peak region, plus and minus tags were simultaneously shifted 
toward the imputed fragment center by a trial amount, ranging from 0 to 100 bp. The 
shift that maximized area overlap of the plus and minus tag density profiles (i.e., a 
measure of “directionality”) was then implemented prior to calculating the location of the 
ChIP-seq tag count maximum (“summit”).  
SII.5.6 Explanatory site interval 
 The interval for designating “explanatory sites” near ChIP-seq summits was 
estimated utilizing count statistics for the CACATG motif, due to its being the most 
prevalent E-box in the set of Twist regions. Specifically, the motif occurrences within 
increasing radii around peak centers (binned by 5 bp) were compared to the number 
expected from a Poisson distribution with the mean equal to the genome average 
density of CACATG motifs. When the probability of the observed number of counts 
coming from the Poisson model fell below 0.001, the distribution was deemed 
indistinguishable from random fluctuations, and the boundary of the previous bin was set 
to be the cutoff for explanatory sites (±50 bp from the summit).  
SII.5.7 Conservation analysis 
 Conservation at each base pair was assessed using phastCons scores (Siepel et 
al. 2005). Genome-wide scores for the fifteen-way insect alignment including D. 
melanogaster, D. simulans, D. sechellia, D. yakuba, D. erecta, D. ananassae, D. 
pseudoobscura, D. persimilis, D. willistoni, D. virilis, D. mojavensis, D. grimshawi, A. 
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gambiae, A. mellifera, and T. castaneum were downloaded from the UCSC genome 
gateway. Statistical analysis of the data is described in the Supplemental Methods.  
SII.6 Annotations 
 Precomputed annotation files for exons and introns were downloaded from the 
FlyBase website, release 5.27 (Tweedie et al. 2009). Here, exons and introns are 
mutually exclusive. 5′ UTRs data are from S. Celniker.  
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SII.5.8 Footnotes 
  [Supplemental material is available for this article. The microarray data from this 
study have been submitted to the NCBI Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE26285, and the 
sequence data from this study have been submitted to the NCBI Sequence Read 
Archive (http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi) under accession no. 
SRA027330.]  
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Supplemental Figure 1.  In vivo Twist occupancy determined by ChIP-Seq versus 
ChIP-chip and the isolation of CRMs. (A) Twist ChIP-chip binding to a standard 
Nimblegen array at a representative locus, rho, relative to previous characterized early 
embryonic enhancer (pink box; Ip, Park et al. 1992).  (B) Twist ChIP-chip binding to a 
high-density custom array to same region for same Twist-IP (blue line) as used in (A); 
differences can be attributed to the assay method and data processing, rather than to 
the input chromatin lengths or other biological variation. Another independent Twist-IP 
prepared from smaller chromatin (sheared to ~250bp average) is shown in orange.  
Brown bar: location of the tiled regions on the custom array.  (C) Twist ChIP-Seq-defined 
occupancy obtained using Twist antibody (blue) compared with sequenced input control 
DNA (green).  (D) Venn diagrams showing the overlap between ChIP-chip and ChIP-
Seq datasets of various sizes/FDRs. False Discovery Rate (FDR) of ~1% supported 
calling 513 high confidence (HC) ChIP-Seq regions and 669 HC ChIP-chip regions.  
FDR of 17% supported calling 1099 MC ChIP-Seq regions and 2013 MC ChIP-chip 
regions.  
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Supplemental Figure 2: Twist ChIP-Seq signals at known and candidate CRMs 
from prior studies.  The number of Twist regions is shown ranked by signal size (reads 
per million in the entire area under the peak).  As expected, lower ChIP signal regions 
are much more numerous than high signal regions.  Regulatory regions that have 
previously been shown to support dorsal-ventral expression in the early embryo 
correspond to both large and small Twist ChIP-Seq peaks.  In addition, regions that have 
been shown in this study to support expression and regions that failed to do so are 
distributed over the range of ChIP signal sizes.   
 
Supplemental Figure 3: Functional analysis of Twist regions by reporter gene 
assay.  Twist regions were tested for their ability to support gene expression in a 
standard reporter gene assay using either lacZ or cherry reporter genes.  In situ 
hybridization using riboprobes to lacZ or cherry were used to monitor gene expression 
supported by these DNA sequences in early embryos. Shown are the 19 of 31 tested 
regions found to support expression. Closest associated genes are indicated in the 
bottom corner of each panel; see Table 2a for exact coordinates of the DNA regions 
tested.  Four additional regions found to support expression are shown in Fig. 1, for a 
total of 23 positives of 31 regions assayed. 
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Supplemental Figure 4: Expression activity is not predicted by ChIP-Seq signal 
size.  ChIP-chip and ChIP-Seq Twist data from this study are shown on the top and 
bottom of each panel, respectively.  Pink boxes mark the locations of previously 
characterized enhancers.  Twist signal is detected at the previously characterized vnd 
early embryonic enhancer located in the second intron (Stathopoulos, Van Drenth et al. 
2002), which is consistent with the early 1-3 hr timepoint assayed in this study.  We do 
not detect significant Twist signal at a second vnd candidate enhancer which was 
identified more recently by ChIP-chip analyses at a slightly later developmental timepoint 
(Zeitlinger et al., 2007); perhaps the enhancers in the first intron support later or weaker 
216 
 
gene expression.  In the cases of dpp and ind, the sites shown are candidate enhancers 
based on motif presence and/or ChIP-chip binding.  We did not see significant signals at 
these sites. dpp and ind are expressed in dorsal and dorsal-lateral regions of the 
embryo, which are outside the spatial domain of most Twist expression.  These therefore 
fall into the group of previously discussed Twist targets that we call "Type III" (see text). 
 
Supplemental Figure 5: Frequency of E-box instances in ChIP-Seq versus ChIP-
chip close to the signal summit (±50bp) or at greater distance from it (±250bp).  
CANNTG E-boxes were tallied around Twist MC ChIP-Seq peaks, the largest 1,000 MC 
Twist ChIP-chip peaks, and the non-repeat fly genome.  Displayed are the proportions of 
the different possible interior ten NN base pairs.  When the areas very close (±50bp) to 
Twist ChIP-Seq peaks are compared to the wider ±250bp areas around Twist peaks, CA 
E-boxes predominate, suggesting that they dominate in supporting ChIP-detectable 
binding.  There is also a distinct lack of AT E-boxes.  The proportion of TA E-boxes 
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remains relatively steady close to and farther from the peaks.  The proportions of E-box 
cores around ChIP-chip summits are very similar to the genomic background 
distribution, suggesting that while ChIP-chip tiling arrays find larger domains putatively 
occupied by Twist, the peak of signal is far less accurate in identifying the explanatory 
Twist binding sites. 
 
 
Supplemental Figure 6: Frequency of CAYRTG or CABVTG E-boxes within ChIP-
chip or ChIP-Seq data as a function of distance from the summit.  Twist 
‘explanatory’ E-boxes were classed in two ways: the more canonical and stringent 
CAYRTG-core E-boxes (CA, TA, and CG) as well as the expanded CABVTG core 
suggested by our data (also including GA, GC, and CC).  YR and BV E-boxes as a 
percent of all 10 possible E-boxes are shown in expanding radii out from the largest 
1,000 Twist MC ChIP-chip peaks and the MC Twist ChIP-Seq peaks.  They are 
compared to the distribution in the non-repeat genome.  The ChIP-Seq data shows a 
marked enrichment of both types of explanatory E-boxes within ±50bp of ERANGE 
peaks (almost 85% of E-boxes are BV and almost 60% are YR) and this drops off 
exponentially with distance from the peak.  The proportion of explanatory E-boxes is 
slightly greater near ChIP-chip summits as compared to the genomic background 
distribution.   
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Supplemental Figure 7: Visual example of the K-S test.  The Kolmogorov-Smirnov 
(K-S) test determines the degree of similarity between two distributions (see 
Supplemental Methods).  In order to determine whether certain motifs were enriched or 
depleted relative to Twist peaks, their cumulative distributions (red, blue, and grey plots) 
were compared to the cumulative distribution function of a uniform distribution (black 
diagonal line).  D (dotted vertical line) is the maximum distance between the motif 
distribution function and the uniform distribution function.  While the P-value determines 
if a distribution is statistically the same as uniform instead of enriched or depleted, the 
absolute value of D reflects the spatial degree (bp around Twist peaks) of the 
enrichment or depletion of a motif.  A large D absolute value reflects a large degree of 
enrichment/depletion; enriched motifs have positive D values and depleted motifs have 
negative D values.  P-values reported are in base 10 (i.e. 2.2E-16 means 2.2*10-16) 
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Supplemental Figure 8: Distribution of additional E-boxes within Twist ChIP-Seq 
data.  The three CABVTG E-boxes not shown in Figure 4: (CACCTG, CACGTG, and 
CAGCTG) also show some enrichment relative to the peak.  Of these, CAGCTG is the 
most prevalent.  CACGTG (the third member of the CAYRTG E-boxes) occurs less 
frequently but is quite enriched around Twist peaks.  The 4 CAANTG E-boxes are not 
enriched relative to Twist peaks, and in fact, the CAATTG palindrome is weakly 
depleted.  See Supplemental Table 3 for the K-S values. 
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Supplemental Figure 9: E-box motif occurrence as a function of Twist ChIP-Seq 
signal size.  The number of CACATG, CAGATG, CATATG, and CABVTG E-boxes were 
counted in a ±250bp radius around each Twist peak.  MC Twist regions were ranked 
according to size (area RPM), and the percentage of regions containing 0, 1, 2, or 3 and 
more motifs is shown for each size category.  CACATG motifs occur within about 50% of 
the whole MC dataset, but the larger peaks are more likely to have multiple occurrences 
of E-boxes.  This trend does not hold true for CATATG and CAGATG, which occur in 
only about 25% of the peaks, and are most likely to occur singly.  Viewed collectively, 
CABVTG E-boxes are present in the large ±250bp radius around over 90% of Twist 
peaks and are also more likely to occur multiply near large Twist peaks.  This suggests 
that the largest signal size features are most likely to be driven by multiple binding sites.   
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Supplemental Figure 10: vein CRM mutagenesis demonstrates the requirement for 
the explanatory E-box. We introduced a single base pair change within potential 
explanatory sites (CACATG > GACATG) we had defined within the vein CRM (A), 
characterized previously (Markstein, Zinzen et al. 2004). Mutating the explanatory CA-
core E-box in this manner resulted in a dramatic loss of reporter gene expression (B). 
Reporter gene expression was abrogated such that the expression domain collapsed 
from 10-12 cells in width to 4-7 cells for the vein CRM; this effect is comparable to the 
expression of vein genes in twist mutant embryos (data not shown). Previously, the 
orientation of this same E-box was also shown to be important for vein CRM expression 
(Zinzen, Senger et al. 2006).   
 
Supplemental Figure 11. MEME outputs.  The other MEME outputs not shown in 
Figure 6 are displayed here and mapped back onto Twist MC regions at 85% threshold.  
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Their K-S values are shown in Supplemental Table 3 where, from top to bottom by 
column, they are called MEME MC ±50 motifs 3, 4, 6, 7, 9, and 10.  
 
Supplemental Figure 12.  Distributions of binding motifs for factors thought to 
interact with Twist.  The motifs for Dorsal (SELEX – GGG(W3-5)CYV, 100% match) 
(Markstein, Markstein et al. 2002, Zinzen, Senger et al. 2006, Liberman and 
Stathopoulos 2009); Zelda (TAGteam – YAGGYAG, 100% match) (ten Bosch, 
Benavides et al. 2006); Suppressor of Hairless [Su(H) – BRTGRGAAH 90% match] 
(Bailey and Posakony 1995); RGGNCAG/Unknown (RGGNCAG, 100% match) 
(Stathopoulos, Van Drenth et al. 2002); and Snail (RCARGWBB, 90% match) 
(Stathopoulos and Levine 2005) are shown relative to Twist peaks.  If these factors 
interact directly with Twist to support expression through these predicted CRM regions, 
we would predict enrichment of the binding motifs relative to Twist peaks.  The SELEX-
derived Dorsal site [GGG(W3-5)CYV (A) as well as other previously described Dorsal 
sites (data not shown)] and Zelda are not enriched relative to Twist peaks.  The Su(H) 
and RGGNCAG motifs are present and weakly clustered around the Twist peaks (B). 
Snail exhibits a significantly enriched binding site distribution near Twist summits, yet 
because the Snail consensus binding sequence overlaps with that of some Twist sites, 
the interpretation of this result with respect to probable Snail activity is not certain.  See 
Supplemental Table 3 for the K-S values of these motifs. 
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Supplemental Figure 13.  E-box and dinucleotide repeat frequencies under Twist 
ChIP-Seq peaks versus the genome.  (A) Twist MC peaks (i.e. “shifted summits”) were 
classed according to genomic location (as in Fig 6; see Supplementary Methods) and 
the closest E-boxes within ±50bp of Twist peaks in each category is shown.  23% of 
promoter proximal, 25% of intergenic, 23% of intronic, and 41% of exonic regions have 
no E-box within ±50bp.  (B) The proportion of E-boxes in all genomic categories is 
shown.  The proportion of CAGCTG E-boxes is greater in promoters than intergenic 
regions or introns, but it is still not as large as the proportion of CAGCTG E-boxes in 
Twist regions associated with promoters.  In order to determine if the E-box proportions 
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under Twist peaks is a direct result of dinucleotide frequencies in different regions of the 
genome, we analyzed all dinucleotides under the narrow ±50bp around Twist peaks (C) 
and the larger ±250bp radius (D).  There is very little change in the frequency of 
dinucleotides under Twist peaks falling into different areas of the genome, suggesting 
that the proportional E-box difference between categories is not due to overall 
dinucleotide representation.  There are slightly fewer A/T-rich dinucleotides very close to 
Twist peaks, which is consistent with an overall depletion of A/T-rich sequences near 
peaks (Suppl. Figure 15). 
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Supplemental Figure 14. Conservation local to summits throughout peak 
rankings.  The average PhastCon score is shown at every base pair around Twist-
occupied sites (“peaks”) and compared to average conservation distribution of 30 
samples of 500 regions from the non-repeat dm3 genome (“random”).  The “summit 
centered” plots are drawn relative to the shifted ERANGE peaks (Twist) and the 
“midpoint centered” plots are drawn relative to the centers of the randomly selected 
genomic background regions.  The “motif centered” Twist plot was re-centered on the 
nearest CABVTG E-box (Twist explanatory motif) within ±150bp of the ERANGE 
summits, and regions with no such motif were left out.  For the “motif centered” random 
plot, random regions were pre-screened to contain one of the CABVTG motifs.  Relative 
to the genomic background, the entire area around Twist occupied sites is highly 
conserved in the HC sample (A).  This occurs not just in the summits, but out to the 
broader area ±150bp.  This conservation is even more increased when centering on the 
nearest CABVTG E-box, although the motif-centered random plot shows that CABVTG 
E-boxes in the Drosophila genome are preferentially conserved relative to the genomic 
background.  The conservation of the 500 peaks added by dropping to the MC threshold 
is smaller overall (B), and the conservation of the additional 1,000 peaks from the LC 
threshold is even smaller (C).  This may suggest that smaller peaks are less likely to be 
conserved or it may be a result of having more false positive peaks as the threshold is 
lowered. 
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Supplemental Figure 15.  Distribution of motifs within the sequenced input DNA 
(i.e. sonicated chromatin).  Twist ChIP-Seq regions are significantly depleted in highly 
A/T-rich sequences.  This depletion is not specific to the ChIP because it is also 
observed for the input control chromatin library.  Twist MC ChIP-Seq peaks are shown 
next to input control data of an equivalent number of regions (1099).  See Supplemental 
methods for the origin of the different control samples shown.  “Enriched input” contains 
regions selected as most significant from the input control over Twist. “Sequenced input 
reads” reads were randomly selected from all uniquely mapping reads in the input 
control.  For Twist and enriched input, mapping is relative to the shifted summits. For the 
sequenced input reads, mapping is relative to the center of each 25bp read. Three 
motifs, the Twist explanatory E-box (CABVTG), AAAAAA [(A)6], and a string of any 16 
A’s or T’s [(W)16] are shown for each dataset and compared to the overall G/C content 
(averaged in 20bp windows).  
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SII.S2 METHODS 
ChIP-chip experimental design and processing.  Arrays from standard catalog of 
Roche Nimblegen were used for this experiment covering the entire Drosophila 
melanogaster genome. The set of three arrays (385,000 probes/array) contain 50-mer 
probes spaced by 48 nucleotides on the genome.  Each array was hybridized with two 
samples - genomic control DNA labeled with Cy3 and experimental sample labeled with 
Cy5.  Two samples were hybridized to the arrays: Twist and mock sample as control (i.e. 
pre-immune). Each measurement was performed using a single biological replicate.  The 
hybridizations were performed at a Nimblegen facility, and both the raw data and 
Cy5/Cy3 ratios for each array (Cy5=635 nm, Cy3=532 nm) were made available to us for 
analysis. 
 
 Design of custom array for ChIP-chip experiment. A custom array (Nimblegen 4-
plex technology, 72,000 probes,) was designed to confirm the above results and also 
probe the neighborhoods of high-confidence transcription factors in more detail. Two 
sets of probes were included in the array: (i) Probes were tiled (60 mer probes, 5 
nucleotide spacing) within 6KB upstream and 1KB downstream of ATG sites of 288 high-
confidence transcription factors in Drosophila melanogaster. The list of transcription 
factors is available on request; (ii) Probes were also tiled (60 mer probes, 5nucleotide 
spacing) within 1KB upstream and downstream of 1,600 peaks detected in the earlier 
ChIP-chip experiments.  In total, the array contained 71,000 60-mer probes from the D.  
melanogaster genome and 1000 random sequences as control. 
 
ChIP-chip bioinformatics.  The data from all arrays were normalized using 
quantile normalization procedure. After normalization, ratios of Cy5/Cy3 were taken for 
each sample for further analysis. The original array design was based on V4 release of 
the Drosophila genome. Therefore, normalized data were mapped on to V5 genome 
assembly (dm3, April 2006) examined visually for validation.  
ChIP-chip peak finding was conducted as previously described (MacArthur, Li et 
al. 2009).  First, quantile normalized data for each probe was replaced by the mean 
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signal of all probes within +/-350 nucleotides from it.  This smoothing step was 
performed in the logarithmic scale.  All probes with normalized smoothed signal above 
90th percentile in the array (normalized signal=2, high signal probes) were considered for 
further analysis.  Multiple high signal neighboring probes (maximum gap 200 
nucleotides) were combined into summits with height equal to the highest smoothed 
intensity within the region.   
 
 ChIP-Seq bioinformatics.  Sequenced reads were trimmed to the first 25 base 
pairs and mapped onto the dm3 (April 2006, BGDP release 5) Drosophila melanogaster 
genome using bowtie 9.1 (Langmead et al., 2009).  No more than two mismatches were 
allowed.  Low-copy multireads (defined as reads mapping in 2 to 10 places) were 
allowed.  Chromosomes U and the Het chromosomes were not used in the downstream 
analyses. 
The ERANGE 3.1 software package was used to identify regions enriched in 
ChIP-Seq defined Twist occupancy. ERANGE finds areas in the genome that are 
densely occupied by reads and then identifies those that exceed signals in the 
background sample (sonicated input DNA) (Pepke, Wold et al. 2009).  Regions that do 
not display proper left/right read directionality are discarded (see also main text).  A 
custom code was used to computationally call a ChIP-Seq signal maximum location (the 
“shifted summit”), which introduced a shift in the position attributed as the “peak” based 
on the degree of read directionality.  For simplicity, the shifted summit is reported as one 
nucleotide.   
In order to get a broad view of what to expect based on the ChIP-Seq 
experimental assay as well as the bioinformatics assay, several different types of 
controls were used.  For the genomic background, the dm3 genome was used minus 
UCSC simple and tandem repeats and minus the Chromosomes U and the Het 
chromosomes.  In order to assay reads that could be sequenced, reads that mapped 
uniquely to the genome were selected at random (“sequenced control reads”).  In order 
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to determine which places in the genome were sequenced well (“aggregated control”), 
ERANGE was run on the sonicated input DNA library requiring only two reads per region 
(no directionality requirement was used and no enrichment relative to another library 
was required).  In order to determine which places in the genome displayed proper read 
directionality and were overrepresented in the sequenced input control library relative to 
twist (“enriched control”), ERANGE was run on the input DNA library vs. twist, requiring 
at least a 1% enrichment per region in the input DNA and a minimum of two reads per 
region.  The directionality filter was used as for Twist regions and the peaks were 
subsequently shifted using the same algorithm as for the Twist peaks. 
A second independent ChIP-Seq algorithm and software package, MACS 1.3.5 
(Zhang, Liu et al. 2008), was also used on the same Twist and input control datasets, 
and we report both sets of "peak calls" (Supplemental Table 4).  The effective genome 
size used was 1.69e8, tag size 25, band width 300, model fold 7, and P-value cutoff 1e-
5.  There were no major discrepancies between motif occurrences relative to ERANGE 
and MACS calls nor to the respective MEME outputs (data not shown). 
 
Selection of confidence thresholds.  None of the distributions of ChIP signals, 
under any algorithm, displayed a crisp natural discontinuity that would clearly define 
"occupied" versus "unoccupied" states.  ERANGE was first run on ChIP-Seq data with a 
stringent gradient of parameters, and the different region sets were evaluated for 
sensitivity and specificity by their inclusion of (1) validated, functional Twist binding 
regions; (2) their overlap with an independent region calling algorithm, MACS and (3) the 
likelihood that the low-confidence end of the region sets were ‘real’ as judged by 
inspection of the read distribution in ChIP and background data.  As a result, we set the 
ERANGE high-confidence (HC) signal and enrichment thresholds at 14 RPM minimum 
(reads in the region per million in the dataset), 1 RPM minimum peak height, and 3-fold 
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enrichment over the control sample), resulting in 513 regions (false discovery rate (FDR) 
<1%, where the ERANGE FDR reflects the relative number of peaks called when using 
the same parameters to call the control library over the twist library).  Medium 
confidence (1099 peaks) and lower-confidence (2000 peaks) were called with the same 
enrichment ratio and minimum peak height but instead using region RPM thresholds of 4 
(FDR 17%) and 2 (FDR 83%), respectively. The MC threshold was selected because of 
the similarity of motif distributions around peaks compared to the HC regions (Fig. 4A), 
and the LC threshold was selected primarily to demonstrate what happens when 
selecting a very low informatics threshold (shown in Figure 3A and Supplemental Figure 
15).   
For comparison sake, HC and MC sets of ChIP-chip regions were defined using 
equivalent FDR measures as found for ChIP-Seq.  To this end, boundaries of ChIP-chip 
regions were defined using a threshold of 3.8 to identify 669 ChIP-chip regions (HC set; 
FDR<1%) and a threshold of 6 to identify 2013 ChIP-chip regions (MC set; FDR 17%).  
We report the MC region boundaries as well as the size and location of the “summit” of 
each region, defined as the midpoint of the highest part of each region (Supplemental 
Table 5). 
 As expected, the weaker ChIP-Seq signals are most numerous in their respective 
distributions (Sup. Fig. 2), which means that the computational threshold selected for 
inclusion has a large impact on subsequent VENN comparisons of Twist set 
membership.  ChIP-chip processed data typically identified physically broader regions on 
the chromosome, partly because array processing algorithms require multiple positive 
tiles to make a signal call. Furthermore, the array data appear to compress the ChIP 
signal range compared with ChIP-Seq, bringing the strongest signal closer to the 
weakest one in the distribution and this, along with other technical differences, may 
account for the decrease in overlap observed when the HC ChIP-Seq set is compared 
with MC versus HC ChIP-chip sets (81% versus 54%). 
 
Acquisition of SELEX data and processing.  SELEX was performed according to a 
previously published method (Roulet, Busso et al. 2002) and a standard SAGE protocol 
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(http://www.sagenet.org/protocol/index.htm) with some exceptions, as follows (for further 
details see Ogawa 2011).  72 bp DNA oligoes were synthesized with three different end 
pairs each containing a restriction enzyme site (BamHI, BglII, or HindIII) and 20 bp 
priming sequences for PCR amplification: 
Random72: GGATTTGCTGGTGCAGTACAGT-GGATCC-(N)16-GGATCC-
TTAGGAGCTTGAAATCGAGCAG   
 
Random72R: TCCATCGCTTCTGTATGACGCA-AGATCT-(N)16-AGATCT-
GTCCTAACCGACTCCGTTGATT  
 
Random72HR: TCCATCGCTTCTGTATGACGCA-AAGCTT-(N)16-AAGCTT-
GTCCTAACCGACTCCGTTGATT  
 
His-tagged Twist protein was bound to TALON Metal Affinity Resins (Clontech).  
For the first round of SELEX, 10 ng of the random 72 bp ds DNA oligonucleotides was 
incubated with the protein bound resin. The input DNA for subsequent rounds of SELEX 
was derived by PCR amplifying 1/10th of the DNA eluted from the previous round.  
For all rounds, SELEX-bound DNA was amplified by PCR according to SAGE 
protocol and then digested with the appropriate restriction enzyme to isolate the 22 bp 
fragment which includes the Twist-binding sequence. Approximately 1 µg of the 22 bp 
DNA fragments were ligated to make concatamers in a 10 µl volume at 16°C overnight.  
The concatemer DNA was treated with T4 DNA polymerase (NEB) and DNA polymerase 
I Klenow fragment (NEB) with dNTP mixture at room temperature for 30 min.  After heat-
inactivation at 65°C for 5 min, the DNA was separated by 2% agarose (Invitrogen, 
UltraPure agarose) gel electrophoresis.  DNA of 300 to 1000 bp was isolated from the 
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gel and purified by using QIAquick Gel purification kit (Qiagen).  The resulting 
concatemer DNA was ligated with SmaI-digested pUC19 plasmid, and subsequently the 
ligation mixture was used to transform DH10B E. coli (Invitrogen ElectroMAX cells). 
Plasmid DNAs from more than 96 clones were sequenced to obtain sequences of over 
1,000 individual DNAs.  The data presented are 17bp reads, on average (Supplemental 
Table 6). 
Two SELEX experiments were performed to analyze the binding preference for 
Twist.  Each involved 5 rounds of amplifications for a total of 10 total datasets. For 
experiment one, rounds 4 and 5 were sequenced; for experiment two, rounds 2,3, and 4 
were sequenced. The data for these 5 rounds were pooled, and the number of E-boxes 
in the entire dataset was counted (Figure 2).  MEME was run on the SELEX sequences, 
and in addition to the CATATG/CACATG E-box, an –AYRTG sequence (suggesting a 
partial E-box) was also returned (data not shown).  E-boxes are present in approximately 
50% of the SELEX sequences and of the remaining 50%, the majority contain a partial 
(5-mer) E-box.  This may be due to the enzyme cut sites and sequencing or possibly to 
Twist binding a partial E-box.  We see no such representation of the partial E-boxes at 
ChIP-Seq in vitro peaks. 
 
MEME analysis.  MEME was run on the MC Twist ChIP-Seq ERANGE regions 
±50bp from the peaks (i.e. “shifted summits”) in order to capture the pieces of DNA that 
show the highest enrichment of explanatory E-boxes (Fig. 2, Fig. 3, Sup. Fig. 8).  MEME 
3.0.8 was used, using the ”zoops” model, 6 bp minimum, and 15 bp maximum motif 
widths.  MEME finds sequences that are similar to each other but statistically unlikely to 
be found in the local background of the sample (Bailey, Williams et al. 2006).  The 
MEME results were mapped at 85% match to the output PSFM’s onto the parent set of 
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Twist regions or the control datasets (Fig. 5, Sup. Fig. 11). 
 
Motif mapping.  Scatter plots were made in order to visualize the distribution of 
motifs relative to Twist peaks (i.e. “shifted summits”).  Motifs were mapped on to the 
genome, and each dot on a scatter plot reflects the distance between the center of the 
motif and its respective Twist peak.  Negative values are to the left of the peaks in the 
reference genome, and positive numbers are to the right. 
 Density plots (i.e. Fig. 3B, top panel) were made by taking the absolute distance 
of each motif from its peak and then summing for the entire dataset the number of motifs 
in 5bp windows outward from the peaks.  Cumulative density plots (i.e. Fig. 3B, bottom 
panel, Sup. Fig. 7) are another way of reporting the data in the density plots, where the 
cumulative fraction of the motifs represented in each 5bp window in (from 0 total motifs 
found at the peak to 100% of the motifs encountered at the maximum 250bp distance 
from the peak).   
 A Kolmogorov-Smirnov (K-S) statistical test was performed to determine whether 
motifs were enriched, depleted or uniformly distributed relative to the set of Twist peaks. 
This method tests the null hypothesis that a distribution of motif distances relative to 
Twist peaks is distributed uniformly.  Distributions of these distances for motifs that are 
unrelated to binding are expected to be statistically similar to the uniform distribution; 
those that are related to binding are expected to be different from uniform.  The statistic 
for testing these hypotheses is the maximum distance between the empirical cumulative 
distribution function of the distances between motifs and peaks and the cumulative 
distribution function of a uniform.  This distance is known as the "D" value (D values and 
both types of distributions are illustrated in Supplemental Figure 7).  Thus we can obtain 
P-values for the probability of the null hypothesis and reject the null hypothesis when the 
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P-value is too small.  All regions were made equal length (±250 bp around each peak) 
for these tests.  A small P-value (threshold 1*10-3) means that a motif distribution is not 
significantly different from uniform and is instead enriched or depleted relative to Twist 
peaks.   
 To relate the K-S test results to a more familiar statistic, we also performed a 
Student’s T-test.  The T-test is used here to test whether the mean of the observed motif 
distance from the peak is equal to the mean of the assumed uniform distribution on the 
standardized regions.  Since we standardized the maximum distance from the peak to 
250bp, the mean is 125bp, and so the T statistic reports whether the mean of each motif 
is different from 125bp.  Note that it is possible to have a distribution quite different in 
shape from the uniform distribution and still have the same mean.  The K-S test would 
determine that the two are significantly different while the T-test would not.  In this 
sense, the K-S test is more powerful than the T-test.  In any case, the statistical 
conclusions from the T-test and the K-S test agree for our observed distributions (see 
the P-values for both tests in Supplementary Table 3).  P-values reported are in base 10 
(i.e. 2.2E-16 means 2.2*10-16) 
 
Genome location analysis.  The gene models we used were primarily based on 
published FlyBase introns and exons but were additionally informed by a set of 
promoters active in the embryo (generously provided by S.Celniker).  We used these 
data to class the genome into four mutually exclusive categories.  “Promoter proximal” 
refers to any summit that occurs within a Celniker promoter or 500 bp upstream. 
“Exonic” refers to any FlyBase exon excluding any regions that fall into the promoter 
proximal category.  “Intronic” regions are any regions within the gene body (from 
FlyBase TSS or Celniker promoter, whichever is upstream, to the last exon) that are not 
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in the exonic or promoter proximal categories.  Intergenic regions are outside of gene 
bodies and had repeats (from UCSC tandem repeats and repeat masker) removed.   
In order to accurately represent the nature of the ChIP-Seq input control data, we 
used it in three different ways.  “Random sequenced input reads” is a set of reads from 
the input control that map uniquely to the genome.  It represents the areas of the non-
repeat genome which are able to be sonicated and sequenced.  “Aggregated input 
control” regions were created by allowing ERANGE to run on the input control without a 
directionality filter or an enrichment requirement.  These regions represent places in the 
genome that have an aggregation of input reads but no other requirements that the 
reads behave similarly to ChIP-Seq peaks.  The “enriched input control” contains regions 
where the input control library is enriched over Twist and also displays the same left/right 
read directionality required for Twist (see also main text) . 
The number of ChIP-chip and control regions in each dataset was picked to be 
the same number as MC Twist regions.  We chose the largest ChIP-chip and 
aggregated control regions (by area), the enriched control regions that were most highly 
enriched over Twist, and a random sample of sequenced control reads.  In order to 
assign regions to each genomic category, we used the shifted summits of Twist ChIP-
Seq and enriched control regions, the highest point of the aggregated control regions, 
the ChIP-chip mock summit (midpoint of the highest part of each regions), and the 
midpoint of each randomly selected sequenced control read.  
 
Motif conservation analysis.  PhastCons scores were obtained (as described in 
the text) for all base pairs for motif occurrences within +/- 150bp of ChIP-Seq summits 
and also for those greater than 150 bp but less than 250 bp away from the summits. 
Number of ChIP-Seq region occurrences for each were CACATG: 396, CACCTG: 74, 
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CACGTG: 63, CAGATG: 173, CAGCTG: 139, CATATG: 105, CA-repeats (3 or more 
dyads): 610, and GA-repeats (3 or more dyads): 255. A chi squared statistic 
corresponding to a one-tailed test for a difference between the two distributions was 
calculated according to the procedure given in Kanji (Kanji 1999 p.83). The two sample 
sets were first joined and the median for the combined set calculated. The number of 
PhastCons scores of the background set that were to the left of the combined set 
median was calculated and designated nl1; the number to the right of the combined 
median is designated nr1. The two analogous quantities for the ChIP-Seq region motif 
set were designated nl2 and nr2 with N = nl1+nr1+nl2+nr2.  Then the chi squared 
statistic is calculated as: 
N*(| nl1*nr2 – nl2*nr1| - N/2)^2 / ((nl1+nl2)*(nl1+nr1)*(nl2+nr2)*(nr1+nr2)) 
The x-axis in Fig. 7C represents this test statistic for each motif. Because 
PhastCons scores are the posterior probability of a given bp to belong to a conserved 
class of bases, we interpret bp with PhastCons scores > 0.9 as almost certainly 
conserved. The fraction of bp in ChIP-Seq motifs having PhastCons score > 0.9 is 
represented as the height of the bars.  
  
237 
 
Sources for SII Supplements 
 
Andrey, G., T. Montavon, B. Mascrez, F. Gonzalez, D. Noordermeer, M. Leleu, D. Trono, 
F. Spitz and D. Duboule (2013). "A switch between topological domains underlies 
HoxD genes collinearity in mouse limbs." Science 340(6137): 1234167. 
Arnosti, D. N. and M. M. Kulkarni (2005). "Transcriptional enhancers: Intelligent 
enhanceosomes or flexible billboards?" J Cell Biochem 94(5): 890-898. 
Asakura, A., G. E. Lyons and S. J. Tapscott (1995). "The regulation of MyoD gene 
expression: conserved elements mediate expression in embryonic axial muscle." 
Dev Biol 171(2): 386-398. 
Auerbach, R. K., G. Euskirchen, J. Rozowsky, N. Lamarre-Vincent, Z. Moqtaderi, P. 
Lefrancois, K. Struhl, M. Gerstein and M. Snyder (2009). "Mapping accessible 
chromatin regions using Sono-Seq." Proc Natl Acad Sci U S A 106(35): 14926-
14931. 
Bailey, A. M. and J. W. Posakony (1995). "Suppressor of hairless directly activates 
transcription of enhancer of split complex genes in response to Notch receptor 
activity." Genes Dev 9(21): 2609-2622. 
Bailey, S. D., X. Zhang, K. Desai, M. Aid, O. Corradin, R. Cowper-Sal Lari, B. Akhtar-
Zaidi, P. C. Scacheri, B. Haibe-Kains and M. Lupien (2015). "ZNF143 provides 
sequence specificity to secure chromatin interactions at gene promoters." Nat 
Commun 2: 6186. 
Bailey, T. L., N. Williams, C. Misleh and W. W. Li (2006). "MEME: discovering and 
analyzing DNA and protein sequence motifs." Nucleic Acids Res 34(Web Server 
issue): W369-373. 
Banerji, J., S. Rusconi and W. Schaffner (1981). "Expression of a beta-globin gene is 
enhanced by remote SV40 DNA sequences." Cell 27(2 Pt 1): 299-308. 
Becker, P., R. Renkawitz and G. Schutz (1984). "Tissue-specific DNaseI hypersensitive 
sites in the 5'-flanking sequences of the tryptophan oxygenase and the tyrosine 
aminotransferase genes." EMBO J 3(9): 2015-2020. 
Benoist, C. and P. Chambon (1981). "In vivo sequence requirements of the SV40 early 
promotor region." Nature 290(5804): 304-310. 
Benyajati, C. and A. Worcel (1976). "Isolation, characterization, and structure of the 
folded interphase genome of Drosophila melanogaster." Cell 9(3): 393-407. 
Berezney, R. and D. S. Coffey (1974). "Identification of a nuclear protein matrix." 
Biochem Biophys Res Commun 60(4): 1410-1417. 
Berghella, L., L. De Angelis, T. De Buysscher, A. Mortazavi, S. Biressi, S. V. Forcales, 
D. Sirabella, G. Cossu and B. J. Wold (2008). "A highly conserved molecular 
switch binds MSY-3 to regulate myogenin repression in postnatal muscle." 
Genes & Development 22(15): 2125-2138. 
Blau, H. M., C. P. Chiu and C. Webster (1983). "Cytoplasmic activation of human 
nuclear genes in stable heterocaryons." Cell 32(4): 1171-1180. 
Blau, H. M., G. K. Pavlath, E. C. Hardeman, C. P. Chiu, L. Silberstein, S. G. Webster, S. 
C. Miller and C. Webster (1985). "Plasticity of the differentiated state." Science 
230(4727): 758-766. 
Branco, M. R. and A. Pombo (2006). "Intermingling of chromosome territories in 
interphase suggests role in translocations and transcription-dependent 
associations." PLoS Biol 4(5): e138. 
Breathnach, R. and P. Chambon (1981). "Organization and expression of eucaryotic split 
genes coding for proteins." Annu Rev Biochem 50: 349-383. 
238 
 
Brent, R. and M. Ptashne (1984). "A bacterial repressor protein or a yeast transcriptional 
terminator can block upstream activation of a yeast gene." Nature 312(5995): 
612-615. 
Brown, K. E., S. S. Guest, S. T. Smale, K. Hahm, M. Merkenschlager and A. G. Fisher 
(1997). "Association of transcriptionally silent genes with Ikaros complexes at 
centromeric heterochromatin." Cell 91(6): 845-854. 
Buckingham, M. and P. W. Rigby (2014). "Gene regulatory networks and transcriptional 
mechanisms that control myogenesis." Dev Cell 28(3): 225-238. 
Buonanno, A., D. G. Edmondson and W. P. Hayes (1993). "Upstream sequences of the 
myogenin gene convey responsiveness to skeletal muscle denervation in 
transgenic mice." Nucleic Acids Res 21(24): 5684-5693. 
Burke, T. W. and J. T. Kadonaga (1996). "Drosophila TFIID binds to a conserved 
downstream basal promoter element that is present in many TATA-box-deficient 
promoters." Genes Dev 10(6): 711-724. 
Burke, T. W. and J. T. Kadonaga (1997). "The downstream core promoter element, 
DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of 
Drosophila." Genes Dev 11(22): 3020-3031. 
Butler, J. E. and J. T. Kadonaga (2001). "Enhancer-promoter specificity mediated by 
DPE or TATA core promoter motifs." Genes Dev 15(19): 2515-2519. 
Cao, Y., Z. Yao, D. Sarkar, M. Lawrence, G. J. Sanchez, M. H. Parker, K. L. 
MacQuarrie, J. Davison, M. T. Morgan, W. L. Ruzzo, R. C. Gentleman and S. J. 
Tapscott (2010). "Genome-wide MyoD binding in skeletal muscle cells: a 
potential for broad cellular reprogramming." Dev Cell 18(4): 662-674. 
Carninci, P., A. Sandelin, B. Lenhard, S. Katayama, K. Shimokawa, J. Ponjavic, C. A. 
Semple, M. S. Taylor, P. G. Engstrom, M. C. Frith, A. R. Forrest, W. B. Alkema, 
S. L. Tan, C. Plessy, R. Kodzius, T. Ravasi, T. Kasukawa, S. Fukuda, M. 
Kanamori-Katayama, Y. Kitazume, H. Kawaji, C. Kai, M. Nakamura, H. Konno, K. 
Nakano, S. Mottagui-Tabar, P. Arner, A. Chesi, S. Gustincich, F. Persichetti, H. 
Suzuki, S. M. Grimmond, C. A. Wells, V. Orlando, C. Wahlestedt, E. T. Liu, M. 
Harbers, J. Kawai, V. B. Bajic, D. A. Hume and Y. Hayashizaki (2006). "Genome-
wide analysis of mammalian promoter architecture and evolution." Nat Genet 
38(6): 626-635. 
Carvajal, J. J., D. Cox, D. Summerbell and P. W. Rigby (2001). "A BAC transgenic 
analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control 
activation and maintenance of gene expression during muscle development." 
Development 128(10): 1857-1868. 
Casas-Delucchi, C. S., A. Brero, H. P. Rahn, I. Solovei, A. Wutz, T. Cremer, H. 
Leonhardt and M. C. Cardoso (2011). "Histone acetylation controls the inactive X 
chromosome replication dynamics." Nat Commun 2: 222. 
Chambeyron, S. and W. A. Bickmore (2004). "Chromatin decondensation and nuclear 
reorganization of the HoxB locus upon induction of transcription." Genes Dev 
18(10): 1119-1130. 
Chen, J. C. J., R. Ramachandran and D. J. Goldhamer (2002). "Essential and 
Redundant Functions of the MyoD Distal Regulatory Region Revealed by 
Targeted Mutagenesis." Developmental Biology 245(1): 213-223. 
Cheng, T. C., M. C. Wallace, J. P. Merlie and E. N. Olson (1993). "Separable regulatory 
elements governing myogenin transcription in mouse embryogenesis." Science 
261(5118): 215-218. 
Chepelev, I., G. Wei, D. Wangsa, Q. Tang and K. Zhao (2012). "Characterization of 
genome-wide enhancer-promoter interactions reveals co-expression of 
239 
 
interacting genes and modes of higher order chromatin organization." Cell Res 
22(3): 490-503. 
Cheutin, T., M. F. O'Donohue, A. Beorchia, C. Klein, H. Kaplan and D. Ploton (2003). 
"Three-dimensional organization of pKi-67: a comparative fluorescence and 
electron tomography study using FluoroNanogold." J Histochem Cytochem 
51(11): 1411-1423. 
Chubb, J. R., S. Boyle, P. Perry and W. A. Bickmore (2002). "Chromatin motion is 
constrained by association with nuclear compartments in human cells." Current 
Biology 12(6): 439-445. 
Chung, J. H., A. C. Bell and G. Felsenfeld (1997). "Characterization of the chicken beta-
globin insulator." Proc Natl Acad Sci U S A 94(2): 575-580. 
Chung, J. H., M. Whiteley and G. Felsenfeld (1993). "A 5' element of the chicken beta-
globin domain serves as an insulator in human erythroid cells and protects 
against position effect in Drosophila." Cell 74(3): 505-514. 
Ciejek, E. M., M. J. Tsai and B. W. O'Malley (1983). "Actively transcribed genes are 
associated with the nuclear matrix." Nature 306(5943): 607-609. 
Cook, P. R. (1999). "The organization of replication and transcription." Science 
284(5421): 1790-1795. 
Cook, P. R. and I. A. Brazell (1978). "Spectrofluorometric measurement of the binding of 
ethidium to superhelical DNA from cell nuclei." Eur J Biochem 84(2): 465-477. 
Cooper, S. J., N. D. Trinklein, E. D. Anton, L. Nguyen and R. M. Myers (2006). 
"Comprehensive analysis of transcriptional promoter structure and function in 1% 
of the human genome." Genome Res 16(1): 1-10. 
Core, L. J. and J. T. Lis (2009). "Paused Pol II captures enhancer activity and acts as a 
potent insulator." Genes Dev 23(14): 1606-1612. 
Courey, A. J., S. E. Plon and J. C. Wang (1986). "The use of psoralen-modified DNA to 
probe the mechanism of enhancer action." Cell 45(4): 567-574. 
Cremer, T., C. Cremer, T. Schneider, H. Baumann, L. Hens and M. Kirsch-Volders 
(1982). "Analysis of chromosome positions in the interphase nucleus of Chinese 
hamster cells by laser-UV-microirradiation experiments." Hum Genet 62(3): 201-
209. 
Davidson, E. H. (2006). CHAPTER 2 - cis-Regulatory Modules, and the 
Structure/Function Basis of Regulatory Logic. The Regulatory Genome. 
Burlington, Academic Press: 31-86.    
de Wit, E. and W. de Laat (2012). "A decade of 3C technologies: insights into nuclear 
organization." Genes Dev 26(1): 11-24. 
Deato, M. D., M. T. Marr, T. Sottero, C. Inouye, P. Hu and R. Tjian (2008). "MyoD 
targets TAF3/TRF3 to activate myogenin transcription." Mol Cell 32(1): 96-105. 
Deato, M. D. and R. Tjian (2007). "Switching of the core transcription machinery during 
myogenesis." Genes Dev 21(17): 2137-2149. 
Deng, W. and S. G. Roberts (2005). "A core promoter element downstream of the TATA 
box that is recognized by TFIIB." Genes Dev 19(20): 2418-2423. 
Dierks, P., A. van Ooyen, M. D. Cochran, C. Dobkin, J. Reiser and C. Weissmann 
(1983). "Three regions upstream from the cap site are required for efficient and 
accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells." Cell 
32(3): 695-706. 
Dierks, P., A. van Ooyen, N. Mantei and C. Weissmann (1981). "DNA sequences 
preceding the rabbit beta-globin gene are required for formation in mouse L cells 
of beta-globin RNA with the correct 5' terminus." Proc Natl Acad Sci U S A 78(3): 
1411-1415. 
240 
 
Dixon, J. R., S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J. S. Liu and B. Ren 
(2012). "Topological domains in mammalian genomes identified by analysis of 
chromatin interactions." Nature 485(7398): 376-380. 
Dostie, J., T. A. Richmond, R. A. Arnaout, R. R. Selzer, W. L. Lee, T. A. Honan, E. D. 
Rubio, A. Krumm, J. Lamb, C. Nusbaum, R. D. Green and J. Dekker (2006). 
"Chromosome Conformation Capture Carbon Copy (5C): a massively parallel 
solution for mapping interactions between genomic elements." Genome Res 
16(10): 1299-1309. 
Dynan, W. S. (1986). "Promoters for housekeeping genes." Trends in Genetics 2: 196-
197. 
Faerman, A., D. J. Goldhamer, R. Puzis, C. P. Emerson, Jr. and M. Shani (1995). "The 
distal human myoD enhancer sequences direct unique muscle-specific patterns 
of lacZ expression during mouse development." Dev Biol 171(1): 27-38. 
Farnham, P. J. and R. T. Schimke (1985). "Transcriptional regulation of mouse 
dihydrofolate-reductase in the cell-cycle." Journal of Biological Chemistry 
260(12): 7675-7680. 
Faye, G., D. W. Leung, K. Tatchell, B. D. Hall and M. Smith (1981). "Deletion mapping of 
sequences essential for in vivo transcription of the iso-1-cytochrome c gene." 
Proc Natl Acad Sci U S A 78(4): 2258-2262. 
Fiering, S., E. Epner, K. Robinson, Y. Zhuang, A. Telling, M. Hu, D. I. Martin, T. Enver, 
T. J. Ley and M. Groudine (1995). "Targeted deletion of 5'HS2 of the murine 
beta-globin LCR reveals that it is not essential for proper regulation of the beta-
globin locus." Genes Dev 9(18): 2203-2213. 
Filippova, D., R. Patro, G. Duggal and C. Kingsford (2014). "Identification of alternative 
topological domains in chromatin." Algorithms Mol Biol 9: 14. 
Fisher-Aylor, K. I. (2011). "Long distance looping maps: RNA Pol2 during differentiation." 
Nuclear Structure and Dynamics. L'Isle sur la Sorgue, France, EMBO. 
Foley, K. P. and J. D. Engel (1992). "Individual stage selector element mutations lead to 
reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic 
confirmation of promoter competition during globin gene switching." Genes Dev 
6(5): 730-744. 
Francastel, C., M. C. Walters, M. Groudine and D. I. Martin (1999). "A functional 
enhancer suppresses silencing of a transgene and prevents its localization close 
to centrometric heterochromatin." Cell 99(3): 259-269. 
Fullwood, M. J., M. H. Liu, Y. F. Pan, J. Liu, H. Xu, Y. B. Mohamed, Y. L. Orlov, S. 
Velkov, A. Ho, P. H. Mei, E. G. Chew, P. Y. Huang, W. J. Welboren, Y. Han, H. 
S. Ooi, P. N. Ariyaratne, V. B. Vega, Y. Luo, P. Y. Tan, P. Y. Choy, K. D. Wansa, 
B. Zhao, K. S. Lim, S. C. Leow, J. S. Yow, R. Joseph, H. Li, K. V. Desai, J. S. 
Thomsen, Y. K. Lee, R. K. Karuturi, T. Herve, G. Bourque, H. G. Stunnenberg, X. 
Ruan, V. Cacheux-Rataboul, W. K. Sung, E. T. Liu, C. L. Wei, E. Cheung and Y. 
Ruan (2009). "An oestrogen-receptor-alpha-bound human chromatin 
interactome." Nature 462(7269): 58-64. 
Galande, S., P. K. Purbey, D. Notani and P. P. Kumar (2007). "The third dimension of 
gene regulation: organization of dynamic chromatin loopscape by SATB1." Curr 
Opin Genet Dev 17(5): 408-414. 
Gasser, S. M. and U. K. Laemmli (1986). "The organisation of chromatin loops: 
characterization of a scaffold attachment site." EMBO J 5(3): 511-518. 
Gasser, S. M. and U. K. Laemmli (1987). "Improved methods for the isolation of 
individual and clustered mitotic chromosomes." Exp Cell Res 173(1): 85-98. 
241 
 
Gerasimova, T. I. and V. G. Corces (1998). "Polycomb and trithorax group proteins 
mediate the function of a chromatin insulator." Cell 92(4): 511-521. 
Gerasimova, T. I., D. A. Gdula, D. V. Gerasimov, O. Simonova and V. G. Corces (1995). 
"A Drosophila protein that imparts directionality on a chromatin insulator is an 
enhancer of position-effect variegation." Cell 82(4): 587-597. 
Gidoni, D., W. S. Dynan and R. Tjian (1984). "Multiple specific contacts between a 
mammalian transcription factor and its cognate promoters." Nature 312(5993): 
409-413. 
Gillies, S. D., S. L. Morrison, V. T. Oi and S. Tonegawa (1983). "A tissue-specific 
transcription enhancer element is located in the major intron of a rearranged 
immunoglobulin heavy chain gene." Cell 33(3): 717-728. 
Gluzman, Y., J. F. Sambrook and R. J. Frisque (1980). "Expression of early genes of 
origin-defective mutants of simian virus 40." Proc Natl Acad Sci U S A 77(7): 
3898-3902. 
Goldhamer, D. J., B. P. Brunk, A. Faerman, A. King, M. Shani and C. P. Emerson, Jr. 
(1995). "Embryonic activation of the myoD gene is regulated by a highly 
conserved distal control element." Development 121(3): 637-649. 
Goldman, M. A., G. P. Holmquist, M. C. Gray, L. A. Caston and A. Nag (1984). 
"Replication timing of genes and middle repetitive sequences." Science 
224(4650): 686-692. 
Greally, J. M., D. J. Starr, S. Hwang, L. Song, M. Jaarola and S. Zemel (1998). "The 
mouse H19 locus mediates a transition between imprinted and non-imprinted 
DNA replication patterns." Hum Mol Genet 7(1): 91-95. 
Griffith, J., A. Hochschild and M. Ptashne (1986). "DNA loops induced by cooperative 
binding of lambda repressor." Nature 322(6081): 750-752. 
Grosschedl, R. and M. L. Birnstiel (1980). "Identification of regulatory sequences in the 
prelude sequences of an H2A histone gene by the study of specific deletion 
mutants in vivo." Proc Natl Acad Sci U S A 77(3): 1432-1436. 
Grosschedl, R. and M. L. Birnstiel (1980). "Spacer DNA sequences upstream of the T-A-
T-A-A-A-T-A sequence are essential for promotion of H2A histone gene 
transcription in vivo." Proc Natl Acad Sci U S A 77(12): 7102-7106. 
Gruss, P., R. Dhar and G. Khoury (1981). "Simian virus 40 tandem repeated sequences 
as an element of the early promoter." Proc Natl Acad Sci U S A 78(2): 943-947. 
Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M. B. Faza, W. Talhout, B. H. Eussen, 
A. de Klein, L. Wessels, W. de Laat and B. van Steensel (2008). "Domain 
organization of human chromosomes revealed by mapping of nuclear lamina 
interactions." Nature 453(7197): 948-951. 
Hakim, O., M. H. Sung, T. C. Voss, E. Splinter, S. John, P. J. Sabo, R. E. Thurman, J. A. 
Stamatoyannopoulos, W. de Laat and G. L. Hager (2011). "Diverse gene 
reprogramming events occur in the same spatial clusters of distal regulatory 
elements." Genome Res 21(5): 697-706. 
Handoko, L., H. Xu, G. Li, C. Y. Ngan, E. Chew, M. Schnapp, C. W. Lee, C. Ye, J. L. 
Ping, F. Mulawadi, E. Wong, J. Sheng, Y. Zhang, T. Poh, C. S. Chan, G. 
Kunarso, A. Shahab, G. Bourque, V. Cacheux-Rataboul, W. K. Sung, Y. Ruan 
and C. L. Wei (2011). "CTCF-mediated functional chromatin interactome in 
pluripotent cells." Nat Genet 43(7): 630-638. 
Harr, J. C., T. R. Luperchio, X. Wong, E. Cohen, S. J. Wheelan and K. L. Reddy (2015). 
"Directed targeting of chromatin to the nuclear lamina is mediated by chromatin 
state and A-type lamins." J Cell Biol 208(1): 33-52. 
242 
 
Hart, D. O., T. Raha, N. D. Lawson and M. R. Green (2007). "Initiation of zebrafish 
haematopoiesis by the TATA-box-binding protein-related factor Trf3." Nature 
450(7172): 1082-1085. 
Hebbes, T. R., A. L. Clayton, A. W. Thorne and C. Crane-Robinson (1994). "Core 
histone hyperacetylation co-maps with generalized DNase I sensitivity in the 
chicken beta-globin chromosomal domain." EMBO J 13(8): 1823-1830. 
Hendrix, D. A., J. W. Hong, J. Zeitlinger, D. S. Rokhsar and M. S. Levine (2008). 
"Promoter elements associated with RNA Pol II stalling in the Drosophila 
embryo." Proc Natl Acad Sci U S A 105(22): 7762-7767. 
Hnisz, D., B. J. Abraham, T. I. Lee, A. Lau, V. Saint-Andre, A. A. Sigova, H. A. Hoke and 
R. A. Young (2013). "Super-enhancers in the control of cell identity and disease." 
Cell 155(4): 934-947. 
Hochschild, A., N. Irwin and M. Ptashne (1983). "Repressor structure and the 
mechanism of positive control." Cell 32(2): 319-325. 
Hong, J. W., D. A. Hendrix and M. S. Levine (2008). "Shadow enhancers as a source of 
evolutionary novelty." Science 321(5894): 1314. 
Hsu, J. Y., T. Juven-Gershon, M. T. Marr, 2nd, K. J. Wright, R. Tjian and J. T. Kadonaga 
(2008). "TBP, Mot1, and NC2 establish a regulatory circuit that controls DPE-
dependent versus TATA-dependent transcription." Genes Dev 22(17): 2353-
2358. 
Htun, H., J. Barsony, I. Renyi, D. L. Gould and G. L. Hager (1996). "Visualization of 
glucocorticoid receptor translocation and intranuclear organization in living cells 
with a green fluorescent protein chimera." Proc Natl Acad Sci U S A 93(10): 
4845-4850. 
Hughes, S. M., J. M. Taylor, S. J. Tapscott, C. M. Gurley, W. J. Carter and C. A. 
Peterson (1993). "Selective accumulation of MyoD and myogenin mRNAs in fast 
and slow adult skeletal muscle is controlled by innervation and hormones." 
Development 118(4): 1137-1147. 
Iborra, F. J., A. Pombo, D. A. Jackson and P. R. Cook (1996). "Active RNA polymerases 
are localized within discrete transcription "factories' in human nuclei." J Cell Sci 
109 ( Pt 6): 1427-1436. 
Ip, Y. T., R. E. Park, D. Kosman, E. Bier and M. Levine (1992). "The dorsal gradient 
morphogen regulates stripes of rhomboid expression in the presumptive …." 
Genes Dev 6: 1728-1739. 
Jackson, D. A., A. B. Hassan, R. J. Errington and P. R. Cook (1993). "Visualization of 
focal sites of transcription within human nuclei." EMBO J 12(3): 1059-1065. 
Jackson, D. A., F. J. Iborra, E. M. Manders and P. R. Cook (1998). "Numbers and 
organization of RNA polymerases, nascent transcripts, and transcription units in 
HeLa nuclei." Mol Biol Cell 9(6): 1523-1536. 
Johnson, D. S., A. Mortazavi, R. M. Myers and B. Wold (2007). "Genome-wide mapping 
of in vivo protein-DNA interactions." Science 316(5830): 1497-1502. 
Juven-Gershon, T., J. Y. Hsu and J. T. Kadonaga (2006). "Perspectives on the RNA 
polymerase II core promoter." Biochem Soc Trans 34(Pt 6): 1047-1050. 
Juven-Gershon, T., J. Y. Hsu and J. T. Kadonaga (2008). "Caudal, a key developmental 
regulator, is a DPE-specific transcriptional factor." Genes Dev 22(20): 2823-
2830. 
Juven-Gershon, T., J. Y. Hsu, J. W. Theisen and J. T. Kadonaga (2008). "The RNA 
polymerase II core promoter - the gateway to transcription." Curr Opin Cell Biol 
20(3): 253-259. 
243 
 
Juven-Gershon, T. and J. T. Kadonaga (2010). "Regulation of gene expression via the 
core promoter and the basal transcriptional machinery." Developmental Biology 
339(2): 225-229. 
Kablar, B., A. Asakura, K. Krastel, C. Ying, L. L. May, D. J. Goldhamer and M. A. 
Rudnicki (1998). "MyoD and Myf-5 define the specification of musculature of 
distinct embryonic origin." Biochem Cell Biol 76(6): 1079-1091. 
Kablar, B., K. Krastel, C. Ying, A. Asakura, S. J. Tapscott and M. A. Rudnicki (1997). 
"MyoD and Myf-5 differentially regulate the development of limb versus trunk 
skeletal muscle." Development 124(23): 4729-4738. 
Kanji, G. K. (1999). 100 Statistical Tests, SAGE Publications Ltd., London, England. 
Kellum, R. and P. Schedl (1991). "A position-effect assay for boundaries of higher order 
chromosomal domains." Cell 64(5): 941-950. 
Kennell, D. and H. Riezman (1977). "Transcription and translation initiation frequencies 
of the Escherichia coli lac operon." Journal of Molecular Biology 114(1): 1-21. 
Kerem, B. S., R. Goitein, G. Diamond, H. Cedar and M. Marcus (1984). "Mapping of 
DNAase I sensitive regions on mitotic chromosomes." Cell 38(2): 493-499. 
Kieffer-Kwon, K. R., Z. Tang, E. Mathe, J. Qian, M. H. Sung, G. Li, W. Resch, S. Baek, 
N. Pruett, L. Grontved, L. Vian, S. Nelson, H. Zare, O. Hakim, D. Reyon, A. 
Yamane, H. Nakahashi, A. L. Kovalchuk, J. Zou, J. K. Joung, V. Sartorelli, C. L. 
Wei, X. Ruan, G. L. Hager, Y. Ruan and R. Casellas (2013). "Interactome maps 
of mouse gene regulatory domains reveal basic principles of transcriptional 
regulation." Cell 155(7): 1507-1520. 
Kim, T. H., Z. K. Abdullaev, A. D. Smith, K. A. Ching, D. I. Loukinov, R. D. Green, M. Q. 
Zhang, V. V. Lobanenkov and B. Ren (2007). "Analysis of the vertebrate insulator 
protein CTCF-binding sites in the human genome." Cell 128(6): 1231-1245. 
Kim, T. H., L. O. Barrera, M. Zheng, C. Qu, M. A. Singer, T. A. Richmond, Y. Wu, R. D. 
Green and B. Ren (2005). "A high-resolution map of active promoters in the 
human genome." Nature 436(7052): 876-880. 
Koch, F., R. Fenouil, M. Gut, P. Cauchy, T. K. Albert, J. Zacarias-Cabeza, S. Spicuglia, 
A. L. de la Chapelle, M. Heidemann, C. Hintermair, D. Eick, I. Gut, P. Ferrier and 
J. C. Andrau (2011). "Transcription initiation platforms and GTF recruitment at 
tissue-specific enhancers and promoters." Nat Struct Mol Biol 18(8): 956-963. 
Kosak, S. T. and M. Groudine (2004). "Gene order and dynamic domains." Science 
306(5696): 644-647. 
Kosak, S. T., J. A. Skok, K. L. Medina, R. Riblet, M. M. Le Beau, A. G. Fisher and H. 
Singh (2002). "Subnuclear compartmentalization of immunoglobulin loci during 
lymphocyte development." Science 296(5565): 158-162. 
Kramer, H., M. Niemoller, M. Amouyal, B. Revet, B. von Wilcken-Bergmann and B. 
Muller-Hill (1987). "lac repressor forms loops with linear DNA carrying two 
suitably spaced lac operators." EMBO J 6(5): 1481-1491. 
Krebs, J. E. and M. Dunaway (1998). "The scs and scs' insulator elements impart a cis 
requirement on enhancer-promoter interactions." Mol Cell 1(2): 301-308. 
Kuntz, S. G., B. A. Williams, P. W. Sternberg and B. J. Wold (2012). "Transcription factor 
redundancy and tissue-specific regulation: evidence from functional and physical 
network connectivity." Genome Res 22(10): 1907-1919. 
Kutach, A. K. and J. T. Kadonaga (2000). "The downstream promoter element DPE 
appears to be as widely used as the TATA box in Drosophila core promoters." 
Mol Cell Biol 20(13): 4754-4764. 
244 
 
Lagrange, T., A. N. Kapanidis, H. Tang, D. Reinberg and R. H. Ebright (1998). "New 
core promoter element in RNA polymerase II-dependent transcription: sequence-
specific DNA binding by transcription factor IIB." Genes Dev 12(1): 34-44. 
Lebkowski, J. S. and U. K. Laemmli (1982). "Evidence for two levels of DNA folding in 
histone-depleted HeLa interphase nuclei." J Mol Biol 156(2): 309-324. 
Li, G., X. Ruan, R. K. Auerbach, K. S. Sandhu, M. Zheng, P. Wang, H. M. Poh, Y. Goh, 
J. Lim, J. Zhang, H. S. Sim, S. Q. Peh, F. H. Mulawadi, C. T. Ong, Y. L. Orlov, S. 
Hong, Z. Zhang, S. Landt, D. Raha, G. Euskirchen, C. L. Wei, W. Ge, H. Wang, 
C. Davis, K. I. Fisher-Aylor, A. Mortazavi, M. Gerstein, T. Gingeras, B. Wold, Y. 
Sun, M. J. Fullwood, E. Cheung, E. Liu, W. K. Sung, M. Snyder and Y. Ruan 
(2012). "Extensive promoter-centered chromatin interactions provide a 
topological basis for transcription regulation." Cell 148(1-2): 84-98. 
Li, G. L., X. A. Ruan, R. K. Auerbach, K. S. Sandhu, M. Z. Zheng, P. Wang, H. M. Poh, 
Y. Goh, J. Lim, J. Y. Zhang, H. S. Sim, S. Q. Peh, F. H. Mulawadi, C. T. Ong, Y. 
L. Orlov, S. Z. Hong, Z. Z. Zhang, S. Landt, D. Raha, G. Euskirchen, C. L. Wei, 
W. H. Ge, H. E. Wang, C. Davis, K. I. Fisher-Aylor, A. Mortazavi, M. Gerstein, T. 
Gingeras, B. Wold, Y. Sun, M. J. Fullwood, E. Cheung, E. Liu, W. K. Sung, M. 
Snyder and Y. J. Ruan (2012). "Extensive Promoter-Centered Chromatin 
Interactions Provide a Topological Basis for Transcription Regulation." Cell 
148(1-2): 84-98. 
Li, Y., W. Huang, L. Niu, D. M. Umbach, S. Covo and L. Li (2013). "Characterization of 
constitutive CTCF/cohesin loci: a possible role in establishing topological 
domains in mammalian genomes." BMC Genomics 14: 553. 
Liberman, L. M. and A. Stathopoulos (2009). "Design flexibility in cis-regulatory control of 
gene expression: synthetic and comparative evidence." Dev Biol 327(2): 578-
589. 
Lieberman-Aiden, E., N. L. van Berkum, L. Williams, M. Imakaev, T. Ragoczy, A. Telling, 
I. Amit, B. R. Lajoie, P. J. Sabo, M. O. Dorschner, R. Sandstrom, B. Bernstein, M. 
A. Bender, M. Groudine, A. Gnirke, J. Stamatoyannopoulos, L. A. Mirny, E. S. 
Lander and J. Dekker (2009). "Comprehensive mapping of long-range 
interactions reveals folding principles of the human genome." Science 326(5950): 
289-293. 
Lim, C. Y., B. Santoso, T. Boulay, E. Dong, U. Ohler and J. T. Kadonaga (2004). "The 
MTE, a new core promoter element for transcription by RNA polymerase II." 
Genes Dev 18(13): 1606-1617. 
Ling, J. Q., T. Li, J. F. Hu, T. H. Vu, H. L. Chen, X. W. Qiu, A. M. Cherry and A. R. 
Hoffman (2006). "CTCF mediates interchromosomal colocalization between 
Igf2/H19 and Wsb1/Nf1." Science 312(5771): 269-272. 
Lis, J., L. Core, A. Martins, C. Danko, A. Siepel, G. Booth, F. Duarte and D. B. Mahat 
(2015). "A Unified Model Describing The Architecture And Creation Of Promoters 
And Enhancers." The FASEB Journal 29(1 Supplement). 
Loots, G. G., R. M. Locksley, C. M. Blankespoor, Z. E. Wang, W. Miller, E. M. Rubin and 
K. A. Frazer (2000). "Identification of a coordinate regulator of interleukins 4, 13, 
and 5 by cross-species sequence comparisons." Science 288(5463): 136-140. 
Lupo, A., E. Cesaro, G. Montano, D. Zurlo, P. Izzo and P. Costanzo (2013). "KRAB-Zinc 
Finger Proteins: A Repressor Family Displaying Multiple Biological Functions." 
Current Genomics 14(4): 268-278. 
MacArthur, S., X. Y. Li, J. Li, J. B. Brown, H. C. Chu, L. Zeng, B. P. Grondona, A. 
Hechmer, L. Simirenko, S. V. Keranen, D. W. Knowles, M. Stapleton, P. Bickel, 
M. D. Biggin and M. B. Eisen (2009). "Developmental roles of 21 Drosophila 
245 
 
transcription factors are determined by quantitative differences in binding to an 
overlapping set of thousands of genomic regions." Genome Biol 10(7): R80. 
Magistri, M., M. A. Faghihi, G. St Laurent, 3rd and C. Wahlestedt (2012). "Regulation of 
chromatin structure by long noncoding RNAs: focus on natural antisense 
transcripts." Trends Genet 28(8): 389-396. 
Mallin, D. R., J. S. Myung, J. S. Patton and P. K. Geyer (1998). "Polycomb group 
repression is blocked by the Drosophila suppressor of Hairy-wing [su(Hw)] 
insulator." Genetics 148(1): 331-339. 
Markstein, M., P. Markstein, V. Markstein and M. S. Levine (2002). "Genome-wide 
analysis of clustered Dorsal binding sites identifies putative target genes in the 
Drosophila embryo." Proceedings of the National Academy of Sciences 99(2): 
763. 
Markstein, M., R. Zinzen, P. Markstein, K. P. Yee, A. Erives, A. Stathopoulos and M. 
Levine (2004). "A regulatory code for neurogenic gene expression in the 
Drosophila embryo." Development 131(10): 2387-2394. 
McKnight, S. and R. Tjian (1986). "Transcriptional selectivity of viral genes in 
mammalian cells." Cell 46(6): 795-805. 
McKnight, S. L., R. C. Kingsbury, A. Spence and M. Smith (1984). "The distal 
transcription signals of the herpesvirus tk gene share a common hexanucleotide 
control sequence." Cell 37(1): 253-262. 
McNally, J. G., W. G. Müller, D. Walker, R. Wolford and G. L. Hager (2000). "The 
Glucocorticoid Receptor: Rapid Exchange with Regulatory Sites in Living Cells." 
Science 287(5456): 1262-1265. 
Mercola, M., X. F. Wang, J. Olsen and K. Calame (1983). "Transcriptional enhancer 
elements in the mouse immunoglobulin heavy chain locus." Science 221(4611): 
663-665. 
Meshorer, E. and T. Misteli (2006). "Chromatin in pluripotent embryonic stem cells and 
differentiation." Nat Rev Mol Cell Biol 7(7): 540-546. 
Mirkovitch, J., M. E. Mirault and U. K. Laemmli (1984). "Organization of the higher-order 
chromatin loop: specific DNA attachment sites on nuclear scaffold." Cell 39(1): 
223-232. 
Mitchell, J. A. and P. Fraser (2008). "Transcription factories are nuclear 
subcompartments that remain in the absence of transcription." Genes Dev 22(1): 
20-25. 
Mohrs, M., C. M. Blankespoor, Z. E. Wang, G. G. Loots, V. Afzal, H. Hadeiba, K. 
Shinkai, E. M. Rubin and R. M. Locksley (2001). "Deletion of a coordinate 
regulator of type 2 cytokine expression in mice." Nat Immunol 2(9): 842-847. 
Monroe, R. J., B. P. Sleckman, B. C. Monroe, B. Khor, S. Claypool, R. Ferrini, L. 
Davidson and F. W. Alt (1999). "Developmental regulation of TCR delta locus 
accessibility and expression by the TCR delta enhancer." Immunity 10(5): 503-
513. 
Morcillo, P., C. Rosen, M. K. Baylies and D. Dorsett (1997). "Chip, a widely expressed 
chromosomal protein required for segmentation and activity of a remote wing 
margin enhancer in Drosophila." Genes Dev 11(20): 2729-2740. 
Mortazavi, A., B. A. Williams, K. McCue, L. Schaeffer and B. Wold (2008). "Mapping and 
quantifying mammalian transcriptomes by RNA-Seq." Nat Methods 5(7): 621-
628. 
Muller, H. P. and W. Schaffner (1990). "Transcriptional enhancers can act in trans." 
Trends in Genetics 6(9): 300-304. 
246 
 
Muller, H. P., J. M. Sogo and W. Schaffner (1989). "An enhancer stimulates transcription 
in trans when attached to the promoter via a protein bridge." Cell 58(4): 767-777. 
Muller, M. M., T. Gerster and W. Schaffner (1988). "Enhancer sequences and the 
regulation of gene-transcription." European Journal of Biochemistry 176(3): 485-
495. 
Nabirochkin, S., M. Ossokina and T. Heidmann (1998). "A nuclear matrix/scaffold 
attachment region co-localizes with the gypsy retrotransposon insulator 
sequence." J Biol Chem 273(4): 2473-2479. 
Nakagomi, K., Y. Kohwi, L. A. Dickinson and T. Kohwi-Shigematsu (1994). "A novel 
DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1." 
Mol Cell Biol 14(3): 1852-1860. 
Namciu, S. J., K. B. Blochlinger and R. E. Fournier (1998). "Human matrix attachment 
regions insulate transgene expression from chromosomal position effects in 
Drosophila melanogaster." Mol Cell Biol 18(4): 2382-2391. 
Neuberger, M. S. (1983). "Expression and regulation of immunoglobulin heavy chain 
gene transfected into lymphoid cells." EMBO J 2(8): 1373-1378. 
Noordermeer, D., M. R. Branco, E. Splinter, P. Klous, W. van Ijcken, S. Swagemakers, 
M. Koutsourakis, P. van der Spek, A. Pombo and W. de Laat (2008). 
"Transcription and chromatin organization of a housekeeping gene cluster 
containing an integrated beta-globin locus control region." PLoS Genet 4(3): 
e1000016. 
Noordermeer, D., E. de Wit, P. Klous, H. van de Werken, M. Simonis, M. Lopez-Jones, 
B. Eussen, A. de Klein, R. H. Singer and W. de Laat (2011). "Variegated gene 
expression caused by cell-specific long-range DNA interactions." Nat Cell Biol 
13(8): 944-951. 
Noordermeer, D. and D. Duboule (2013). "Chromatin looping and organization at 
developmentally regulated gene loci." Wiley Interdiscip Rev Dev Biol 2(5): 615-
630. 
Ogawa, N., and Biggin, M. D. (2011). High-throughput SELEX determination of DNA 
sequences bound by transcription factors in vitro. Methods in Mol. Biol. . B. 
Deplanke, Humana Press, Clifton, New Jersey: in press. 
Ohtsuki, S., M. Levine and H. N. Cai (1998). "Different core promoters possess distinct 
regulatory activities in the Drosophila embryo." Genes Dev 12(4): 547-556. 
Ong, C. T. and V. G. Corces (2014). "CTCF: an architectural protein bridging genome 
topology and function." Nat Rev Genet 15(4): 234-246. 
Osborne, C. S., L. Chakalova, K. E. Brown, D. Carter, A. Horton, E. Debrand, B. 
Goyenechea, J. A. Mitchell, S. Lopes, W. Reik and P. Fraser (2004). "Active 
genes dynamically colocalize to shared sites of ongoing transcription." Nat Genet 
36(10): 1065-1071. 
Ozdemir, A., K. I. Fisher-Aylor, S. Pepke, M. Samanta, L. Dunipace, K. McCue, L. C. 
Zeng, N. Ogawa, B. J. Wold and A. Stathopoulos (2011). "High resolution 
mapping of Twist to DNA in Drosophila embryos: Efficient functional analysis and 
evolutionary conservation." Genome Research 21(4): 566-577. 
Palstra, R. J., M. Simonis, P. Klous, E. Brasset, B. Eijkelkamp and W. de Laat (2008). 
"Maintenance of long-range DNA interactions after inhibition of ongoing RNA 
polymerase II transcription." PLoS One 3(2): e1661. 
Panne, D., T. Maniatis and S. C. Harrison (2007). "An atomic model of the interferon-
beta enhanceosome." Cell 129(6): 1111-1123. 
Pepke, S., B. Wold and A. Mortazavi (2009). "Computation for ChIP-seq and RNA-seq 
studies." Nat Methods 6(11 Suppl): S22-32. 
247 
 
Peric-Hupkes, D., W. Meuleman, L. Pagie, S. W. Bruggeman, I. Solovei, W. Brugman, S. 
Graf, P. Flicek, R. M. Kerkhoven, M. van Lohuizen, M. Reinders, L. Wessels and 
B. van Steensel (2010). "Molecular maps of the reorganization of genome-
nuclear lamina interactions during differentiation." Mol Cell 38(4): 603-613. 
Phillips-Cremins, J. E., M. E. Sauria, A. Sanyal, T. I. Gerasimova, B. R. Lajoie, J. S. Bell, 
C. T. Ong, T. A. Hookway, C. Guo, Y. Sun, M. J. Bland, W. Wagstaff, S. Dalton, 
T. C. McDevitt, R. Sen, J. Dekker, J. Taylor and V. G. Corces (2013). 
"Architectural protein subclasses shape 3D organization of genomes during 
lineage commitment." Cell 153(6): 1281-1295. 
Pickersgill, H., B. Kalverda, E. de Wit, W. Talhout, M. Fornerod and B. van Steensel 
(2006). "Characterization of the Drosophila melanogaster genome at the nuclear 
lamina." Nat Genet 38(9): 1005-1014. 
Plon, S. E. and J. C. Wang (1986). "Transcription of the human beta-globin gene is 
stimulated by an SV40 enhancer to which it is physically linked but topologically 
uncoupled." Cell 45(4): 575-580. 
Pope, B. D., T. Ryba, V. Dileep, F. Yue, W. S. Wu, O. Denas, D. L. Vera, Y. L. Wang, R. 
S. Hansen, T. K. Canfield, R. E. Thurman, Y. Cheng, G. Gulsoy, J. H. Dennis, M. 
P. Snyder, J. A. Stamatoyannopoulos, J. Taylor, R. C. Hardison, T. Kahveci, B. 
Ren and D. M. Gilbert (2014). "Topologically associating domains are stable units 
of replication-timing regulation." Nature 515(7527): 402-+. 
Reeve, J. N. (2003). "Archaeal chromatin and transcription." Mol Microbiol 48(3): 587-
598. 
Robin, J. D., A. T. Ludlow, K. Batten, M. C. Gaillard, G. Stadler, F. Magdinier, W. E. 
Wright and J. W. Shay (2015). "SORBS2 transcription is activated by telomere 
position effect-over long distance upon telomere shortening in muscle cells from 
patients with facioscapulohumeral dystrophy." Genome Res 25(12): 1781-1790. 
Robinson, S. I., D. Small, R. Idzerda, G. S. McKnight and B. Vogelstein (1983). "The 
association of transcriptionally active genes with the nuclear matrix of the chicken 
oviduct." Nucleic Acids Res 11(15): 5113-5130. 
Roulet, E., S. Busso, A. A. Camargo, A. J. Simpson, N. Mermod and P. Bucher (2002). 
"High-throughput SELEX SAGE method for quantitative modeling of 
transcription-factor binding sites." Nat Biotechnol 20(8): 831-835. 
Sandelin, A., P. Carninci, B. Lenhard, J. Ponjavic, Y. Hayashizaki and D. A. Hume 
(2007). "Mammalian RNA polymerase II core promoters: insights from genome-
wide studies." Nat Rev Genet 8(6): 424-436. 
Sanyal, A., B. R. Lajoie, G. Jain and J. Dekker (2012). "The long-range interaction 
landscape of gene promoters." Nature 489(7414): 109-U127. 
Schaffner, W., G. Kunz, H. Daetwyler, J. Telford, H. O. Smith and M. L. Birnstiel (1978). 
"Genes and spacers of cloned sea urchin histone DNA analyzed by sequencing." 
Cell 14(3): 655-671. 
Schmidt, J. V., J. M. Levorse and S. M. Tilghman (1999). "Enhancer competition 
between H19 and Igf2 does not mediate their imprinting." Proceedings of the 
National Academy of Sciences 96(17): 9733-9738. 
Serfling, E., M. Jasin and W. Schaffner (1985). "Enhancers and eukaryotic gene-
transcription." Trends in Genetics 1(8): 224-230. 
Serfling, E., A. Lubbe, K. Dorsch-Hasler and W. Schaffner (1985). "Metal-dependent 
SV40 viruses containing inducible enhancers from the upstream region of 
metallothionein genes." EMBO J 4(13B): 3851-3859. 
Shopland, L. S., C. R. Lynch, K. A. Peterson, K. Thornton, N. Kepper, J. Hase, S. Stein, 
S. Vincent, K. R. Molloy, G. Kreth, C. Cremer, C. J. Bult and T. P. O'Brien (2006). 
248 
 
"Folding and organization of a contiguous chromosome region according to the 
gene distribution pattern in primary genomic sequence." J Cell Biol 174(1): 27-38. 
Siebenlist, U., R. B. Simpson and W. Gilbert (1980). "E. coli RNA polymerase interacts 
homologously with two different promoters." Cell 20(2): 269-281. 
Simonis, M., P. Klous, E. Splinter, Y. Moshkin, R. Willemsen, E. de Wit, B. van Steensel 
and W. de Laat (2006). "Nuclear organization of active and inactive chromatin 
domains uncovered by chromosome conformation capture-on-chip (4C)." Nat 
Genet 38(11): 1348-1354. 
Smale, S. T. and D. Baltimore (1989). "The 'initiator' as a transcription control element." 
Cell 57(1): 103-113. 
Smale, S. T. and J. T. Kadonaga (2003). "The RNA polymerase II core promoter." Annu 
Rev Biochem 72: 449-479. 
Small, D., B. Nelkin and B. Vogelstein (1985). "The association of transcribed genes with 
the nuclear matrix of Drosophila cells during heat shock." Nucleic Acids Res 
13(7): 2413-2431. 
Spitz, F., F. Gonzalez and D. Duboule (2003). "A global control region defines a 
chromosomal regulatory landscape containing the HoxD cluster." Cell 113(3): 
405-417. 
Splinter, E., H. Heath, J. Kooren, R. J. Palstra, P. Klous, F. Grosveld, N. Galjart and W. 
de Laat (2006). "CTCF mediates long-range chromatin looping and local histone 
modification in the beta-globin locus." Genes Dev 20(17): 2349-2354. 
Stathopoulos, A. and M. Levine (2002). "Whole-Genome Expression Profiles Identify 
Gene Batteries in Drosophila." Developmental Cell 3(4): 464-465. 
Stathopoulos, A. and M. Levine (2005). "Genomic Regulatory Networks and Animal 
Development." Developmental Cell 9(4): 449. 
Stathopoulos, A., M. Van Drenth, A. Erives, M. Markstein and M. Levine (2002). "Whole-
genome analysis of dorsal-ventral patterning in the Drosophila embryo." Cell 
111(5): 687-701. 
Suen, C. S., T. J. Berrodin, R. Mastroeni, B. J. Cheskis, C. R. Lyttle and D. E. Frail 
(1998). "A transcriptional coactivator, steroid receptor coactivator-3, selectively 
augments steroid receptor transcriptional activity." J Biol Chem 273(42): 27645-
27653. 
Sumiyama, K., S. Q. Irvine, D. W. Stock, K. M. Weiss, K. Kawasaki, N. Shimizu, C. S. 
Shashikant, W. Miller and F. H. Ruddle (2002). "Genomic structure and functional 
control of the Dlx3-7 bigene cluster." Proc Natl Acad Sci U S A 99(2): 780-785. 
Tai, P. W. L., K. I. Fisher-Aylor, C. L. Himeda, C. L. Smith, A. P. MacKenzie, D. L. 
Helterline, J. C. Angello, R. E. Welikson, B. J. Wold and S. D. Hauschka (2011). 
"Differentiation and fiber type-specific activity of a muscle creatine kinase intronic 
enhancer." Skeletal Muscle 1:25. 
Tapscott, S. J., A. B. Lassar and H. Weintraub (1992). "A novel myoblast enhancer 
element mediates MyoD transcription." Mol Cell Biol 12(11): 4994-5003. 
ten Bosch, J. R., J. A. Benavides and T. W. Cline (2006). "The TAGteam DNA motif 
controls the timing of Drosophila pre-blastoderm transcription." Development 
133(10): 1967. 
Thanos, D. and T. Maniatis (1995). "Virus induction of human IFN beta gene expression 
requires the assembly of an enhanceosome." Cell 83(7): 1091-1100. 
Theveny, B., A. Bailly, C. Rauch, M. Rauch, E. Delain and E. Milgrom (1987). 
"Association of DNA-bound progesterone receptors." Nature 329(6134): 79-81. 
249 
 
Tiwari, V. K., L. Cope, K. M. McGarvey, J. E. Ohm and S. B. Baylin (2008). "A novel 6C 
assay uncovers Polycomb-mediated higher order chromatin conformations." 
Genome Res 18(7): 1171-1179. 
Tolhuis, B., R.-J. Palstra, E. Splinter, F. Grosveld and W. de Laat (2002). "Looping and 
Interaction between Hypersensitive Sites in the Active β-globin Locus." Molecular 
Cell 10(6): 1453-1465. 
Udvardy, A., E. Maine and P. Schedl (1985). "The 87A7 chromomere. Identification of 
novel chromatin structures flanking the heat shock locus that may define the 
boundaries of higher order domains." J Mol Biol 185(2): 341-358. 
van Steensel, B. and S. Henikoff (2000). "Identification of in vivo DNA targets of 
chromatin proteins using tethered dam methyltransferase." Nat Biotechnol 18(4): 
424-428. 
van Werven, F. J., H. van Bakel, H. A. van Teeffelen, A. F. Altelaar, M. G. Koerkamp, A. 
J. Heck, F. C. Holstege and H. T. Timmers (2008). "Cooperative action of NC2 
and Mot1p to regulate TATA-binding protein function across the genome." Genes 
Dev 22(17): 2359-2369. 
Verschure, P. J., I. van Der Kraan, E. M. Manders and R. van Driel (1999). "Spatial 
relationship between transcription sites and chromosome territories." J Cell Biol 
147(1): 13-24. 
Weber, F., J. de Villiers and W. Schaffner (1984). "An SV40 'enhancer trap' incorporates 
exogenous enhancers or generates enhancers from its own sequences." Cell 
36(4): 983-992. 
Whyte, W. A., D. A. Orlando, D. Hnisz, B. J. Abraham, C. Y. Lin, M. H. Kagey, P. B. 
Rahl, T. I. Lee and R. A. Young (2013). "Master transcription factors and 
mediator establish super-enhancers at key cell identity genes." Cell 153(2): 307-
319. 
Wiesendanger, B., R. Lucchini, T. Koller and J. M. Sogo (1994). "Replication fork 
barriers in the Xenopus rDNA." Nucleic Acids Res 22(23): 5038-5046. 
Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein 
and R. Axel (1979). "Transformation of mammalian cells with genes from 
procaryotes and eucaryotes." Cell 16(4): 777-785. 
Willy, P. J., R. Kobayashi and J. T. Kadonaga (2000). "A basal transcription factor that 
activates or represses transcription." Science 290(5493): 982-985. 
Wold, B., M. Wigler, E. Lacy, T. Maniatis, S. Silverstein and R. Axel (1979). "Introduction 
and expression of a rabbit beta-globin gene in mouse fibroblasts." Proc Natl Acad 
Sci U S A 76(11): 5684-5688. 
Wurtele, H. and P. Chartrand (2006). "Genome-wide scanning of HoxB1-associated loci 
in mouse ES cells using an open-ended Chromosome Conformation Capture 
methodology." Chromosome Res 14(5): 477-495. 
Yaffe, D. and O. Saxel (1977). "Serial passaging and differentiation of myogenic cells 
isolated from dystrophic mouse muscle." Nature 270(5639): 725-727. 
Yee, S. P. and P. W. Rigby (1993). "The regulation of myogenin gene expression during 
the embryonic development of the mouse." Genes Dev 7(7A): 1277-1289. 
Zakany, J., C. Fromental-Ramain, X. Warot and D. Duboule (1997). "Regulation of 
number and size of digits by posterior Hox genes: a dose-dependent mechanism 
with potential evolutionary implications." Proc Natl Acad Sci U S A 94(25): 13695-
13700. 
Zeitlinger, J., A. Stark, M. Kellis, J. W. Hong, S. Nechaev, K. Adelman, M. Levine and R. 
A. Young (2007). "RNA polymerase stalling at developmental control genes in 
the Drosophila melanogaster embryo." Nat Genet 39(12): 1512-1516. 
250 
 
Zeitlinger, J., R. P. Zinzen, A. Stark, M. Kellis, H. Zhang, R. A. Young and M. Levine 
(2007). "Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests 
integration of diverse patterning processes in the Drosophila embryo." Genes 
Dev 21(4): 385-390. 
Zeng, M. e. a. (2015). in review. 
Zhang, Y., T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson, B. E. Bernstein, C. 
Nusbaum, R. M. Myers, M. Brown, W. Li and X. S. Liu (2008). "Model-based 
analysis of ChIP-Seq (MACS)." Genome Biol 9(9): R137. 
Zhao, Z., G. Tavoosidana, M. Sjolinder, A. Gondor, P. Mariano, S. Wang, C. Kanduri, M. 
Lezcano, K. S. Sandhu, U. Singh, V. Pant, V. Tiwari, S. Kurukuti and R. Ohlsson 
(2006). "Circular chromosome conformation capture (4C) uncovers extensive 
networks of epigenetically regulated intra- and interchromosomal interactions." 
Nat Genet 38(11): 1341-1347. 
Zinzen, R., K. Senger, M. Levine and D. Papatsenko (2006). "Computational Models for 
Neurogenic Gene Expression in the Drosophila Embryo." Current Biology 16(13): 
1358-1365. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
251 
 
 
Chapter Supplemental III: Materials and Methods: Experimental Protocols 
SIII.1: Cell Growth Protocol and Differentiation treatment for the C2C12 Cell Line 
From: Wold mouse ENCODE 
Date: May 17, 2011 
Prepared by: Katherine Fisher-Aylor and Brian Williams 
C2C12 cell culture, differentiation treatment, and cross-linking protocol 
 The cell line C2C12 is an immortal line of mouse skeletal myoblasts originally 
derived from satellite cells from the thigh muscle of a two month old female C3H mouse 
donor 70h after a crush injury (Yaffe and Saxel, 1977; karyotyping available in Casas-
Delucchi, 2011). From the C2s the immortal subline C2C12 was selected (Blau et al., 
1985). These cells differentiate well into myocytes under appropriate culture conditions 
given below. The cells are adherent in culture and are grown on Nunc delta surface 
plastic culture dishes. They grow as undifferentiated myoblasts in growth medium (15-
20% fetal bovine serum, with 20% used here). Myogenic differentiation is initiated upon 
reaching confluence by switching the cells to medium containing 2% horse serum 
supplemented with insulin. C2C12’s are commercially available but because variable 
handling of this line can select for cells with different kinetics or poor differentiation 
performance, the Wold lab will provide plugs of these C2C12’s upon request. 
(See: (1) Yaffe and Saxel, 1977; Nature Vol. 270, 725-727; (2) Casas-Delucchi et al., 
2011; Nature Communications Vol. 2, 222. (3) Blau et al., 1985; Science Vol. 230, 758-
766). 
Cell culture protocol for cycling (exponentially growing) cells 
 Cells are grown at 37°C in a humidified incubator with 5% CO2. 
 
 
 
252 
 
Myoblast growth medium 
final   stock   example 
DMEM          395 mL 
FBS (fetal bovine serum)    20%   100%   100 mL 
Final           500 mL 
 
Materials 
DMEM (high glucose + glutamine, no Sodium Pyruvate)  GIBCO #11965 
FBS         HyClone #30071.03 
 
Antibiotics: We use 1X Penicillin/Streptomycin (100X stock = Gibco # 15140). This 
comes out to final concentrations of 100 units/mL penicillin and 100 ug/mL streptomycin. 
Liquid Nitrogen Storage 
 Freeze cells in growth medium supplemented with 10% (v/v) DMSO in 1 ml 
aliquots of approximately 0.5-1 x 106 cells. When grown on 15 cm dishes, the cells 
reach confluence at ~2.6 X 106 cells per dish. 
Cell culture and passage 
1.  Thaw a 1-ml aliquot of cells as quickly as possible in water bath at 37°C. Transfer 
cells to 24 mL warm media in a 50 mL conical tube. Mix gently. Plate the cells in a 15cm 
Nunc delta surface plates. Place in incubator. After one day, remove the medium and 
add fresh media. 
2.  When cells are 50-60% confluent (meaning that very few of them are physically 
touching each other), split 1:4 or 1:5 (at most). It is important to not let the cells become 
fully confluent because they can begin to fuse and partially differentiate upon cell-cell 
contact. To passage, remove and discard culture medium. Rinse twice with PBS 
(Calcium and Magnesium free). For a 15 cm dish, add 2.5mL of 0.25% (w/v) trypsin + 
0.53 mM EDTA solution (Gibco #25300) prewarmed to 37°C, and observe cells under an 
inverted microscope until cell aspect changes to round (usually within 60-90 seconds). 
Aspirate the majority of the trypsin and let stand for an additional 1-2 minutes, then tap 
the plate to dislodge cells. Add 10mL of myoblast growth medium to the dish, and collect 
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cells by gently pipetting. (If using 10cm dishes, the volume of trypsin is reduced to 1 mL, 
and the time is reduced to 1 minute in trypsin). Dilute cells in a larger flask to the 
appropriate volume using growth media and aliquot to new Nunc dishes. There is no 
need to feed the cells in between passages. This is a fairly quickly growing cell line 
(doubling time is approximately 12h); you will need to passage them every 1-2 days. 
Differentiation treatment 
 Differentiate for 24 hours to 7 days by rinsing fully confluent cells once with PBS 
and adding 25mL of low-serum differentiation medium. Feed with fresh differentiation 
medium every 24 hours up to the 72h timepoint and after that, every 12 hours (as these 
cells differentiate, they begin to deplete and acidify the medium more quickly). The 
timepoints we typically use are 24h, 60h, 5D, and 7D. Feed the cells no closer than 6h 
before fixation to avoid seeing serum-response effects in the cell prep. 
Differentiation medium 
final   stock   example 
DMEM          489.5mL 
Donor equine serum     2%   100%   10 mL 
Insulin (add no more than 24h before use)  1uM   1mM   0.5 mL 
Final           500 mL 
 
Materials 
DMEM (high glucose + glutamine, no Sodium Pyruvate)  GIBCO #11965 
Donor equine serum       HyClone #SH30074.02 
insulin         Sigma-Aldrich #I-6634 
 
Insulin: 1,000X stock is 1mg/mL in water with 10-20 μl of acetic acid added to acidify the 
water so it dissolves (use minimum possible). Filter sterilize with 0.2 um filter. Store at -
20°C in small aliquots until use. 
Antibiotics: We use 1X Penicillin/Streptomycin (100X stock = Gibco # 15140). This 
comes out to final concentrations of 100 units/mL penicillin and 100 ug/mL streptomycin. 
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Cell cross-linking and harvest for ChIP 
1.  Remove the medium from the culture plates and add a solution of PBS with 1% 
formaldehyde (Sigma-Aldrich # F87750). Swirl gently, and incubate at room temperature 
for 10 minutes. 
2.  Stop the cross-linking reaction by adding glycine to a final concentration of 0.125 
M and swirl gently to mix. Use a stock solution of 2.5M glycine dissolved in H20. 
Incubate for 10 minutes. 
3.  Remove PBS/FA/glycine from plates and gently wash cells twice with 15 mL 
room temperature PBS. 
4.  To detach the cells from the dishes, add dilute trypsin (2mL PBS + 0.4mL of 
Gibco trypsin+EDTA (Gibco #25300)) for 10 min at 37°C, then quench with 100uL horse 
serum or FBS. Transfer to ice or 4°C. 
5.  Add 2 mL of cold PBS and scrape into a 15mL falcon tube; rinse plate once with 
5mL of cold PBS and combine. 
6.  Pellet cells at 360 X g for 5 minutes at 4°C. 
7.  Aspirate PBS/trypsin solution and resuspend cells in 5 ml cold (4°C) PBS + 1 uM 
PMSF. 
8.  Pellet cells at 360 X g for 5 minutes at 4°C. 
9.  Carefully aspirate PBS and add 6 ml cold (4°C) Farnham lysis buffer (5 mM 
PIPES pH 8.0 / 85 mM KCl / 0.5% NP-40) + Roche Protease Inhibitor Cocktail Tablet 
(Complete 11836145001). This step lyses the cell membrane, leaving the nuclear 
envelope intact. 
10.  Pellet nuclei at 360 X g for 5 minutes at 4°C. 
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11.  Place the nuclear pellet on ice. Carefully remove supernatant and either proceed 
to sonication step or snap freeze in liquid nitrogen and store at -80°C or in liquid 
nitrogen. 
RNA yields 
 A 15 cm dish of undifferentiated cells yields about 20 ugs of total RNA collected 
with Qiagen RNEasy reagents. A 15 cm dish of differentiated cells yields about 60 ugs of 
total RNA. 
SIII.2: C2C12 fixation protocol 
Katherine Fisher-Aylor 
last updated 12/2012 
 
RNA extraction (for RNA-Seq) 
 
1. Rinse 2x with PBS 
2. Add 2.25mL room temperature mirVana binding + lysis buffer 
3. Scrape into a 14mL snap-cap tube 
4. Shear 20x through a 21.5g needle using a 3mL syringe. 
5. Put in -80C freezer. 
ALTERNATE PROTOCOL (better for isolating small RNAs): use MirVana lysis       
RIPA lysis (for protein) 
1. Rinse 2x with PBS 
2. Add 2mL RIPA+PIC 
3. Incubate at 4C, tilting occasionally 
4. Scrape into 2x Eppendorf tubes 
5. Spun at 10Kxg 15 min at 4C 
6. Aliquot into 5 Eppendorf tubes and put in -80C freezer 
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ICC fixation (to determine % myogenin positive nuclei) 
1. Add 0.9 mL of 37% formaldehyde (w/MeOH) to 5mL of medium in 6cm plate.  
Final concentration should be 4% formaldehyde. 
2. Put on rotator 20 minutes at room temperature. 
3. Rinse 2x with PBS 
4. Store wrapped in parafilm in PBS at 4C. 
ChIP fixation  
1. Rinse with PBS. 
2. Add 1% formaldehyde (our stock is Mallinkrodt chemicals 37% FA w/MeOH) 
diluted in PBS to plates.  Final concentration should be 1%.  Use enough to 
cover the surface of the plate (typically 25mL/15cm plate). 
3. Incubate on rotator at room temperature for 10-15 minutes. 
4. Quench by adding 2mL 2.5M glycine directly to the 25mL fixation solution 
(7.5g/40mL H2O) and incubate 10 min on rotator at room temp. 
5. Rinse 2x with cold PBS 
*plates can stay at 4C here for several hours (I’ve tested up to 12h). 
6. Add 2mL PBS+0.4mL trypsin/EDTA (0.05M trypsin) and incubate 10 minutes at 
37C (NOT sterile incubator) 
7. Add 100uL equine or fetal bovine serum to each dish and tilt to inactivate trypsin. 
8. Put plates in refrigerator until scraped; put scraped cells in refrigerator too. 
*plates can stay here at 4C for a few hours (I’ve tested up to 2h) 
9. Scrape cells into a 15mL tube. 
10. Wash plates with PBS and scrape into the same tube. 
11. Spin at 360 rcf, 4C for 5 minutes 
12. Remove supernatant and resuspend in 5mL PBS+PMSF (1x) 
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13.  Spin at 360 rcf, 4C for 5 minutes.  Remove supernatant. 
14. Resuspend in MC lysis buffer (1/2/3mL depending on cell amount) 
15. Put at -80C to freeze OR spin at 360 rcf, remove supernatant, and freeze as a 
pellet.  A flash freeze is unnecessary. 
Collection of nuclei for genomic DNA assay (to determine the # of nuclei per plate) 
1. Rinse 2x in PBS 
2. Scrape into an eppendorf tube; store at -20C 
SOLUTIONS 
 
RIPA buffer (store at 4C) 
   1x PBS 
   1% NP-40 
   0.5% sodium deoxycholate 
   0.1% SDS 
      add Roche complete EDTA-free protease inhibitor cocktail right before using. 
 
MC lysis buffer (store at 4C) 
   10mM Tris pH 7.5 
   10mM NaCl 
   3mM MgCl2 
   0.5% NP-40 
      add Roche complete EDTA-free protease inhibitor cocktail right before using. 
 
100x PMSF (store at -20C) 
   100% EtOH 
   100mM PMSF 
 
SIII.3: Genomic DNA assay to quantify the number of nuclei per plate of adherent 
cells 
Katherine Fisher-Aylor 
last updated 8/1/10 
 
Protocol and reagents are from Epicentre MasterPure Complete DNA and RNA 
Purification Kit 
 
1. Cells should have been collected by simply scraping them in PBS into an 
eppendorf.  I freeze these samples at -20C. 
2. Collect approximately 0.5x10^5 to 2x10^6 nuclei (this is what the volumes in the 
kit are optimized for).  For a 15cm plate of exponential C2's, I use 25% of a plate.  For a 
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15cm plate of packed 60h C2's, I use 1% of a plate.  Thaw and resuspend the whole-
plate samples, calculate the total volume, and take a percentage accordingly.  
3. If the volume of your sub-samples is larger than 30uL, spin them for 5 minutes at 
360xg and reduce the volume to 30uL. 
4. Add 300uL of T+C lysis buffer to each tube.  Then add 2uL of 50ug/uL proteinase 
K to each tube and vortex briefly to mix. 
5. Incubate 30 minutes at 65C, shaking every 10 minutes. 
6. Cool tubes to 37. 
7. Add 1uL 5ug/uL RNase A and mix.  BE CAREFUL WHICH 
PIPETS/CONTAINERS YOU USE WITH RNASE SINCE OUR LAB WORKS WITH 
RNA. 
8. Incubate 30 minutes at 37C. 
9. Put on ice 5 minutes. 
10. Add 150uL MPC Protein Precipitation Reagent to each sample and vortex 10 
seconds. 
11. Centrifuge for 10 minutes at maximum speed, 4C.  If the pellet is small or loose, 
add extra MPC and spin again.  Note: the MPC only works when it is kept cold.  If the 
tubes warm up, cool them down and try again. 
12. Transfer the supernatant to a new tube and discard pellet. 
13. Add 500uL Isopropyl alcohol and mix. 
14. Pellet the DNA by spinning 10 minutes at maximum speed, 4C. 
15. Remove the supernatant and save the pellet. 
16. Rinse the pellet with 75% EtOH by pipetting 200uL into the tube, gently flicking, 
and removing it.  If your pellet dislodges or breaks, spin 1 minute at maximum speed. 
17. Remove all residual EtOH.  Bench dry 30 minutes or until all liquid is gone. 
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18. Resuspend the DNA in 35uL TE. 
19. Nano-Drop (or even better, Q-bit) the DNA to determine its concentration.   
20. Knowing the final concentration, the final volume (35uL), and the % per plate that 
you started with, you know the amount of DNA per plate.  Assuming 6.5pg DNA/nucleus 
for a mouse cell, you know the approximate number of nuclei per plate.  I usually expect 
about 1x10^6 cells per C2 exponential plate, 5x10^7 cells per C2 24h plate, and 
between 1 and 3x10^8 cells per C2 60h plate. 
 Note: this method has its own biases and may even be biased differently for 
exponential and differentiated cells.  For a more certain determination, it is 
recommended also to count the number of nuclei (with Hoescht or other nuclear stain) 
under a microscope and extrapolate by area the number of cells per plate.  Then 
average those results with the results of the genomic DNA assay. 
SIII.4: ChIP-Seq protocol 
Wold lab ChIP protocol 
Katherine Fisher-Aylor version 
Last updated 2/2013 
This is based on G Kwan’s ChIP protocol, a derivative of the Johnson et al. 2008 
protocol 
 
NOTE 1: “wash” = 5 minutes on magnet followed by incubation on rotator at 4C 
NOTE 2: the times listed here are literal i.e. a 5 minutes wash means 5 minutes 
from the time the solution goes into the tube to the time it is taken out. 
Day 1: antibody-bead coupling. 
1. Make fresh 5mg/mL BSA (8mL per IP):  BSA fraction V in PBS, sterile filtered 
using a 0.2um syringe filter (cellulose acetate okay).  Store at 4C until day 2. 
2. Add resuspended (vortexed) magnetic bead slurry to 1.5mL protein low-bind 
tube.  See “technique considerations” for bead amount. 
3. Wash 3x for 5-10 minutes in 0.9mL 5mg/mL BSA  
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4. Resuspend in 1mL BSA and add antibody.  See “technique considerations” for 
antibody amount. 
5. Incubate 20-24 hours on rotator at 4C (until Day 2, step 5)1 
Day 2: sonication and antibody-chromatin binding 
 ** KF note: Sonication is a very important step in the success of a ChIP, but it 
varies widely from sonicator to sonicator.  This and most current protocols call for the 
majority of the (ChIPpable) DNA to be sheared to an average length of 200bp.  Treat this 
as a “black box” step at your own risk.  My best suggestion is to verify your sonication 
results each time you sonicate by reverse-crosslinking the chromatin and assaying the 
DNA distribution on a gel. ** 
1. Resuspend nuclear lysates in 0.5 – 2 mL RIPA+PIC with 5e7 nuclei per tube 
(more chromatin per volume  more viscosity.  You will need to tune this for your 
sonicator.).  Keep the chromatin at 4C for the duration of the sonication. 
2. Sonicate: 
 Misonix 3000 protocol: Sonicate on cold EtOH (-20C).  Mix the EtOH with a stir 
bar during the sonication.  Throw out any samples that foam. 
a. Unscrew the tip (we use 1/16” tapered microtips) and determine how it 
looks.  A very slight ‘crater’ on the tip is okay.  If it has a large hole or multiple holes, it 
will probably be inefficient.  Switch it out for a new one or use extra cycles. 
b. Wipe the probe tip with ddH2O, then 75% EtOH 
c. Place the tip of the ~4-6cm from the bottom of the tube, near the 300uL 
mark.  Don’t let the probe touch the sides of the tube.2 
                                                 
1 I have let this incubation go up to 48h without having the ChIP fail.  However, I do not know if it is 
better, worse, or the same. 
2 For tubes with 1mL volume, it appears best for the probe tip to be higher.  However, I have not done a 
side-by-side comparison of sonication efficiency vs. probe placement. 
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d. Sonicate 25 cycles: 30 seconds on with 60 seconds rest in between 
cycles at setting 3.5.  The power output should read 9-12 W.  To be sure to avoid 
foaming, use setting 3.0 (6-9 W) for the first 5 cycles. 
Biorupter protocol:  Divide each tube of chromatin up into 3-4 TPX (hard plastic) tubes of 
200-300 uL.  Put them in the machine and fill the extra slots with tubes of water so the 
efficiency will be the same for all experiments.  Make sure the water is exactly at the 
level marked on the side of the bath.  Cycles are 30sec on, 60sec off on ‘high’ with the 
chiller running.  If the chiller isn’t working, add ice every 5-10 cycles and remove the 
extra water (though we think this massively decreases efficiency and will need ~125 
cycles).   
3. The volume of sonicate that needs to be added to each tube of ChIP reaction 
(i.e. to the tubes of rinsed, antibody-coated beads) is 1mL at a concentration of 2.5 * 
10^7 nuclei’s equivalents of sonicated chromatin.  Use RIPA to adjust your concentration 
and volume accordingly. 
4. Centrifuge the sonicates at 14K RPM for 15 minutes at 4C. 
5. Meanwhile: wash beads 3x for 5-10 minutes in 5mg/mL BSA.  After the last 
wash, resuspend beads in 100uL BSA. 
6.  Remove 5%-10% of supernatant for “input DNA” controls for QPCR and 
ChIPseq.  Keep these at the same temperature as the ChIPs for the duration of the 
protocol and reverse crosslink them at the same time as your ChIP.  
7. Add the supernatant from a centrifuged tube of sonicate to the 100uL suspension 
of beads.   
 For clarity, one “ChIP reaction” is the sonicate from 2.5 * 10^7 nuclei plus one 
tube of antibody-coated beads from Day 1. 
8. Incubate the ChIP reactions 20-24h on rotator at 4C. 
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Day 3: reversal of crosslinks 
 Make sure the water bath is set to 65C and has plenty of water in it. 
1. Wash 5x with LiCl wash buffer: 1.2mL volume, 10-15 minute washes on rotator 
at 4C.   
2. Rinse pellet 1x with 1mL TE 
3. Resuspend in 200uL IP Elution Buffer at room temperature (this solution 
precipitates at 4C) 
4. Incubate IP’s and input DNA at 65C for 1 hour, shaking every 15 minutes to 
resuspend beads – or put them on the shaking heating block.  This dissociates the 
antibodies from the beads.   
5. Spin at 14K RPM for 3 minutes to pellet beads, then remove and save the 
supernatant.  Put the supernatant in DNA low-bind tubes. 
6. Add 2ug 50mg/ml proteinase K to the samples.  
7. To the input DNA, add the equivalent volume of IP elution buffer to put it in as 
similar a solution to the ChIPs as possible.  
8. Incubate IP’s and input DNA at 65C 8-12 hours to reverse formaldehyde cross-
links. 
Day 4: Cleanup 
 The columns and reagents used are from the Qiagen Qiaquick PCR cleanup kit 
unless otherwise noted. 
Prep: warm an aliquot of {110 x your sample number}uL EB to 55C.   
 This temperature is necessary in step 6 to avoid losing small pieces of DNA in 
the range that ChIP protocols traditionally require. 
1. Optional:  Add 150 uL of nuclease-free water to the IP’s.  Extract IP’s, depleted 
DNA, and input DNA with an equal volume of phenol/chloroform/isoamyl alcohol 
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(25:24:1) by vortexing 20 seconds, then spinning 3 min at 14K RPM.  Remove and save 
the aqueous (top) phase.  For IP’s, withdraw about 325 uL.s 
2. Add 3X the volume of Qiagen buffer PM and mix.  To avoid losing long pieces of 
DNA, bring pH of this solution to 7.   
 This is necessary because the elution buffer the samples are in is basic, ~pH 10.  
The kit explains the pH issue and has instructions.  Don’t add indicator dye to the ChIP 
samples; rather, use a side sample of input or depleted DNA, or even elution buffer plus 
RIPA in the same ratio the ChIPs/input DNA are in, to figure out how much acid to use to 
bring the pH down. 
3. Add the sample to a spin column, let sit 2 minutes, then spin 2 min at 14K RPM..  
If you have more than a 750 uL volume, add half the sample, spin, dump the liquid, then 
repeat with the other half of the sample.  This binds the DNA to the column. 
4. Dump the liquid, then wash the DNA with 750 uL Buffer PE (make sure EtOH has 
been added to it).  Pipette on the buffer, let stand 2 minutes, then spin 2 minutes at 14K 
RPM. 
5. Dump the liquid, then spin 2 minutes at 14K RPM to dry. 
6. Pipette 100 uL 55C buffer EB directly onto the column membrane.  Let stand 2 
minutes, then spin 2 minutes at 14K RPM into DNA low-bind tubes. 
7. Optional:3 re-elute by pipetting the eluate back onto the column membrane and 
spinning again. 
8. Save eluate as your ChIP, input DNA, or depleted DNA.  Store at 4C.4 
                                                 
3 Some think this gives a higher yield.   
4 ChIPs should be stable at 4C for a month or so in TE buffer and DNA low-bind tubes.  For long-term 
storage, -80C is best, though you must avoid repeated freeze-thaws. 
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SOLUTIONS 
RIPA buffer (store at 4C) 
 1x PBS 
 1% NP-40 
 0.5% sodium deoxycholate 
 0.1% SDS -- but better to increase this to 1% SDS for the sonication only 
 add Roche complete EDTA-free protease inhibitor cocktail right before using. 
 
LiCl IP wash buffer (store at 4C) 
 100mM Tris 
500mM LiCl 
 1% NP-40 
 1% sodium deoxycholate 
 
IP elution buffer (store at room temp) 
 1% SDS 
 0.1 M NaHCO3 
 
KF note: Technique considerations  
1. Do not assume your magnet will instantly clear a sample.  The commercial ChIP 
magnet I use requires up to 5 minutes to fully clear a sample.  Test this with your in-
house magnets. 
2. Use aerosol-barrier tips and sterile solutions. 
3. Don’t cut the wash times short.  In general, if you cannot stick to a listed wash 
time, longer wash times are better (with the possible exception of the LiCl wash, which I 
have not varied).  Much longer washes don’t improve results, but they don’t appear to 
hurt them either. 
KF note: Optimization considerations 
1. Antibody/bead ratio is a major factor to consider in optimizing ChIP results.  In 
general, 5ug of monoclonal antibodies + 100uL of beads or 10ug of polyclonal 
antibodies + 200uL of beads works well. 
2. Chromatin amount is another major factor to consider.  TF’s with few binding 
sites may require different amounts of chromatin as broad-scale chromatin marks.  
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Ubiquitous TF’s and factors such as RNA polymerase II are somewhere in the middle.  
As a rule of thumb, 2.5*10^7 nuclei per ChIP works well.   
3. Sonication: what you are aiming for, especially if you want to sequence your 
sample on an Illumina sequencer, is having the majority of your sample between 100 
and 250bp.  Note that the misonix tip looses efficiency after about 10h of sonication, and 
I imagine other sonicators have similar problems.  Again: treat the sonication step as a 
“black box” at your own risk.   
SIII.5: ChIP protocol for successful ChIA-PET experiments 
Katherine Fisher-Aylor 
Wold lab at Caltech 
Written 7/1/2010 
Last updated 9/3/2013 
 
ChIP fixation (adherent cells) 
WARNING: keep the plates in a fume hood even when you are scraping them.  The 
fumes from the EGS-fixed cells are very dangerous and DO NOT disappear after rinsing 
plates the way formaldehyde fumes do.  I learned this the hard way. 
1. Rinse plates 2x with PBS (I don’t know if it matters, but the PBS we use has no 
Ca2+ or Mg2+). 
2. Dissolve EGS (Pierce) at 10mM in 50% glacial acetic acid/50% ddH2O.  Do this 
soon before you are ready to use it because EGS hydrolyzes very quickly in solution.5 
3. Dilute the 10mM EGS to 1.5mM in PBS.   
4. Add the 1.5mM EGS to the cells for 30 minutes at room temperature on a rotator. 
5. Add formaldehyde6 to the EGS solution to a final concentration of 1%.  Incubate 
15 minutes at room temperature on a rotator. 
                                                 
5 Changing the brand and solvent of the EGS causes the chromatin to appear very different.  I am currently 
investigating different combinations.  With this fixative, the chromatin will appear white and fluffy but 
dense and difficult to resuspend.  During sonication, it will leave a very large pellet (I suspect this is 
cellular debris that has been crosslinked by the EGS) and will be milky white in solution. 
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6. Quench by adding glycine to a final concentration of 0.2M and incubate 10 min 
on rotator at room temp.  The glycine stock I use is simply dissolved in water at 2.5M 
and is not buffered. 
7. Rinse 2x with cold PBS 
8. Add 2mL PBS + 0.4mL 0.05% trypsin/EDTA (Gibco) to each dish and incubate 
10 minutes at 37C  
9. Add 100uL equine or fetal bovine serum to each dish and tilt to inactivate trypsin. 
10. Scrape cells into 15mL tube and put on ice.  Keep plates at 4C until scraped. 
11. Spin at 360 rcf, 4C for 5 minutes 
12. Remove supernatant and resuspend cell pellet in 5mL PBS + 1mM PMSF  
13.  Spin at 360 rcf, 4C for 5 minutes.  Remove supernatant. 
14. Resuspend cell pellet in 3mL MC lysis buffer. 
15. Spin at 360 rcf, 4C for 5 minutes.  Remove supernatant. 
16. Repeat steps 15 and 16. 
17. Put the nuclear pellet at -80C to freeze. 
MC lysis buffer 
 10mM Tris pH 7.5 
 10mM NaCl 
 3mM MgCl2 
 0.5% NP-40 
 add Roche complete EDTA-free protease inhibitor cocktail before using. 
 
PMSF: stock solution is 100mM in 100% EtOH.  Store at -20C.   
ChIP Day 1: antibody-bead coupling 
 
1. Make fresh 5mg/mL BSA (8mL per IP):  BSA fraction V in PBS, sterile filtered 
using a 0.2um syringe filter (cellulose acetate is okay).  This can be stored at 4C until 
day 2. 
                                                                                                                                                 
6  Our stock formaldehyde is 37% containing 10% MeOH from Mallinckrodt Chemicals 
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2. Add 100uL resuspended (vortexed) magnetic bead slurry (Dynal M280 sheep 
anti-mouse beads) to 1.5mL protein low-bind Eppendorf tube. 
3. Wash 3x for 5-10 minutes in 0.9mL 5mg/mL BSA at 4C on a rotator. 
4. Resuspend in 1mL 5mg/mL BSA and add 5ug mouse monoclonal polII CTD4H8 
antibody (Millipore). 
5. Incubate 48 hours on rotator at 4C (until Day 2, step 5) 
 Our standard ChIP incubation time is 20-24h.  I do not know if 48h is 
better; I do it for consistency only because this is how my first successful ChIA-
PET was made (it took a long time to sonicate the chromatin properly). 
Day 2: sonication and antibody-chromatin binding 
1. Resuspend nuclear lysates in 1mL RIPA, with ~1x10^8 nuclei per tube.  
2. Sonicate to a length of 300-500bp.  I have not yet been able to sonicate EGS-
fixed chromatin successfully in the biorupter, so I am using a Misonix 3000 biorupter.   I 
use 25 cycles (30sec on, 60sec) off at 15W**. 
 ** The devil is in the details of this step.  In order to get the proper fragment 
length, I under-sonicate, reverse-crosslink a sub-sample, run it out on a gel, and then 
repeat until I get the proper fragment distribution.  The attached picture is the gel for my 
first successful ChIA-PET sample compared to one of my successful conventional ChIP 
samples. 
 
268 
 
 
 
3. Centrifuge at 14K RPM for 15 minutes at 4C. 
4. Remove 100uL of supernatant for “input DNA” controls for QPCR and ChIPseq.  
Keep these at the same temperature as the ChIPs for the duration of the protocol. 
5. Meanwhile: wash beads 3x for 5-10 minutes in 5mg/mL BSA.  After the last 
wash, resuspend the beads in 100uL BSA. 
6. Add 1 tube of sonicated chromatin each tube of beads (1mL of chromatin 
originally from 1x10^8 cells per 100uL of beads.  Note, though, that the yield of DNA 
from sonicated EGS-fixed chromatin appears to be half of that from FA-fixed chromatin).   
7. Incubated 28h on rotator at 4C  
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Our standard incubation time is 20-24h.  This again is for consistency’s sake; I do 
not know if it is a meaningful difference. 
Day 3: wash 
1. Wash 5x with LiCl wash buffer: 1.2mL volume, 10-15 minute washes on rotator 
at 4C 
2. Rinse pellet 1x with 1mL TE 
3. Resuspend in 1mL TE 
 At this point, I removed 10% of each sample to assay the effectiveness of each 
tube.  I then resuspended each of the 5 best IP’s in 200uL TE and combined them into 
one tube.  Each of the samples sent therefore consisted of chromatin from 2.5x10^8 - 
5x10^8 myotube cells or 2x10^8 – 4x10^8 myoblast cells 
 on 500uL beads.  These samples were topped off with TE and wrapped up to send to 
Singapore with 4C cold packs.  The libraries were built in Singapore within 45 days and 
were stored in the dark at 4C until building. 
The following is for the ChIA-PET controls 
Day 3: reversal of crosslinks  
4. Resuspend in 200uL IP Elution Buffer at room temperature (this solution 
precipitates at 4C) 
5. Incubate IP’s and input DNA at 65C for 1 hour, shaking every 15 minutes to 
resuspend beads.   
6. Spin at 14K RPM for 3 minutes to pellet beads, then remove and save the 
supernatant in DNA low-bind Eppendorf tubes. 
7. Added 2ug 50mg/ml proteinase K to the IP’s and 5ug to the input DNA samples. 
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8. Incubate IP’s, depleted DNA, and input DNA at 65C 8-12 hours to reverse cross-
links.  
 Full disclosure: I suspect the EGS crosslinks are not sufficiently reversed in this 
method.  This does not affect the ChIA-PET since the crosslinks are far from the ligated 
ends of DNA that are selected, but it does affect making a good EGS-crosslinked ChIP-
Seq control.  KFA is working on this. 
Day 4: Cleanup 
 Warm the EB at 55C 
The columns and reagents used are from the Qiagen Qiaquick PCR cleanup kit  
1. Add 3X the volume of Qiagen buffer PM and mix. 
2. Add the sample to a spin column, let sit 2 minutes, then spin 2 min at 14K RPM..   
3. Remove the liquid, then add 750uL buffer PE, let stand 2 minutes, then spin 2 
minutes at 14K RPM. 
4. Remove the liquid, then spin 2 minutes at 14K RPM to dry. 
5. Pipette 100 uL 55C buffer EB directly onto the column membrane.  Let stand 2 
minutes, then spin 2 minutes at 14K RPM into DNA low-bind Eppendorf tubes. 
6. Save eluate as your ChIP or input DNA.  Store at 4C for a few months or -20C 
long-term. 
 My successful ChIA-PETs have all come from ChIPs that have at least 0.07ug of 
DNA per tube, assayed after the above crosslink reversal and purification.   
RIPA buffer 
 1x PBS 
 1% NP-40 
 0.5% sodium deoxycholate 
 0.1% SDS 
 add Roche complete EDTA-free protease inhibitor cocktail right before using. 
 
 
LiCl IP wash buffer 
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 100mM Tris 
500mM LiCl 
 1% NP-40 
 1% sodium deoxycholate 
 
IP elution buffer 
 1% SDS 
 0.1 M NaHCO3 
 
SIII.6: Analysis of DNA sonication/fragmentation results 
Katherine Fisher-Aylor 
Last updated 11/6/13 
 
Summary: purify your DNA and then run 1ug on a 2% agarose gel at low voltage. 
1. Reverse-crosslink your sheared chromatin.   
a. To a small sub-sample of chromatin (usually ~5uL of sonicate) add 5uL of 
50mg/mL proteinase K plus 1x volume IP elution buffer 
b. Incubate at 65C for 8-12 hours (2 hours is a bit short and will give a lower 
yield of DNA and a slightly different looking gel). 
2. Purify your DNA.  Also a few ways to do this. 
a. Column purification.  WARNING: some columns impose a size 
selection.  This is highly undesirable for us, since we want to know exactly what our 
fragmented distribution looks like.  For the Qiagen columns I list here, I have not noticed 
any such size selection in the past.  But be warned and I’d try one of the below methods 
from time to time to make sure the columns aren’t changing!  If you are using a different 
kit, don’t take the manufacturer’s word for it – try it yourself using a column vs. one of the 
non-column methods below.  Also note that these columns give you approximately a 
25% yield compared to a standard P:C:IAA extraction plus EtOH precipitation. 
i. The kit is the Qiagen min-elute PCR cleanup kit 
ii. Warm elution buffer to 50C (or you will lose small fragments) 
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iii. Add 3x volume of buffer PM.  Ensure the pH is low enough 
according to kit directions or you will lose long fragments; remember the IP elution buffer 
is basic. 
iv. Add the above mixture to a column, and let stand 1 minute. Spin 1 
minute at maximum speed in a microfuge and discard the eluate.  If the starting volume 
is greater than 750uL, you will need to do this in two batches. 
v. To the columns, add 750uL of buffer PE (make sure ethanol has 
been added).  Let stand 1 minute then spin 1 minute at max speed and discard eluate. 
vi. Spin again to completely dry the columns.  Discard the round-
bottom tubes and switch the purple columns to fresh eppendorf tubes. 
vii. Pipette 100uL of warmed elution buffer onto the column 
membranes and let stand 1-2 minutes.  Spin 2 minutes at maximum speed into the clean 
eppendorf tubes.  Store at 4C short term, -80C long-term (but avoid repeated freeze-
thaws). 
b. Ethanol precipitation (Molecular Cloning method).   Note that the phenol 
extraction also decreases your yield and that phenol contamination can confuse nano-
Drop readings and overestimate the amount of DNA you have (its wavelength is 270 
compared to DNA at 260, so pay attention to the wavelength curve on the nano-
Drop….or use the Qubit). 
i. Add an equal volume of phenol/chloroform/isoamyl alcohol 
25:24:1.  Vortex to mix, then spin 5 minutes at maximum speed.  Keep the upper 
(aqueous) later by carefully pipetting it into a clean eppendorf tube.  Alternatively, you 
can extract using phenol/chloroform 1:1 (vortex, spin, remove upper layer) and then 
chloroform/isoamyl alcohol 24:1 (vortex, spin, remove upper layer).  This might decrease 
phenol contamination. 
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ii. Add NaCl to 0.2M.  The reason for using this salt as opposed to 
LiCl or NaOAc is the SDS in the IP elution buffer. 
iii. Add 2 volumes cold 100% EtOH and mix. 
iv. Put at -80C for 20 minutes 
v. Spin 20 minutes at maximum speed, 4C.  Keep track of how your 
tube is oriented in the centrifuge so you know where the pellet will be (in case it is small 
enough to be invisible). 
vi. Pipette off the supernatant and discard.  Add 200uL 70% EtOH 
and mix to rinse the pellet. 
vii. Spin 5 minutes at max speed, 4C.  Pipette off the supernatant. 
viii. Repeat steps vi and vii. 
ix. Bench-dry (takes approximately 30 minutes) or dry in the speed-
vac.   
x. Resuspend in 100uL TE. 
c. Singapore/’blue paint’ precipitation method 
i. Follow step b.i above. 
ii. Add 10% volume of 3M NaOAc, pH 5.2, 0.4% volume of 15mg/mL 
GlycoBlue (Ambion), and 1x volume of Isopropyl alcohol 
iii. Follow steps b.iii-b.x. 
3. Pour a 2% agarose gel (because we are targeting the 50-500bp length).   
a. In a glass Erlenmeyer flask: 50mL 1x TAE + 1g agarose  
b. Heat in microwave 1:10, then swirl to dissolve/mix. 
c. Once cooled enough to handle, add 4uL 5mg/mL EtBr. 
d. Pour into a small casting tray and add the comb with 6 or 10 teeth and let 
set for 20 minutes. 
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4. Mix the samples to be run on the gel.  
a. 1ug of DNA 
b. Bring up to 20uL with water 
c. 4uL 6x gel loading buffer – no dye!  The dye will obscure the smooth 
‘smear’ in the gel and your pictures will be misleading.  If you are having a hard time 
loading the gel without dye, add just a tiny amount of buffer+dye to your solutions by 
dipping the tip of a pipette into it and swirling it in your sample.. 
5. Make your ladder DNA.  You must have a ladder that resolves the 100-500bp 
range (such as the 100bp ladder from New England Biolabs).  Ideally, you should also 
include a larger ladder that will tell you how big your biggest fragments are (I use Roche 
Marker VII, which goes up to 8.5kb).   
a. 1ug ladder DNA 
b. bring up to 20uL with water 
c. 4uL 6x gel loading buffer + dye.  
d. It is okay to make this in advance and store it at 4C.  However, make sure 
to dilute the DNA in TE not water! 
6. Orient the gel properly in the gel box (DNA runs towards the positive electrode, 
which is red in US apparati).  Cover in 1x TAE containing 8uL EtBr/100mL.  This saves 
you from having to stain/destain later and having the smaller sizes diffuse or from the 
EtBr out-migrating the DNA.  Don’t use TAE that has been used more than twice or that 
has evaporated because your gel will melt. 
7. Load the 24uL samples onto the gel. 
8. Run at a low voltage such as 140 to give the different lengths of DNA time to 
migrate past each other properly.  Run until the lower DNA dye band is ~1.5 inches from 
the bottom of the gel (approximately 45 minutes at 140). 
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9. Visualize on a UV light box.  For pictures, the exposure time will usually be 
between 1/4 and 1/8 second. 
10. Discard the TAE and gel in an EtBr disposal container. 
SOLUTIONS 
IP elution buffer 
1. 1% SDS 
2. 0.1 M NaHCO3 
 
50x TAE 
1. 242g Tris base 
2. 57.1 mL glacial acetic acid 
3. 100mL 0.5 M EDTA (pH 8.0) 
4. Bring up to 1L with ddH2O 
5. Dilute to 1x with ddH2O when using. 
 
6x gel loading buffer: 
1. 15% Ficoll in water.  Store at room temperature. 
6x gel loading buffer plus dye: 
2. 0.25% bromophenol blue (lower ~300bp band.  You especially don’t want this 
one obscuring your fragmented samples) 
3. 0.025% xylene cyanol FF (upper ~4kb band) 
 
What to expect from a “good” sonication 
 This varies depending on the application.  I’ve attached a gel of what in my 
experience makes a good ChIP-Seq library and a good ChIA-PET library, respectively.  
If you are trying to duplicate someone else’s results, ask them for one of their sonication 
gels (hoping they HAVE one) and don’t take their word for what the DNA was sheared to 
as an “average length”.  Also please note that the size distribution matters (another 
reason to ignore the reported “average length”): the amount of long chromatin leftover 
after sonication might be good or bad for different applications.  We have some 
evidence, anecdotal and experimental, that suggests that having long chromatin left 
behind is GOOD for the activator ChIP-Seq’s we’ve done.   
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SIII.7: QPCR assay 
 
 
SIII.8: ChIA-PET library building protocol 
 
Protocol from Yijun Ruan @ Genome Institute of Singapore in early 2010 
DNA Blunting with T4 DNA Polymerase 
1. Resuspend the beads by pipetting up and down. Pellet the beads by 
centrifugation at 800 rpm, 4 oC, for 5 min and discard the supernatant. 
2. Split the beads into 2 tubes such that the final volume of 100% beads is < 150 l. 
 To each tube, add the following: 
10Buffer for T4 DNA Polymerase (Promega)                50 l 
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  10mM dNTPs                                                        5 l 
  T4 DNA Polymerase (Promega, 7.9 u/l)                        6.3 l  
  (The concentration of T4 DNA polymerase is 0.1 u/l) 
  H2O                                                                   438.7 l 
                                                                                       500 l 
 
3. Resuspend the beads using the above reaction mix. Incubate the beads at 37oC 
with rotation on the Intelli-Mixer (Skyline, Program F8, 30 rpm) for 15 min. 
4. Wash the beads with 1 ml Wash Buffer (10 mM Tris-Cl, pH 7.5; 1 mM EDTA; 500 
mM NaCl) 3 times. Mix well by inverting tubes. Pellet the beads by centrifugation at 800 
rpm, 4oC, for 5 min after every wash. 
Adding hM&M linker (Biotin) to the crosslinked ChIP DNA  
5. Prepare the reaction mix as follows: Mix water with the linkers well first, then mix 
in the PEG buffer well before adding ligase.  
  Biotinylated linkers (200 ng/l; IDT)                              10 l 
  5T4 DNA Ligase Buffer with PEG (Invitrogen)         200 l 
  T4 DNA Ligase (30 u/l, Fermentas)                      4 l (at ≥0.1 u/l) 
  H2O                                                                                  786 l 
                                                                                                         1,000 l 
  
6. Resuspend the beads with above reaction mix. Mix well. Incubate at 16oC with 
rotation on the Intelli-Mixer (Program F8, 30 rpm) for 16 hours.  
Remove the excess linkers 
7. The beads are then washed 3 times as above to remove the excess linkers.  
Add Phosphate group to 5’ ends  
8. Prepare the reaction mix as follows:                   
10T4 DNA Ligase Buffer (NEB)                                    100 l 
  T4 DNA Polynucleotide Kinase (10u/ul, NEB)                20 l (at ~0.2 u/l) 
  H2O                                                                                 880 l 
 
                        1,000 l 
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9. Resuspend the beads with the above reaction mix. Incubate at 37oC with rotation 
on the Intelli-Mixer (Program F8, 30 rpm) for 30 min. 
Circularization  
10. Add 6 l of T4 DNA Ligase (30 u/l, Fermentas) into the above reaction. Mix 
immediately. Incubate at 22°C with rotation on the Intelli-Mixer (Program F8, 30 rpm) for 
24 hours. 
Elution and reverse crosslinking 
11. Separate the material into 575 l aliquots. To each aliquot, add 150 l of ChIP 
Elution Buffer [final concentration of 1% SDS (Bio-rad), 0.1 M NaHCO3 (Sigma)] and 5 
l of Proteinase K (20 mg/ml, Ambion). Incubate the mixture at 65°C overnight.  
DNA purification  
12. The beads are pelleted and the supernatant is split into tubes of 500 l. Do 
phenol/chloroform (Ambion) extraction with 500 l phenol/chloroform using Phase-lock 
gel (Eppendorf) and isopropanol precipitation:  
  DNA (after phenol extraction)                    ~500 l 
  3M NaOAc, pH5.2 (Ambion)                                            50 l 
  GlycoBlue (Ambion;15 mg/ml)                                     2 l 
  Isopropanol (Sigma)                  500 l 
  
13. Incubate the above at -80oC for 30 min; pellet DNA by centrifugation at maximum 
speed, 4oC  for 30 min. Wash the DNA pellet with 750 l 70% ethanol twice and 
resuspend DNA in 20 l of EB buffer (Qiagen). 
Nick repair  
  DNA                                                                               20 l 
  10E. coli DNA Ligation Buffer (NEB)                            5 l 
  10 mM dNTPs (Eppendorf)                                             1 l 
  E. coli DNA Ligase (10 u/l, NEB)                                  1 l 
  E. coli DNA Polymerase I (10 u/l, NEB)                       4 l 
  H2O                                                                               19 l 
                                                                                        50 l     
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Incubate at 16 oC for 16 hours. 
14. DNA is adjusted to 200 l with water and purified with 200 l of 
phenol/chloroform using Phase-lock gel. The DNA is then ethanol precipitated as 
follows: 
DNA (after phenol extraction)              ~200 l 
  3 M NaOAc, pH5.2 (Ambion)                                 20 l 
  Ethanol (Merck)           600 l 
 
15. Incubate the above at -80 oC for 30 min; pellet DNA by centrifugation at 
maximum speed, 4oC for 30 min. Wash the DNA pellet with 750 l 70% ethanol twice 
and resuspend DNA in 20 l of EB buffer. 
16. Mme I digestion to release PETs 
 
 DNA                                                                                              10 l 
 10NEBuffer 4 (NEB)                                                             4 l 
 10SAM (freshly prepared; NEB)                                          4 l 
 Mme I (2 u/l, NEB)                                                                  1 l 
 Unbiotinylated linker (200 ng/l, to quench the excess MmeI; IDT)     4 l 
 H2O                                                                                            17 l 
                                                                                                               40 l 
 Incubate at 37 oC for 2 hours.  
 
Prepare the Dynabeads  
17. Mix Dynabeads (Invitrogen) well and transfer 50 l of resuspended Dynabeads to 
a 1.5 ml tube. Stand for 1 min in the Magnetic Particle Collector (MPC; Dynal/Invitrogen). 
Remove the supernatant. Wash the beads twice with 100 l of 2B&W Buffer (final 
concentration: 10 mM Tris-HCl pH7.5 (Ambion), 1m M EDTA (Ambion), 2 M NaCl (1st 
Base)). Each time a wash is done, the following processes should be performed: mix, 
short spin, stand for 1 min, remove supernatant. When washing, do not let the 
dynabeads dry out. After removing supernatant from beads, immediately add another 
batch of supernatant. Do not spin the dynabeads at more than 800 rpm. Resuspend 
beads in 40 l of 2B&W Buffer. 
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Immobilization of the iPETs 
18. Add 40 l digestion mix (from Step 16) to the resuspended beads and mix well. 
Incubate at 22°C with rotation on the Intelli-Mixer (Program F8, 30 rpm) for 30 min. With 
the help of the MPC, wash the beads twice with 100 l of 1B&W Buffer (final 
concentration: 5 mM Tris-HCl pH7.5 (Ambion), 0.5mM EDTA (Ambion), 1M NaCl (1st 
Base)).  
Ligation of modified 454 NN-adapters to the immobilized iPETs 
  
19. Prepare the ligation mix: 
 
  Adapter A (200 ng/l, IDT)                                               8 l 
  Adapter B (200 ng/l, IDT)                                          8 l           
  10T4 DNA Ligase Buffer (Fermentas)                 5 l  
  T4 DNA Ligase (30 u/l, Fermentas)                           1 l 
  H2O                                                                            28 l 
  
                                                                                                          50 l 
 
20. Resuspend the beads with the above ligation mix. Incubate at 22°C with rotation 
on the Intelli-Mixer (Program F8, 30rpm) for 16 hours.  
Nick translation  
21. Wash the beads twice with 100ul of 1B&W Buffer with the help of the MPC. 
22. Prepare the nick translation reaction mix: 
            10NEBuffer 2 (NEB)                                 5 l 
            10 mM dNTPs (Eppendorf)                     2.5 l (500 uM final conc.) 
  E. coli DNA Polymerase I (10 u/l, NEB)    4 l             
  H2O                                                     38.5 l 
                                                                                               50 l 
 
23. Resuspend the beads with the above reaction mix. Incubate at 22°C with rotation 
on the Intelli-Mixer (Program F8, 30rpm) for 1h. 
Trial/QC PCR 
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24. Wash the beads twice with 100 l of 1B&W Buffer with the help of the MPC. 
Resuspend the beads in 50 l of EB buffer. Transfer the mixture to a fresh 1.5 ml tube. 
 
25. For each PCR reaction, in a 0.2 ml PCR tube, add and mix well: 
  Beads suspension           2 l 
  Primer A (100 M, IDT)          0.25 l 
  Primer B-Biotin (100 M, IDT)         0.25 l 
  HotStarTaq Master Mix (Qiagen)         25 l 
  H2O             22 l 
 
                                50 l 
 
The cycle conditions are: 
 
  95 oC, 15 min 
  94 oC, 30 sec 
  55 oC, 1 min          20 cycles 
  72 oC, 1 min 
  72 oC, 10 min 
 
26. Remove the Dynabeads with the help of the MPC. Add 10 l of 6x loading dye 
(Fermentas) to the 50 l reaction and run all in one lane of a 5-well 6% TBE PAGE gel 
(Invitrogen). Run at 200V for 30 min. Stain with SYBR Green I (Invitrogen) for 15 min to 
visualize products. View using the Blue-light Darkreader (Clare Chemical).  
Large scale PCR and PCR product purification 
27. Estimate number of PCR reactions required based on the results from the trial 
PCR. Scale up accordingly. Pool the PCR products. Remove the Dynabeads with the 
help of MPC. Purify DNA by isopropanol precipitation with GlycoBlue as described 
earlier. Resuspend the DNA pellet in 40 l TE buffer (Qiagen). Add 8 l of 6x Loading 
Dye.   
28. Run all on two lanes of the 6% TBE PAGE gel (Invitrogen, 5-wells), 200V, for 30 
min together with 1g of 25 bp DNA Ladder (Invitrogen) and 4 l of Low DNA Mass 
283 
 
Ladder (Invitrogen). Stain with SYBR Green I for 15 min to visualize products. View 
using the Blue-light Darkreader.  
29. The product is expected to be 164-174 bp in length, so a fairly broad smear 
should be seen. Excise the DNA bands of correct size.  
DNA purification using the gel-crush method 
30. DNA of interest is excised and collected into 0.6 ml micro tubes that have been 
pierced at the bottom with a 21G needle (Becton-Dickinson). The pierced tube is placed 
inside a 1.5 ml screw-cap micro tube, and centrifuged at 13K rpm, 4 oC for 5 min. The 
gel slices are thus conveniently shredded and collected in the bottom of each 1.5ml 
tube.  
31. Add 200 l of TE buffer to each 1.5 ml screw-cap micro tube and stir the gel 
pieces with the pipette tip. Make sure the gel pieces are immersed with the buffer. 
32. The 1.5 ml screw-cap micro tubes containing shredded gel are frozen at -80 oC 
for 1-2 h, and then transferred directly to 37oC incubation. The shredded gel is thus 
macerated at 37oC for 16 h. 
33. The gel pieces together with the buffer in each 1.5 ml tube are transferred to the 
filter cup of a SpinX microspin filter unit (Corning) and are centrifuged at 13,000 rpm, 4oC 
for 10 min. At the same time, rinse the 1.5ml tubes, which have been used to macerate 
the shredded gel, with 200 l TE buffer (Qiagen) and collect the liquid by brief spin. 
34. When the above centrifugation finishes, add each of 200 l rinsing buffer to the 
filter cup of each filter unit. Stir to loose the gel pie with a pipette tip. Centrifuge again at 
13,000 rpm, 4oC for 20 min. 
35. Pool the filter-through. Perform isopropanol precipitation. Resuspend the DNA in 
20 l of TE buffer.  
 
284 
 
 
 
Gel picture of the MmeI-cut ChIA-PETs.  
 
36.  Quality Control: Analyze the DNA using a DNA1000 Labchip (Agilent) using 1 l 
of sample to determine the quality and quantity of the recovered DNA. 
 
Agilent Bioanalyzer picture of the MmeI-cut ChIA-PETs.  
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ChIA-PET DNA sequencing analysis 
37. At this point, the purified ChIA-PET templates are ready for multiplex sequencing 
analysis by GS20 or GSFLX. The sequencing was done following the manufacturer’s 
protocol conditions. 
 
 
